0001493152-16-012406.txt : 20160815 0001493152-16-012406.hdr.sgml : 20160815 20160815150958 ACCESSION NUMBER: 0001493152-16-012406 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160815 DATE AS OF CHANGE: 20160815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRASCIENCE INC CENTRAL INDEX KEY: 0000727672 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411448837 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13092 FILM NUMBER: 161832115 BUSINESS ADDRESS: STREET 1: 11568 SORRENTO VALLEY ROAD STREET 2: SUITE 11 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 847-0200 MAIL ADDRESS: STREET 1: 11568 SORRENTO VALLEY ROAD STREET 2: SUITE 11 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC /MN DATE OF NAME CHANGE: 19931119 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC DATE OF NAME CHANGE: 19920703 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2016

 

Commission file number 0-13092

 

SPECTRASCIENCE, INC.

(Exact name of registrant

as specified in its charter)

 

Minnesota   41-1448837

(State or other jurisdiction

of incorporation or organization)

  (I.R.S. Employer
Identification Number)

 

11568 Sorrento Valley Rd., Suite 11

San Diego, California 92121

(Address of principal executive offices, including zip code)

 

(858) 847-0200

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration was required to submit and post such files). YES [X] NO [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Accelerated filer [  ]
   
Non-accelerated filer [  ] Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [  ] NO [X]

 

The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding on August 15, 2016 was 715,742,635.

 

 

 

 
 

 

SPECTRASCIENCE, INC.

 

FORM 10-Q

For the Six Months Ended June 30, 2016

 

TABLE OF CONTENTS

 

PART I FINANCIAL INFORMATION:    
       
Item 1. Financial Statements (Unaudited)   3
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   20
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk   26
       
Item 4. Controls and Procedures   26
       
PART II OTHER INFORMATION    
       
Item 1. Legal Proceedings   26
       
Item 1A. Risk Factors   26
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   27
       
Item 3. Defaults Upon Senior Securities   27
       
Item 4. Mine Safety Disclosures   27
       
Item 5. Other Information   28
       
Item 6. Exhibits   28
       
SIGNATURES   28

 

2
 

 

PART I FINANCIAL INFORMATION:

 

Item 1. Financial Statements

 

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

 

   June 30, 2016   December 31, 2015 
   (Unaudited)     
ASSETS          
Current assets:          
Cash  $27,860   $127,493 
Accounts receivable, net   950    7,061 
Inventory, current portion   159,731    111,887 
Prepaid expenses and other current assets   213,232    284,305 
Total current assets   401,773    530,746 
           
Fixed assets, net   -    316 
Long-term inventory   150,000    150,000 
Patents, net   1,104,998    1,185,472 
   $1,656,771   $1,866,534 
           
LIABILITIES AND SHAREHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable  $1,114,495   $941,106 
Secured convertible note payable   500,000    - 
Note payable   137,982    137,982 
Notes payable- related parties   35,000    - 
Convertible debt, net of discounts and costs of $275,872 as of June 30, 2016 and $430,156 as of December 31, 2015   6,193,715    5,744,604 
Derivative liability   769,905    620,321 
Accrued Expenses   1,674,716    1,411,333 
Total current liabilities   10,425,813    8,855,346 
           
COMMITMENTS AND CONTINGENCIES          
           
Mezzanine equity          
Series B Convertible Preferred Stock, $.01 par value; 2,585,000 shares authorized, issued and outstanding as of June 30, 2016 and December 31, 2015; liquidation value of $517,000 plus accumulated and and unpaid dividends of $106,931 as of June 30, 2016 and December 31, 2015, respectively   25,850    25,850 
Series C Convertible Preferred Stock, $.01 par value; 500,000 shares authorized, issued and outstanding as of June 30, 2016 and December 31, 2015; liquidation value of $100,000 as of June 30, 2016 and December 31, 2015, respectively   5,000    5,000 
Total mezzanine equity   30,850    30,850 
           
Shareholders’ deficit          
Series A Convertible Preferred Stock, $.01 par value; 0 shares authorized, issued and outstanding as of June 30, 2016 and December 31, 2015   -    - 
Common stock, $.01 par value; 746,915,000 shares authorized; 673,176,881 and 431,247,207 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively   6,731,769    4,312,472 
Additional paid in capital   36,111,807    38,166,818 
Accumulated deficit   (51,643,468)   (49,498,952)
Total shareholders’ deficit   (8,799,892)   (7,019,662)
   $1,656,771   $1,866,534 

 

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

 

3
 

 

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statements of Operation

(Unaudited)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2016   2015   2016   2015 
                 
Revenue  $950   $-   $950   $- 
Cost of revenue   868    (6,000)   868    (12,000)
Gross profit   82    6,000    82    12,000 
                     
Operating expenses:                    
Research and development   194,155    157,329    388,162    332,009 
General and administrative   306,213    344,811    614,054    726,265 
Sales and marketing   101,214    94,098    180,627    133,960 
    601,582    596,238    1,182,843    1,192,234 
                     
Loss from operations   (601,500)   (590,238)   (1,182,761)   (1,180,234)
                     
Other income (expense)                    
Interest expense   (208,347)   (147,041)   (579,299)   (291,543)
Change in fair value of derivative and warrant liabilities   624,873    277,361    (262,621)   (400,223)
Amortization of derivative and warrant liabilities discount   (94,735)   (233,187)   (236,296)   (523,296)
Amortization of deferred debt issuance costs and original issue discount   (62,920)   (84,576)   (125,450)   (172,390)
Gain on extinguishment of debt   245,908    36,641    247,074    119,369 
Income on foreign exchange transactions   13,616    -    4,691    - 
Other income (expense), net   (5,077)   (2,221)   (9,854)   (4,634)
    513,318    (153,023)   (961,755)   (1,272,717)
                     
Net loss  $(88,182)  $(743,261)  $(2,144,516)  $(2,452,951)
                     
Basic and diluted loss per share  $(0.00)  $(0.00)  $(0.00)  $(0.01)
                     
Weighted average common shares outstanding:                    
Basic and diluted   668,866,352    197,124,162    640,797,803    195,747,368 

 

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

 

4
 

 

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statement of Shareholders’ Deficit

For the six months ended June 30, 2016

(unaudited)

 

           Additional       Total 
   Common Stock   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Capital   Deficit   Deficit 
                     
Balance December 31, 2015   431,247,207   $4,312,472   $38,166,818   $(49,498,952)  $(7,019,662)
                          
Conversion of convertible debt   241,929,674    2,419,297    (2,136,665)   -    282,632 
Non cash stock option expense   -    -    80,002    -    80,002 
Non cash issuance of warrant for consulting services   -    -    1,652    -    1,652 
Net loss   -    -    -    (2,144,516)   (2,144,516)
                          
Balance June 30, 2016   673,176,881   $6,731,769   $36,111,807   $(51,643,468)  $(8,799,892)

 

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

 

5
 

 

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Six Months Ended June 30, 
   2016   2015 
Operating activities:          
Net loss  $(2,144,516)  $(2,452,951)
Adjustments to reconcile net loss to cash used in operating activities:          
Amortization and depreciation   80,789    82,887 
Non-cash interest   31,364    - 
Non-cash issuance of stock options and warrants   80,003    100,369 
Non-cash expense related to commitment of common stock in excess of authorized shares   132,130    - 
Loss on issuance of variable rate notes   84,434    - 
Amortization of derivative and warrant liabilities discount   236,296    523,296 
Amortization of deferred debt issuance costs and original issue discount   125,450    172,390 
Issuance of common stock for services   700    - 
Change in fair value of derivative and warrant liabilities   262,620    400,223 
Gain on extinguishment of debt   (247,073)   (119,369)
Changes in assets and liabilities:          
Accounts receivable   6,111    - 
Inventory   (47,845)   (5,599)
Prepaid expense and other assets   71,073    40,576 
Accounts payable   173,391    108,753 
Accrued expenses   274,152    219,661 
Net cash used in operating activities   (880,921)   (929,764)
           
Investing activities:          
Purchases of fixed assets   -    - 
Net cash used in investing activities   -    - 
           
Financing activities:          
Proceeds from issuance of convertible notes payable   300,000    820,750 
Proceeds from issuance of notes payable to related parties   35,000    - 
Proceeds from issuance of secured note payable   500,000    - 
Proceeds from exercise of stock options   -    4,500 
Debt issuance costs   (53,712)   (76,780)
Net cash provided by financing activities   781,288    748,470 
           
Net decrease in cash   (99,633)   (181,294)
           
Cash, beginning of year   127,493    223,529 
           
Cash, end of period  $27,860   $42,235 
           
Supplemental Disclosure of Cash Flow Information:          
Cash paid during the period for:          
Interest  $-   $- 
Income taxes  $-   $- 
Non Cash Investing and Financing Activities:          
Conversion of convertible notes and accrued interest to common stock  $88,550   $157,839 
Exchange of convertible notes and accrued interest to new notes  $42,896   $- 
Conversion of accrued interest to note payable  $-   $15,000 

 

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

 

6
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements

 

1. Nature of Business and Basis of Presentation

 

Description of Business

 

SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The “Company,” hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (“LUMA”), Spectra Science International, Inc. (“International”) and SpectraScience (UK) Limited (“SpectraUK”). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the “WavSTAT System”).

 

The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.

 

On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company’s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.

 

The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.

 

Basis of Presentation

 

The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the three and six month periods ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

7
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

Going Concern

 

Historically, the Company’s sources of cash have come from the issuance and sale of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2016, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

 

As of June 30, 2016, the Company had a working capital deficit of $10,024,040 and cash of $27,860, compared to a working capital deficit of $8,324,600 and cash of $127,493 as of December 31, 2015. In December 2011, the Company entered into an Engagement Agreement with Laidlaw & Company (UK) Ltd., which Engagement Agreement was amended in July 2012. Under the Engagement Agreement, Laidlaw agreed to assist the Company in raising up to $20.0 million in capital over a two-year period from the date of the Engagement Agreement. Subsequent to March 31, 2013, the Company has engaged other agents to assist the Company with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2016, the Company raised $811,000, net of transaction costs of $24,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

 

The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of June 30, 2016, Convertible Debentures with a face value of $4,882,276 held by 79 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

2. Summary of Significant Accounting Policies

 

Revenue recognition

 

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

 

8
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

Consolidation

 

The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

 

Use of Estimates

 

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

 

Inventory Valuation

 

The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

 

Valuation of Long-lived Assets

 

The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

 

9
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

Variable Conversion Rate Debentures

 

Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued in 2015 or will be issued in subsequent periods at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

 

Over Commitment of Shares

 

Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes-Merton option-pricing model (the “Black-Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.

 

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

 

All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.

 

As of June 30, 2016, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2016, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP and the Company’s prior Amended 2001 Stock Plan of which up to 22,727,003 shares were exercisable. Awards under the Company’s EIP generally vest over four years.

 

10
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

The fair value of options granted are estimated at the date of grant using a Black-Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:

 

   Three months ended June 30,   Six months ended June 30, 
   2016   2015   2016   2015 
Expected term   None    None    None    5 years 
Exercise price   None    None    None   $0.01 
Expected volatility   None    None    None    210%
Expected dividends   None    None    None    None 
Risk-free interest rate   None    None    None    1.48%
Forfeitures   None    None    None    None 

 

Earnings (Loss) Per Share

 

Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.

 

For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

 

   June 30, 2016   June 30, 2015 
           
Preferred Stock   3,085,000    3,085,000 
Convertible debentures   247,559,219    101,009,574 
Options   34,168,800    39,718,802 
Warrants   132,875,170    99,995,693 
Total   417,688,189    243,809,069 

 

11
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2016   2015   2016   2015 
                 
Numerator:                    
Net loss for basic earnings per share  $(88,182)  $(743,261)  $(2,144,516)  $(2,452,951)
Net loss for diluted earnings per share  $(88,182)  $(743,261)  $(2,144,516)  $(2,452,951)
                     
Denominator:                    
Weighted average basic shares outstanding   668,866,352    197,124,162    640,797,803    195,747,368 
Denominator for diluted earnings per share-                    
Adjusted weighted average shares   668,866,352    197,124,162    640,797,803    195,747,368 
                     
Loss per share                    
Basic  $(0.00)  $(0.00)  $(0.00)  $(0.01)
Diluted  $(0.00)  $(0.00)  $(0.00)  $(0.01)

 

Inventory

 

Inventory consisted of the following at June 30, 2016 and December 31, 2015:

 

   June 30, 2016   December 31, 2015 
         
Raw materials  $257,114   $216,704 
Finished goods   52,617    45,183 
    309,731    261,887 
Reserve for obsolescence   -    - 
    309,731    261,887 
Less long-term portion   150,000    150,000 
   $159,731   $111,887 

 

During the six months ended June 30, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount has been included in raw materials.

 

Recently Adopted and Issued Accounting Pronouncements

 

In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, which amended Interest – Imputation of Interest of the Accounting Standards Codification. The amended guidance requires that debt issuance costs related to a recognized debt liability, which were presented as deferred charges (assets), be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. The amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.

 

12
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which provides guidance for accounting for leases. The new guidance requires companies to recognize the assets and liabilities for the rights and obligations created by leased assets, initially measured at the present value of the lease payments. The accounting guidance for lessors is largely unchanged. The ASU is effective for annual and interim periods beginning after December 15, 2018. It is to be adopted using a modified retrospective approach. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s financial statements.

 

Reclassifications

 

Certain reclassifications have been made to the 2015 financial statements in order for them to conform to the 2016 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

 

3. Liabilities

 

Note Payable

 

In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest will accrue at 20% from October 1, 2015 until paid. The note remained outstanding at June 30, 2016 and is accruing interest at 20%. The warrant was valued at $1,659 using the Black-Scholes Pricing Model and was recorded as additional paid-in capital and expensed to non-cash interest in 2014.

 

Notes Payable- Related Parties

 

During the six months ended June 30, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remains $35,000 at June 30, 2016.

 

Convertible Debentures

 

As of June 30, 2016, the Company has issued and outstanding Convertible Debentures (“Debentures”) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share. The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through March 31, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to March 31, 2013 do not contain such an exchange clause. The gross amount of Debentures outstanding is $6,232,345 as of June 30, 2016.

 

During the six months ended June 30, 2016, the Company has issued and outstanding Convertible Debentures (“Variable Debentures”) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company’s common stock based on the Company’s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $237,242 as of June 30, 2016 which includes $11,466 of principal either added to the original notes or issued as new notes related to forbearance agreements as a result of the Company not having an adequate number of authorized shares to honor the noteholders conversion requests and $109,496 of variable rate notes purchased from previous note holders and consolidated into the holdings of one new noteholder.

 

13
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

As of June 30, 2016 and December 31, 2015, the balances of the Debentures are as follows:

 

   June 30, 2016   December 31, 2015 
         
Balance at beginning of period  $6,174,760   $4,496,602 
Issuance of debentures for cash   300,000    1,970,250 
Original issue discount   -    145,263 
Issuance of debentures for forbearance   29,712    - 
Debentures converted to common stock   (84,356)   (437,355)
Debentures exchanged for new debentures   49,471    - 
Convertible debt   6,469,587    6,174,760 
Less unamortized costs of financing   275,872    430,156 
Convertible debt, net of unamortized costs  $6,193,715   $5,744,604 
           
Convertible debt in default  $4,882,276   $4,313,199 

 

Secured Convertible Note

 

During the three months ended June 30, 2016, the Company issued for cash of $500,000 a Secured Convertible Debenture (the “Debenture”) to an accredited investor. The terms of the Debenture are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company.

 

Derivative Liability

 

Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using a Black-Scholes option valuation model using similar assumptions to those described under “Stock-Based Compensation.” The time period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the time period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.

 

The assumptions used in determining fair value represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change, including changes in the market value of the Company’s common stock, managements’ assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company’s common stock, the Company’s fair value estimates could be materially different in the future.

 

14
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company’s stock price, which is subject to significant fluctuation and is not under its control. The resulting effect on net loss is therefore subject to significant fluctuation and will continue to be so until the Company’s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.

 

In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Sholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock. For the six months ended June 30, 2016, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 341,000,000 shares

 

As of June 30, 2016 and December 31, 2015, the balances of the Derivative Liability are as follows:

 

           Commitment     
          In Excess of     
   Warrants   Conversion
Feature
   Authorized Stock   Total 
                 
Balance at January 1, 2015  $764,958   $296,881   $-   $1,061,839 
                     
Liability on issuance of debt and warrants   -    1,306,372    -    1,306,372 
Change in fair value at year end   (704,538)   (469,906)   -    (1,174,444)
Elimination of liability on conversion   -    (637,874)   -    (637,874)
Over commitment of stock   -    -    64,428    64,428 
Balance at December 31, 2015   60,420    495,473    64,428    620,321 
                     
Liability on issuance of debt and warrants   44,394    233,017    -    277,411 
Change in fair value at year end   124,709    137,911    -    262,620 
Elimination of liability on conversion   -    (522,577)   -    (522,577)
Over commitment of stock   -    -    132,130    132,130 
Balance at June 30, 2016  $229,523   $343,824   $196,558   $769,905 

 

Debentures with warrants attached issued subsequent to March 31, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

 

4. Shareholders’ Deficit

 

Common Stock

 

During the six months ended June 30, 2016, holders of Convertible Debentures with a face value of $84,356 and accrued interest of $4,194 converted their debentures into 241,929,674 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $50,595.

 

15
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

Warrants

 

During the six months ended June 30, 2016, in conjunction with the sale of Convertible Debentures, the Company issued five-year common stock purchase warrants to acquire up to 15,000,000 shares to holders of the Debentures. These warrants have an exercise price of $0.02 per share.

 

In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black-Sholes Option pricing model and was included as non-cash expenses and additional paid-in capital during the six months ended June 30, 2016.

 

The balance of all warrants outstanding as of June 30, 2016 is as follows:

 

       Weighted 
       Average 
       Exercise 
   Warrants   Price 
Outstanding at January 1, 2016   116,875,170   $0.08 
Granted   16,000,000   $0.02 
Cancelled   -   $- 
Exercised   -   $- 
Outstanding at June 30, 2016   132,875,170   $0.08 
           
Exercisable at June 30, 2016   132,875,170   $0.08 

 

Stock Options

 

Options outstanding as of June 30, 2016 are as follows:

 

       Weighted Average   Weighted Average Remaining   Aggregate 
       Exercise Price   Contractual   Intrinsic 
   Options   Per Share   Term (years)   Value (1) 
Outstanding at January 1, 2016   34,168,800   $0.02    8.03      
Granted   -   $-    -      
Cancelled   -   $-    -      
Exercised   -   $-    -      
Outstanding at June 30, 2016   34,168,800   $0.02    7.54   $- 
                     
Exercisable at June 30, 2016   22,727,003   $0.02    7.54   $- 
                     
Weighted average fair value of options granted during the period   -   $-           

 

(1) These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company’s common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol “SCIE”.

 

16
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

At June 30, 2016, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $253,326, which we expect to be recognized over the next four years.

 

Series AA Preferred Shares

 

On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.0001 per share, designated “Series AA Super Voting Preferred Stock,” for which the board of directors established the rights, preferences and limitations thereof.

 

Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors.

 

5. Fair Value Measurements

 

Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines

required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.

 

The Company’s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:

 

Level 1: uses quoted market prices in active markets for identical assets or liabilities.

 

Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.

 

Level 3: uses unobservable inputs that are not corroborated by market data.

 

The fair value of the Company’s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. A Binomial Lattice option valuation model was used to determine the fair value with similar assumptions to those described under “Stock-Based Compensation”. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.

 

17
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2016:

 

   Fair Value Measurements Using 
   Quoted Prices in   Significant Other   Significant     
   Active Markets for   Observable   Unobservable     
   Identical Assets   Inputs   Inputs     
   (Level 1)   (Level 2)   (Level 3)   Total 
                 
As of June 30, 2016                    
Derivative liability  $-   $-   $343,824   $343,824 
Warrant liability   -    -    229,523    229,523 
Commitment in excess of authorized stock   -    -    196,558    196,558 
Total  $-   $-   $769,905   $769,905 

 

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended June 30, 2016:

 

           Commitment     
   Warrant   Derivative   In Excess of   Total 
   Liability   Liability   Authorized Stock   Liability 
Balance December 31, 2015  $60,420   $495,473   $64,428   $620,321 
                     
Liability on issuance of debt and warrants   44,394    233,017    -    277,411 
                     
Elimination of liability on conversion   -    (522,577)   -    (522,577)
                     
Change in estimated fair value (1)   124,709    137,911    -    262,620 
                     
Commitment in excess of authorized stock   -    -    132,130    132,130 
                     
Balance June 30, 2016  $229,523   $343,824   $196,558   $769,905 

 

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

 

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2016:

 

   Derivative Liability  Warrant Liability
Expected term  6 months to 2 years  5 years
Exercise price  $0.00025 - $0.099  $0.02 - $0.1287
Expected volatility  272% to 334%  249% to 283%
Expected dividends  None  None
Risk-free interest rate  0.37% to 1.05%  1.21% to 1.49%
Forfeitures  None  None

 

In computing the fair value of the derivative and warrant liability at June 30, 2016, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

 

18
 

 

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

 

6. Contingencies

 

None

 

7. Subsequent Events

 

Variable Rate Convertible Debentures

 

In July and August 2016, a holder of Variable Rate Convertible Debentures with principal of $85,800 and accrued interest of $551 converted their debentures into 42,565,754 shares of common stock. The same investor purchased $111,279 of previously issued and outstanding Variable Rate Convertible Debentures for an exchange amount of $174,043.

 

Secured Convertible Debenture

 

In July 2016, the Company issued for cash of $100,000 a Secured Convertible Debenture (the “Debenture”) to an accredited investor. The terms of the Debenture are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company and is shared equally with a previous secured party.

 

Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

 

19
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements that are not related to historical results, including, without limitation, statements regarding our business strategy and objectives, our anticipated duration of periods of net loss, our near term operating goals, our expectations regarding the market for our products, the introduction of our products in new international markets and our beliefs with respect to opportunities and industry conditions in those markets, our beliefs about our products, product development, acquisition or licensing of complementary technologies and expectations with respect to our products’ performance and acceptance, the results of and our intentions with respect to our distribution agreement with PENTAX Europe GmbH, our beliefs about the strengths of our intellectual property portfolio, our regulatory goals and developments, anticipated clinical trials and research, our agreements with Laidlaw and other agents and their effect on our future capital resources and future financial position, our expectations with respect to stock option expense recognition, our future cash needs, the sufficiency of our working capital and our operating losses for the remainder of the current fiscal year. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, there can be no assurance that such assumptions will prove to be accurate and actual results could differ materially from those discussed in the forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause or contribute to such differences, including, but not limited to, changes in law or regulatory policies, unanticipated competition from other similar businesses, adverse outcomes from litigation, unexpected employee departures or disruptions, adverse market and general economic factors and other factors described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2015. Such forward-looking statements are qualified in their entirety by the cautions and risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

 

Business

 

SpectraScience, Inc. (the “Company,” “SpectraScience,” “we,” “our,” or “us”) develops and manufactures innovative Laser Induced Fluorescence spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without removing tissue from the body. The WavSTAT Optical Biopsy System (the “WavSTAT System”) is SpectraScience’s first product to incorporate its proprietary fluorescence technology for clinical use. The WavSTAT System carries the CE mark designation which allows for the sale and marketing in the European Union for the diagnosis of cancer. We are developing light-based diagnostics for additional indications including inflammatory bowel disease and esophageal cancer. Once these additional applications are developed we plan to self-certify for CE mark approval for sale in the European Union and then file an application with the FDA seeking permission to begin marketing for that indication for use in the United States. We believe we have a strong intellectual property portfolio that will allow us to continue to expand our WavSTAT cancer diagnosis platform to address the diagnosis of multiple cancers, utilize additional proprietary bio-photonic techniques to improve the WavSTAT’s overall diagnostic performance and ultimately allow for the detection of cancer and pre-cancer over a relatively large area of examined tissue.

 

Our principal executive offices are located at 11568 Sorrento Valley Rd., Suite 11, San Diego, CA 92121. We can be reached by telephone at (858) 847-0200; by fax at (858) 847-0880; or by email at info@spectrascience.com. We have a Web site at http://www.spectrascience.com. The information contained on our Web site shall not be deemed to be a part of this Report.

 

Plan of Operation

 

During the six-month period ended June 30, 2016, SpectraScience carried forward on the improvements made to the WavSTAT4 in fiscal 2011 and continued working with PENTAX Europe, GmbH (“PENTAX”) and other distributors, for distribution of its products in Europe, the Middle East and Africa.

 

20
 

 

Over the next 12 months, SpectraScience intends to:

 

Market and sell the WavSTAT4 Optical Biopsy System colon cancer diagnostic application through PENTAX and other distribution channels in the European Union;

 

Conduct country-specific evaluation trials to demonstrate the effectiveness and cost benefit of the WavSTAT4 Optical Biopsy System in each relevant European jurisdiction;

 

Coordinate the creation and publication of scientific papers and presentations related to the country-specific evaluation trials to support widespread education and adoption of the WavSTAT4;

 

Pursue the introduction of the WavSTAT4 colon cancer application in other international markets, in particular China, Saudi Arabia and India;

 

Begin meeting with the FDA towards the preparation and submission of a Supplemental PMA filing with the FDA and plan for additional clinical trials to support eventual approval for sale in the United States;

 

Begin the design and planning for the next generation of multi-modal fluorescence and broadband spectroscopy systems at our facility in San Diego, California.

 

Continue to expand and refine our intellectual property portfolio.

 

Results of Operations

 

Comparison of the Three Months Ended June 30, 2016 and 2015

 

   Three Months Ended June 30,   Favorable     
   2016   2015   (Unfavorable)   % 
                 
Revenue  $950   $-   $950    NM 
Cost of revenue   868    (6,000)   (6,868)   NM 
Gross profit   82    6,000    (5,918)   NM 
                     
Operating expenses:                    
Research and development   194,155    157,329    (36,826)   23.4%
General and administrative   306,213    344,811    38,598    11.2%
Sales and marketing   101,214    94,098    (7,116)   7.6%
    601,582    596,238    (5,344)   -0.9%
                     
Loss from operations   (601,500)   (590,238)   (11,262)   -1.9%
                     
Other income (expense)   513,318    (153,023)   666,341    -435.5%
                     
Net loss  $(88,182)  $(743,261)  $655,079    -88.1%

 

Revenues

 

There was minimal revenue during the three months ended June 30, 2016 and no revenue during the three months ended June 30, 2015. We anticipate that revenue will increase as a result of our distribution agreement with PENTAX and continuing direct sales efforts in certain locations once sufficient information has been accumulated from our MORDIS trials in Europe.

 

21
 

 

Cost of Revenue

 

There was minimal cost of revenue during the three months ended June 30, 2016 compared to a negative cost of sales of $6,000 during the three months ended June 30, 2015. The negative amount was the result of two systems coming off of warranty with no associated costs. We anticipate that as revenue increases as a result of our distribution agreement with PENTAX and continuing direct sales efforts in certain locations once sufficient information has been accumulated from our MORDIS trials in Europe, that associated costs will also increase. The following table reflects the status of the warranty reserve as of June 30, 2016 and 2015:

 

   Three months ended June 30, 
   2016   2015 
         
Balance at the beginning of the period  $-   $12,000 
           
Increase in warranty expense   -    - 
Systems coming off warranty   -    (6,000)
Balance at the end of the period  $-   $6,000 

 

Research and Development Expenses

 

Research and development expenses increased by $36,826, 23.4%, to $194,155 for the quarter ended June 30, 2016 from $157,329 for the three months ended June 30, 2015. This increase was due to an increase in clinical costs of approximately $35,000. We anticipate that clinical costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

 

General and Administrative Expenses

 

General and administrative expenses decreased by $38,598, 11.2%, to $306,213 for the quarter ended June 30, 2016 compared to $344,811 for the quarter ended June 30, 2015. This decrease was due primarily to a reduction in costs associated with the issuance of stock options in an amount of approximately $19,000, a reduction in legal and professional fees of approximately $12,000 and a reduction in travel and related expenses of approximately $4,000. We anticipate that general and administrative expenses will increase as we increase our activity in Europe.

 

Sales and Marketing Expenses

 

Sales and marketing expenses increased by $7,116, 7.6%, to $101,214 for the quarter ended June 30, 2016 from $94,098 for the quarter ended June 30, 2015. The primary reason for the increase was an increase in travel and related costs. We anticipate that sales and marketing expenses will increase as we increase our activity in Europe.

 

Other Income (Expense)

 

Other income (expense) for the quarter ended June 30, 2016 was income of $513,318 compared to expense of $153,023 for the quarter ended June 30, 2015. This change was due primarily to a change in valuation of our derivative liabilities. We anticipate continued large fluctuations in other income (expense) as a result of quarterly re-evaluating these obligations.

 

22
 

 

Comparison of the Six Months Ended June 30, 2016 and 2015

 

   Six Months Ended June 30,   Favorable     
   2016   2015   (Unfavorable)   % 
                 
Revenue  $950   $-   $950    NM 
Cost of revenue   868    (12,000)   (12,868)   -107.2%
Gross profit   82    12,000    (11,918)   -99.3%
                     
Operating expenses:                    
Research and development   388,162    332,009    (56,153)   -16.9%
General and administrative   614,054    726,265    112,211    15.5%
Sales and marketing   180,627    133,960    (46,667)   -34.8%
    1,182,843    1,192,234    9,391    0.8%
                     
Loss from operations   (1,182,761)   (1,180,234)   (2,527)   -0.2%
                     
Other income (expense)   (961,755)   (1,272,717)   310,962    24.4%
                     
Net loss  $(2,144,516)  $(2,452,951)  $308,435    12.6%

 

Revenues

 

There was minimal revenue during the six months ended June 30, 2016 and no revenue during the six months ended June 30, 2015. We anticipate that revenue will increase as a result of our distribution agreement with PENTAX and continuing direct sales efforts in certain locations once sufficient information has been accumulated from our MORDIS trials in Europe.

 

Cost of Revenue

 

There was minimal cost of revenue during the six months ended June 30, 2016 compared to a negative cost of sales of $12,000 during the six months ended June 30, 2015. The negative amount was the result of four systems coming off of warranty with no associated costs. We anticipate that as revenue increases as a result of our distribution agreement with PENTAX and continuing direct sales efforts in certain locations once sufficient information has been accumulated from our MORDIS trials in Europe, that associated costs will also increase. The following table reflects the status of the warranty reserve as of June 30, 2016 and 2015:

 

   Six months ended June 30, 
   2016   2015 
         
Balance at the beginning of the period  $-   $12,000 
           
Increase in warranty expense   -    - 
Systems coming off warranty   -    (12,000)
Balance at the end of the period  $-   $- 

 

23
 

 

Research and Development Expenses

 

Research and development expenses increased by $56,153, 16.9%, to $388,162 for the six months ended June 30, 2016 from $332,009 for the six months ended June 30, 2015. This increase was due to an increase in clinical costs of approximately $38,000, an increase in regulatory costs of approximately $10,000 and an increase in consulting costs of approximately $10,000. We anticipate that clinical costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

 

General and Administrative Expenses

 

General and administrative expenses decreased by $112,211, 15.5%, to $614,054 for the six months ended June 30, 2016 compared to $726,265 for the six months ended June 30, 2015. This decrease was due primarily to a reduction in costs associated with the issuance of stock options in an amount of approximately $55,000, a reduction in legal and professional fees of approximately $45,000 and a reduction in travel and related expenses of approximately $5,000. We anticipate that general and administrative expenses will increase as we increase our activity in Europe.

 

Sales and Marketing Expenses

 

Sales and marketing expenses increased by $46,667, 34.8%, to $180,627 for the six months ended June 30, 2016 from $133,960 for the six months ended June 30, 2015. The primary reason for the increase was an increase in stock option expense of approximately $19,000, an increase in travel and related costs of approximately $14,000 and an increase in payroll costs of approximately $11,000. We anticipate that sales and marketing expenses will increase as we increase our activity in Europe.

 

Other Income (Expense)

 

Other income (expense) for the six months ended June 30, 2016 was expense of $961,755 compared to expense of $1,272,717 for the six months ended June 30, 2015. This change was due primarily to a change in valuation of our derivative liabilities. We anticipate continued large fluctuations in other income (expense) as a result of quarterly re-evaluating these obligations.

 

24
 

 

Liquidity and Capital Resources

 

   As of   Increase 
   June 30, 2016   December 31, 2015   (Decrease) 
Working Capital               
                
Current assets  $401,773   $530,746   $(128,973)
Current liabilities   10,425,813    8,855,346    1,570,467 
Working capital deficit  $(10,024,040)  $(8,324,600)  $1,699,440 
                
Long-term debt  $-   $-   $- 
                
Stockholders’ deficit  $(8,799,892)  $(7,019,662)  $1,780,230 

 

   Six Months Ended June 30,   Increase 
   2016   2015   (Decrease) 
Statements of Cash Flows Select Information               
                
Net cash provided (used) by:               
Operating activities  $(880,921)  $(929,764)  $(48,843)
Investing activities  $-   $-   $- 
Financing activities  $781,288   $748,470   $32,818 

 

   As of   Increase 
   June 30, 2016   December 31, 2015   (Decrease) 
Balance Sheet Select Information               
                
Cash  $27,860   $127,493   $(99,633)
                
Accounts receivable  $950   $7,061   $(6,111)
                
Inventory  $309,731   $261,887   $47,844 
                
Accounts payable and accrued expenses  $2,789,211   $2,352,439   $436,772 

 

Historically, the Company’s sources of cash have come from the issuance and sales of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2016, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 Systems in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

 

25
 

 

As of June 30, 2016, the Company had a working capital deficit of $10,024,040 and cash of $27,860, compared to a working capital deficit of $8,324,600 and cash of $127,493 as of December 31, 2015. In December 2011, the Company entered into an Engagement Agreement with Laidlaw & Company (UK) Ltd., which Engagement Agreement was amended in July 2012. Under the Engagement Agreement, Laidlaw agreed to assist the Company in raising up to $20.0 million in capital over a two-year period from the date of the Engagement Agreement. Subsequent to March 31, 2013, the Company has engaged other agents to assist the Company with raising capital and has commenced raising capital on its own. During the three months ended June 30, 2016, The Company raised $811,000, net of transaction costs of $24,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period covered by this Report (the “Evaluation Date”). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the Evaluation Date.

 

Changes in Internal Financial Controls

 

There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None

 

Item 1A. Risk Factors

 

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

 

26
 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

      Number of        
   Date of  Common Shares   Source of    
Common Stock  Issuance  Issued   Payment  Amount 
  5/5/2016   1,138,090   Conversion of debt  $3,870 
   6/1/2016   1,400,000   Conversion of debt  $6,020 
   6/24/2016   3,125,000   Conversion of debt  $15,937 

 

With respect to the above equity securities issuances, the Company relied on exemptions provided by Sections 4(a)(2) and 3(a)9 of the Securities Act of 1933, as amended (the “Securities Act”). No advertising or general solicitation was employed in offering the securities. The securities were issued to a limited number of persons all of whom were accredited investors as that term is defined in Rule 501 of Regulation D under the Securities Act. All were capable of analyzing the merits and risks of their investment, acknowledged in writing that they were acquiring the securities for investment and not with a view toward distribution or resale, and understood the speculative nature of their investment. All securities issued contained a restrictive legend prohibiting transfer of the shares except in accordance with federal securities laws.

 

Item 3. Defaults Upon Senior Securities

 

As of August 15, 2016 there are Unsecured Convertible Debentures with a face value of $4,882,276 held by 79 individual Holders in default. As a result, the outstanding principal amount of these Debentures, plus accrued but unpaid interest, liquidated damages and other amounts owing shall become immediately due and payable in cash at the election of the Holders. As of August 15, 2016, none of the Holders of these Debentures have elected to provide notice of default.

 

Item 4. Mine Safety Disclosures

 

None

 

27
 

 

Item 5. Other Information

 

On August 8, 2016, the Company, via a Written Consent of Shareholders, voted on the following proposal:

 

Proposal: Amend the Company’s Amended and Restated Articles of Incorporation to increase the number of authorized shares of capital stock from 750,000,000 to 1,250,000,000, consisting of an increase in authorized shares of common stock from 746,000,000 to1,246,000,000.

 

Of 3,703,742,635 shares eligible to vote as of August 8, 2016 (the “Record Date”), of which 3,000,000,000 were represented by the Series AA Super Voting Power Class, the holders of record of 3,000,000,000 shares voted via the Written Consent of Shareholders.

 

For   Against   Abstain   Broker Non-Votes 
 3,000,000,000    0    0    0 

 

None

 

Item 6. Exhibits

 

31.1 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1  Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2 Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101 Financial statements from the quarterly report on Form 10-Q of the Company for the quarter ended June 30, 2016, formatted in XBRL; (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statement of Shareholders’ Equity, (iv) the Consolidated Statements of Cash Flows, and (v) the Notes to the Consolidated Financial Statements.

 

28
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

SpectraScience, Inc.

(Registrant)

   
Date: August 15, 2016 /s/ Michael P. Oliver
  Michael P. Oliver
  President and Chief Executive Officer
  (Principal executive officer)
   
Date: August 15, 2016 /s/ Lowell W. Giffhorn
  Lowell W. Giffhorn
  Chief Financial Officer
  (Principal financial officer and principal accounting officer)

 

29
 

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Michael P. Oliver, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of SpectraScience, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

    /s/ Michael P. Oliver
  Name:  Michael P. Oliver
  Title:  Chief Executive Officer
  Date:  August 15, 2016

 

 
 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Lowell W. Giffhorn, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of SpectraScience, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

    /s/ Lowell W. Giffhorn
  Name: Lowell W. Giffhorn
  Title: Chief Financial Officer
  Date: August 15, 2016

 

 
 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SpectraScience, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael P. Oliver, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Michael P. Oliver
 

Michael P. Oliver

Chief Executive Officer

Date: August 15, 2016

 

 
 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of SpectraScience, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lowell W. Giffhorn, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

  /s/ Lowell W. Giffhorn
 

Lowell W. Giffhorn

Chief Financial Officer

Date: August 15, 2016

 

 
 

 

EX-101.INS 6 scie-20160630.xml XBRL INSTANCE FILE 0000727672 2016-01-01 2016-06-30 0000727672 2016-08-15 0000727672 2016-06-30 0000727672 2015-12-31 0000727672 us-gaap:SeriesBPreferredStockMember 2016-06-30 0000727672 us-gaap:SeriesBPreferredStockMember 2015-12-31 0000727672 us-gaap:SeriesCPreferredStockMember 2016-06-30 0000727672 us-gaap:SeriesCPreferredStockMember 2015-12-31 0000727672 us-gaap:SeriesAPreferredStockMember 2016-06-30 0000727672 us-gaap:SeriesAPreferredStockMember 2015-12-31 0000727672 2016-04-01 2016-06-30 0000727672 2015-04-01 2015-06-30 0000727672 2015-01-01 2015-06-30 0000727672 us-gaap:CommonStockMember 2016-01-01 2016-06-30 0000727672 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-06-30 0000727672 us-gaap:RetainedEarningsMember 2016-01-01 2016-06-30 0000727672 us-gaap:CommonStockMember 2015-12-31 0000727672 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0000727672 us-gaap:RetainedEarningsMember 2015-12-31 0000727672 us-gaap:CommonStockMember 2016-06-30 0000727672 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0000727672 us-gaap:RetainedEarningsMember 2016-06-30 0000727672 2014-12-31 0000727672 2015-06-30 0000727672 SCIE:EngagementAgreementMember SCIE:LaidlawAndCompanyUKLtdMember 2012-07-01 2012-07-12 0000727672 SCIE:EngagementAgreementMember SCIE:LaidlawAndCompanyUKLtdMember 2016-01-01 2016-06-30 0000727672 us-gaap:ConvertibleDebtSecuritiesMember 2016-06-30 0000727672 us-gaap:EquipmentMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000727672 us-gaap:EquipmentMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000727672 SCIE:Amended2011EquityIncentivePlanMember 2016-06-30 0000727672 SCIE:EquityIncentivePlan2001Member 2016-06-30 0000727672 SCIE:Amended2011EquityIncentivePlanMember 2016-01-01 2016-06-30 0000727672 SCIE:Amended2011EquityIncentivePlanMember SCIE:IncentiveStockOptionsMember 2016-01-01 2016-06-30 0000727672 SCIE:OncoscopeIncMember 2016-06-30 0000727672 us-gaap:PreferredStockMember 2016-01-01 2016-06-30 0000727672 us-gaap:ConvertibleDebtSecuritiesMember 2016-01-01 2016-06-30 0000727672 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember 2016-01-01 2016-06-30 0000727672 us-gaap:PreferredStockMember 2015-01-01 2015-06-30 0000727672 us-gaap:ConvertibleDebtSecuritiesMember 2015-01-01 2015-06-30 0000727672 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-06-30 0000727672 us-gaap:WarrantMember 2015-01-01 2015-06-30 0000727672 us-gaap:NotesPayableOtherPayablesMember 2014-11-30 0000727672 us-gaap:NotesPayableOtherPayablesMember 2014-11-01 2014-11-30 0000727672 SCIE:PromissoryNotesMember SCIE:TwoAffiliatesMember 2016-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MinimumMember 2016-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MaximumMember 2016-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000727672 SCIE:ConvertibleDebenturesMember 2016-01-01 2016-06-30 0000727672 us-gaap:MinimumMember SCIE:ConvertibleDebentures1Member 2016-01-01 2016-06-30 0000727672 us-gaap:MaximumMember SCIE:ConvertibleDebentures1Member 2016-01-01 2016-06-30 0000727672 SCIE:ConvertibleDebentures1Member us-gaap:MinimumMember 2016-06-30 0000727672 SCIE:ConvertibleDebentures1Member us-gaap:MaximumMember 2016-06-30 0000727672 SCIE:ConvertibleDebentures1Member 2016-01-01 2016-06-30 0000727672 SCIE:PromissoryNotesMember SCIE:TwoAffiliatesMember 2016-01-01 2016-06-30 0000727672 SCIE:SecuredConvertibleDebentureMember 2016-01-01 2016-06-30 0000727672 SCIE:SecuredConvertibleDebentureMember 2016-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember 2015-01-01 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2015-01-01 2015-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2015-01-01 2015-12-31 0000727672 2015-01-01 2015-12-31 0000727672 us-gaap:WarrantMember 2016-01-01 2016-06-30 0000727672 SCIE:ConversionFeatureMember 2016-01-01 2016-06-30 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember 2016-06-30 0000727672 us-gaap:WarrantMember 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2015-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2016-06-30 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-06-30 0000727672 us-gaap:WarrantMember 2014-12-31 0000727672 SCIE:ConversionFeatureMember 2014-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2014-12-31 0000727672 SCIE:ConvertibleDebenturesMember 2016-06-30 0000727672 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:CommonStockMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember us-gaap:ConvertibleDebtSecuritiesMember 2016-06-30 0000727672 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:WarrantMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember SCIE:ConsultantMember 2016-03-31 0000727672 us-gaap:WarrantMember SCIE:ConsultantMember 2016-06-30 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2016-06-30 0000727672 us-gaap:WarrantMember 2016-01-01 2016-06-30 0000727672 us-gaap:WarrantMember 2015-12-31 0000727672 us-gaap:WarrantMember 2016-06-30 0000727672 us-gaap:EmployeeStockOptionMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SCIE:WarrantLiabilityMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SCIE:WarrantLiabilityMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember SCIE:WarrantLiabilityMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-06-30 0000727672 us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2016-01-01 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-01-01 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2015-12-31 0000727672 us-gaap:FairValueInputsLevel3Member 2015-12-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2015-12-31 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member 2016-06-30 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2015-12-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-01-01 2016-06-30 0000727672 SCIE:WarrantLiabilityMember 2016-01-01 2016-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember 2016-06-30 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2016-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MinimumMember 2016-06-30 0000727672 SCIE:WarrantLiabilityMember us-gaap:MaximumMember 2016-06-30 0000727672 us-gaap:SubsequentEventMember SCIE:SecuredConvertibleDebenturesMember 2016-07-01 2016-07-31 0000727672 us-gaap:SubsequentEventMember SCIE:SecuredConvertibleDebenturesMember 2016-07-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2016-08-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2016-07-01 2016-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SCIE:IndividualInvestors SCIE:IntellectualProperty SPECTRASCIENCE INC 0000727672 10-Q 2016-06-30 false --12-31 Smaller Reporting Company Q2 2016 715742635 27860 127493 223529 42235 950 7061 159731 111887 213232 284305 401773 530746 316 150000 150000 1104998 1185472 1656771 1866534 1114495 941106 500000 137982 137982 35000 35000 6193715 5744604 769905 620321 1674716 1411333 10425813 8855346 25850 25850 5000 5000 30850 30850 6731769 4312472 36111807 38166818 -51643468 -49498952 -8799892 -7019662 4312472 38166818 -49498952 6731769 36111807 -51643468 1656771 1866534 275872 430156 0.01 0.01 0.01 0.01 0.01 0.01 0.0001 2585000 2585000 500000 500000 0 0 3000 2585000 2585000 500000 500000 0 0 2585000 2585000 500000 500000 0 0 1000000 517000 517000 100000 100000 106931 106931 0.01 0.01 746915000 746915000 673176881 431247207 673176881 431247207 950 950 868 868 -6000 -12000 82 82 6000 12000 388162 194155 157329 332009 614054 306213 344811 726265 180627 101214 94098 133960 1182843 601582 596238 1192234 -1182761 -601500 -590238 -1180234 579299 208347 147041 291543 -262621 624873 277361 -400223 236296 94735 233187 523296 125450 62920 84576 172390 247074 245908 36641 119369 50595 4691 13616 -9854 -5077 -2221 -4634 -961755 513318 -153023 -1272717 -2144516 -88182 -743261 -2452951 -2144516 0.00 0.00 0.00 -0.01 640797803 668866352 197124162 195747368 282692 2419297 -2136665 -241929674 341000000 42565754 80002 80002 1652 1652 431247207 673176881 80789 82887 31364 80003 100369 132130 84434 700 262620 400223 -6111 47845 5599 -71073 -40576 173391 108753 274152 219661 -880921 -929764 300000 820750 100000 174043 35000 500000 4500 53712 76780 781288 748470 -99633 -181294 88550 157839 42896 15000 <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1. Nature of Business and Basis of Presentation</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Description of Business</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The &#147;Company,&#148; hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (&#147;LUMA&#148;), Spectra Science International, Inc. (&#147;International&#148;) and SpectraScience (UK) Limited (&#147;SpectraUK&#148;). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the &#147;WavSTAT System&#148;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company&#146;s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Basis of Presentation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the three and six month periods ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company&#146;s Annual Report on Form 10-K for the year ended December 31, 2015.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Going Concern</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Historically, the Company&#146;s sources of cash have come from the issuance and sale of equity securities and debentures. The Company&#146;s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company&#146;s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2016, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016, the Company had a working capital deficit of $10,024,040 and cash of $27,860, compared to a working capital deficit of $8,324,600 and cash of $127,493 as of December 31, 2015. In December 2011, the Company entered into an Engagement Agreement with Laidlaw &#38; Company (UK) Ltd., which Engagement Agreement was amended in July 2012. Under the Engagement Agreement, Laidlaw agreed to assist the Company in raising up to $20.0 million in capital over a two-year period from the date of the Engagement Agreement. Subsequent to March 31, 2013, the Company has engaged other agents to assist the Company with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2016, the Company raised $811,000, net of transaction costs of $24,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of June 30, 2016, Convertible Debentures with a face value of $4,882,276 held by 79 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2. Summary of Significant Accounting Policies</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue recognition</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company&#146;s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Consolidation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Risks and Uncertainties</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company&#146;s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Use of Estimates</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company&#146;s Convertible Debentures. Actual results could differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory Valuation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company&#146;s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Valuation of Long-lived Assets</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management&#146;s estimate of future cash flows to determine recoverability of these assets. If management&#146;s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Variable Conversion Rate Debentures</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued in 2015 or will be issued in subsequent periods at deeply discounted variable conversion prices. The downward pressure placed on the Company&#146;s stock as a result of these conversions can be classified as &#147;death spirals&#148; since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Over Commitment of Shares</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-Based Compensation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, <i>Compensation&#151;Stock Compensation </i>(&#147;ASC 718&#148;), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes-Merton option-pricing model (the &#147;Black-Scholes Model&#148;). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, <i>Equity-Based Payments to Non-Employees</i> (&#147;ASC 505-50&#148;). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders&#146; equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the &#147;EIP&#148;). The EIP provides for the grant of incentive stock options (&#147;ISOs&#148;), nonqualified stock options (&#147;NQSOs&#148;) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2016, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP and the Company&#146;s prior Amended 2001 Stock Plan of which up to 22,727,003 shares were exercisable. Awards under the Company&#146;s EIP generally vest over four years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of options granted are estimated at the date of grant using a Black-Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Three months ended June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Six months ended June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected term</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">210</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividends</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1.48</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeitures</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Earnings (Loss) Per Share</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 54%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Preferred Stock</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,085,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,085,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debentures</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">247,559,219</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">101,009,574</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">39,718,802</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">99,995,693</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">417,688,189</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">243,809,069</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Three Months Ended</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Six Months Ended</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Numerator:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net loss for basic earnings per share</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(88,182</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(743,261</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,144,516</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,452,951</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net loss for diluted earnings per share</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(88,182</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(743,261</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,144,516</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,452,951</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Denominator:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average basic shares outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">668,866,352</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">197,124,162</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">640,797,803</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">195,747,368</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Denominator for diluted earnings per share-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Adjusted weighted average shares</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">668,866,352</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">197,124,162</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">640,797,803</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">195,747,368</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Loss per share</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consisted of the following at June 30, 2016 and December 31, 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">257,114</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 24%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">216,704</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">52,617</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">45,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">309,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">261,887</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Reserve for obsolescence</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">309,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">261,887</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Less long-term portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">159,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">111,887</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope&#146;s bankruptcy proceeding for a total of $40,000. This amount has been included in raw materials.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Recently Adopted and Issued Accounting Pronouncements</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, which amended Interest &#150; Imputation of Interest of the Accounting Standards Codification. The amended guidance requires that debt issuance costs related to a recognized debt liability, which were presented as deferred charges (assets), be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. The amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which provides guidance for accounting for leases. The new guidance requires companies to recognize the assets and liabilities for the rights and obligations created by leased assets, initially measured at the present value of the lease payments. The accounting guidance for lessors is largely unchanged. The ASU is effective for annual and interim periods beginning after December 15, 2018. It is to be adopted using a modified retrospective approach. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company&#146;s financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Reclassifications</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to the 2015 financial statements in order for them to conform to the 2016 presentation. Such reclassifications have no impact on the Company&#146;s financial position or results of operations.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3. Liabilities</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Note Payable</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest will accrue at 20% from October 1, 2015 until paid. The note remained outstanding at June 30, 2016 and is accruing interest at 20%. The warrant was valued at $1,659 using the Black-Scholes Pricing Model and was recorded as additional paid-in capital and expensed to non-cash interest in 2014.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Notes Payable- Related Parties</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remains $35,000 at June 30, 2016.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Convertible Debentures</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016, the Company has issued and outstanding Convertible Debentures (&#147;Debentures&#148;) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share. The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through March 31, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to March 31, 2013 do not contain such an exchange clause. The gross amount of Debentures outstanding is $6,232,345 as of June 30, 2016.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2016, the Company has issued and outstanding Convertible Debentures (&#147;Variable Debentures&#148;) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company&#146;s common stock based on the Company&#146;s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $237,242 as of June 30, 2016 which includes $11,466 of principal either added to the original notes or issued as new notes related to forbearance agreements as a result of the Company not having an adequate number of authorized shares to honor the noteholders conversion requests and $109,496 of variable rate notes purchased from previous note holders and consolidated into the holdings of one new noteholder.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;<i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016 and December 31, 2015, the balances of the Debentures are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at beginning of period</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,174,760</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,496,602</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Issuance of debentures for cash</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">300,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,970,250</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Original issue discount</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">145,263</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Issuance of debentures for forbearance</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">29,712</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Debentures converted to common stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(84,356</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(437,355</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Debentures exchanged for new debentures</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">49,471</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debt</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,469,587</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,174,760</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Less unamortized costs of financing</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">275,872</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">430,156</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debt, net of unamortized costs</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,193,715</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5,744,604</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debt in default</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,882,276</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,313,199</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Secured Convertible Note</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the three months ended June 30, 2016, the Company issued for cash of $500,000 a Secured Convertible Debenture (the &#147;Debenture&#148;) to an accredited investor. The terms of the Debenture are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Derivative Liability</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company&#146;s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using a Black-Scholes option valuation model using similar assumptions to those described under &#147;Stock-Based Compensation.&#148; The time period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the time period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The assumptions used in determining fair value represent management&#146;s best estimates, but these estimates involve inherent uncertainties and the application of management&#146;s judgment. As a result, if factors change, including changes in the market value of the Company&#146;s common stock, managements&#146; assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company&#146;s common stock, the Company&#146;s fair value estimates could be materially different in the future.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company&#146;s stock price, which is subject to significant fluctuation and is not under its control. The resulting effect on net loss is therefore subject to significant fluctuation and will continue to be so until the Company&#146;s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Sholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock. For the six months ended June 30, 2016, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 341,000,000 shares</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016 and December 31, 2015, the balances of the Derivative Liability are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">In Excess of</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Conversion</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Feature</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Authorized Stock</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at January 1, 2015</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">764,958</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">296,881</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,061,839</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability on issuance of debt and warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,306,372</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,306,372</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value at year end</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(704,538</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(469,906</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(1,174,444</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Elimination of liability on conversion</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(637,874</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(637,874</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Over commitment of stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at December 31, 2015</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">60,420</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">495,473</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">620,321</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability on issuance of debt and warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">44,394</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">233,017</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">277,411</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value at year end</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">124,709</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">137,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">262,620</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Elimination of liability on conversion</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Over commitment of stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Debentures with warrants attached issued subsequent to March 31, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>4. Shareholders&#146; Deficit</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2016, holders of Convertible Debentures with a face value of $84,356 and accrued interest of $4,194 converted their debentures into 241,929,674 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $50,595.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Warrants</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2016, in conjunction with the sale of Convertible Debentures, the Company issued five-year common stock purchase warrants to acquire up to 15,000,000 shares to holders of the Debentures. These warrants have an exercise price of $0.02 per share.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black-Sholes Option pricing model and was included as non-cash expenses and additional paid-in capital during the six months ended June 30, 2016.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The balance of all warrants outstanding as of June 30, 2016 is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Average</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Price</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 74%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at January 1, 2016</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">116,875,170</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">16,000,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock Options</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Options outstanding as of June 30, 2016 are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average Remaining</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Aggregate</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise Price</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Contractual</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Per Share</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Term (years)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Value (1)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at January 1, 2016</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">8.03</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">7.54</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">22,727,003</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">7.54</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average fair value of options granted during the period</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 24px; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company&#146;s common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol &#147;SCIE&#148;.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.25in">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">At June 30, 2016, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $253,326, which we expect to be recognized over the next four years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Series AA Preferred Shares</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company&#146;s Articles of Incorporation, as amended (the &#147;Articles of Incorporation&#148;), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.0001 per share, designated &#147;Series AA Super Voting Preferred Stock,&#148; for which the board of directors established the rights, preferences and limitations thereof.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>5. Fair Value Measurements</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1: uses quoted market prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3: uses unobservable inputs that are not corroborated by market data.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the Company&#146;s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. A Binomial Lattice option valuation model was used to determine the fair value with similar assumptions to those described under &#147;Stock-Based Compensation&#148;. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2016:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Fair Value Measurements Using</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Quoted Prices in</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Significant Other</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Significant</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Active Markets for</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Observable</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Unobservable</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Identical Assets</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inputs</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inputs</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(Level 1)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(Level 2)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(Level 3)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 46%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Derivative liability</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant liability</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment in excess of authorized stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended June 30, 2016:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Derivative</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">In Excess of</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Authorized Stock</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance December 31, 2015</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">60,420</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">495,473</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">620,321</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability on issuance of debt and warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">44,394</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">233,017</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">277,411</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Elimination of liability on conversion</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Change in estimated fair value (1)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">124,709</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">137,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">262,620</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment in excess of authorized stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">(1) Included in the Condensed Statements of Operation on the line &#147;Change in fair value of derivative and warrant liabilities.&#148;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2016:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Derivative Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant Liability</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected term</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 30%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6 months to 2 years</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 28%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$0.00025 - $0.099</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$0.02 - $0.1287</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">272% to 334%</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">249% to 283%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividends</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.37% to 1.05%</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1.21% to 1.49%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeitures</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In computing the fair value of the derivative and warrant liability at June 30, 2016, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>6. Contingencies</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">None</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>7. Subsequent Events</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Variable Rate Convertible Debentures</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July and August 2016, a holder of Variable Rate Convertible Debentures with principal of $85,800 and accrued interest of $551 converted their debentures into 42,565,754 shares of common stock. The same investor purchased $111,279 of previously issued and outstanding Variable Rate Convertible Debentures for an exchange amount of $174,043.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Secured Convertible Debenture</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2016, the Company issued for cash of $100,000 a Secured Convertible Debenture (the &#147;Debenture&#148;) to an accredited investor. The terms of the Debenture are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company and is shared equally with a previous secured party.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue recognition</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company&#146;s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Consolidation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Risks and Uncertainties</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company&#146;s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Use of Estimates</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company&#146;s Convertible Debentures. Actual results could differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory Valuation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company&#146;s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Valuation of Long-lived Assets</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management&#146;s estimate of future cash flows to determine recoverability of these assets. If management&#146;s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Variable Conversion Rate Debentures</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued in 2015 or will be issued in subsequent periods at deeply discounted variable conversion prices. The downward pressure placed on the Company&#146;s stock as a result of these conversions can be classified as &#147;death spirals&#148; since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Over Commitment of Shares</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-Based Compensation</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, <i>Compensation&#151;Stock Compensation </i>(&#147;ASC 718&#148;), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes-Merton option-pricing model (the &#147;Black-Scholes Model&#148;). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, <i>Equity-Based Payments to Non-Employees</i> (&#147;ASC 505-50&#148;). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders&#146; equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the &#147;EIP&#148;). The EIP provides for the grant of incentive stock options (&#147;ISOs&#148;), nonqualified stock options (&#147;NQSOs&#148;) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2016, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP and the Company&#146;s prior Amended 2001 Stock Plan of which up to 22,727,003 shares were exercisable. Awards under the Company&#146;s EIP generally vest over four years.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of options granted are estimated at the date of grant using a Black-Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Three months ended June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Six months ended June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected term</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">210</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividends</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1.48</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeitures</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Earnings (Loss) Per Share</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 54%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Preferred Stock</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,085,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,085,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debentures</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">247,559,219</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">101,009,574</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">39,718,802</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">99,995,693</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">417,688,189</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">243,809,069</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Three Months Ended</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Six Months Ended</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Numerator:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net loss for basic earnings per share</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(88,182</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(743,261</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,144,516</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,452,951</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net loss for diluted earnings per share</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(88,182</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(743,261</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,144,516</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,452,951</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Denominator:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average basic shares outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">668,866,352</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">197,124,162</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">640,797,803</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">195,747,368</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Denominator for diluted earnings per share-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Adjusted weighted average shares</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">668,866,352</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">197,124,162</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">640,797,803</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">195,747,368</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Loss per share</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Inventory</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consisted of the following at June 30, 2016 and December 31, 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">257,114</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 24%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">216,704</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">52,617</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">45,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">309,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">261,887</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Reserve for obsolescence</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">309,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">261,887</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Less long-term portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">159,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">111,887</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">During the six months ended June 30, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope&#146;s bankruptcy proceeding for a total of $40,000. This amount has been included in raw materials.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Recently Adopted and Issued Accounting Pronouncements</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, which amended Interest &#150; Imputation of Interest of the Accounting Standards Codification. The amended guidance requires that debt issuance costs related to a recognized debt liability, which were presented as deferred charges (assets), be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. The amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which provides guidance for accounting for leases. The new guidance requires companies to recognize the assets and liabilities for the rights and obligations created by leased assets, initially measured at the present value of the lease payments. The accounting guidance for lessors is largely unchanged. The ASU is effective for annual and interim periods beginning after December 15, 2018. It is to be adopted using a modified retrospective approach. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company&#146;s financial statements.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Reclassifications</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain reclassifications have been made to the 2015 financial statements in order for them to conform to the 2016 presentation. Such reclassifications have no impact on the Company&#146;s financial position or results of operations.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Three months ended June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Six months ended June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected term</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%">&#160;</td> <td style="width: 1%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">210</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividends</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1.48</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeitures</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 54%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Preferred Stock</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,085,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 20%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,085,000</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debentures</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">247,559,219</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">101,009,574</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">39,718,802</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">99,995,693</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">417,688,189</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">243,809,069</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Three Months Ended</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Six Months Ended</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="6" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30,</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Numerator:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net loss for basic earnings per share</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(88,182</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(743,261</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,144,516</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,452,951</font></td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net loss for diluted earnings per share</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(88,182</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(743,261</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,144,516</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,452,951</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Denominator:</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average basic shares outstanding</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">668,866,352</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">197,124,162</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">640,797,803</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">195,747,368</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Denominator for diluted earnings per share-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Adjusted weighted average shares</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">668,866,352</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">197,124,162</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">640,797,803</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">195,747,368</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Loss per share</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Basic</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Diluted</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.00</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(0.01</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consisted of the following at June 30, 2016 and December 31, 2015:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Raw materials</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">257,114</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 24%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">216,704</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Finished goods</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">52,617</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">45,183</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">309,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">261,887</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Reserve for obsolescence</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">309,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">261,887</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Less long-term portion</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">150,000</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">159,731</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">111,887</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016 and December 31, 2015, the balances of the Debentures are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2016</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at beginning of period</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,174,760</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 16%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,496,602</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Issuance of debentures for cash</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">300,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,970,250</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Original issue discount</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">145,263</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Issuance of debentures for forbearance</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">29,712</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Debentures converted to common stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(84,356</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(437,355</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Debentures exchanged for new debentures</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">49,471</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debt</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,469,587</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,174,760</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Less unamortized costs of financing</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">275,872</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">430,156</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debt, net of unamortized costs</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,193,715</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5,744,604</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Convertible debt in default</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,882,276</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,313,199</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2016 and December 31, 2015, the balances of the Derivative Liability are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">In Excess of</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Conversion</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">Feature</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Authorized Stock</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at January 1, 2015</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">764,958</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">296,881</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,061,839</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability on issuance of debt and warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,306,372</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,306,372</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value at year end</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(704,538</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(469,906</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(1,174,444</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Elimination of liability on conversion</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(637,874</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(637,874</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Over commitment of stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at December 31, 2015</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">60,420</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">495,473</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">620,321</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability on issuance of debt and warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">44,394</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">233,017</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">277,411</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Change in fair value at year end</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">124,709</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">137,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">262,620</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Elimination of liability on conversion</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Over commitment of stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The balance of all warrants outstanding as of June 30, 2016 is as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Average</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrants</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Price</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 74%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at January 1, 2016</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">116,875,170</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">16,000,000</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,875,170</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Options outstanding as of June 30, 2016 are as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted Average Remaining</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Aggregate</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise Price</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Contractual</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Options</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Per Share</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Term (years)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Value (1)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at January 1, 2016</font></td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">8.03</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 10%; text-align: right; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cancelled</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34,168,800</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">7.54</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable at June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">22,727,003</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">7.54</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Weighted average fair value of options granted during the period</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 24px; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(1)</font></td> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company&#146;s common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol &#147;SCIE&#148;.</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2016:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Fair Value Measurements Using</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Quoted Prices in</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Significant Other</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Significant</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Active Markets for</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Observable</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Unobservable</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Identical Assets</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inputs</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inputs</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(Level 1)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(Level 2)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(Level 3)</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 46%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Derivative liability</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 8%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant liability</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment in excess of authorized stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended June 30, 2016:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Derivative</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">In Excess of</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Authorized Stock</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance December 31, 2015</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">60,420</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">495,473</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">64,428</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 10%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">620,321</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Liability on issuance of debt and warrants</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">44,394</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">233,017</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">277,411</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Elimination of liability on conversion</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(522,577</font></td> <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Change in estimated fair value (1)</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">124,709</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">137,911</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">262,620</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Commitment in excess of authorized stock</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">132,130</font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="text-align: right; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Balance June 30, 2016</font></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">229,523</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">343,824</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">196,558</font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,905</font></td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">(1) Included in the Condensed Statements of Operation on the line &#147;Change in fair value of derivative and warrant liabilities.&#148;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2016:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Derivative Liability</font></td> <td style="text-align: center; line-height: 115%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant Liability</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected term</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 30%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6 months to 2 years</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 28%; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$0.00025 - $0.099</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$0.02 - $0.1287</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">272% to 334%</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">249% to 283%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Expected dividends</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">0.37% to 1.05%</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1.21% to 1.49%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Forfeitures</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td> <td style="line-height: 115%">&#160;</td> <td style="text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">None</font></td></tr> </table> <p style="margin: 0pt"></p> 34 28 10024040 8324600 20000000 811000 P2Y 24000 4882276 4313199 4882276 79 P2Y P3Y 40000000 34168800 34168800 34168800 22727003 P4Y P10Y 257114 216704 40000 P0Y P0Y P0Y P5Y 0.01 2.10 0.0148 417688189 243809069 3085000 247559219 34168800 132875170 3085000 101009574 39718802 99995693 -2452951 -88182 -743261 -2144516 -2452951 -88182 -743261 -2144516 195747368 668866352 197124162 640797803 195747368 668866352 197124162 640797803 -0.01 0.00 0.00 0.00 -0.01 0.00 0.00 0.00 52617 45183 309731 261887 309731 261887 145263 100000 84356 85800 P5Y P5Y P5Y 0.09 0.0745 0.1287 0.01 0.02 50000 115000 137982 0.10 0.20 0.10 0.20 0.00 0.10 0.08 1659 1652 0.05 0.10 0.00 0.10 0.01 0.099 0.01 0.02 0.1287 0.40 0.50 6232345 237242 P9M P1Y 0.00 0.50 109496 11466 500000 6174760 4496602 300000 1970250 29712 -84356 -437355 49471 6469587 6174760 275872 430156 769905 620321 1061839 29523 60420 495473 64428 343824 196558 764958 296881 60420 620321 229523 495473 343824 769905 64428 196558 277411 1306372 1306372 44394 233017 -262620 726216 469906 1174444 -137911 124709 137911 262620 522577 637874 637874 522577 132130 64428 64428 132130 4194 15000000 1000000 253326 241929674 16000000 132875170 0.02 0.08 116875170 132875170 0.08 0.08 22727003 0.02 0.02 0.02 0.004 P8Y11D P7Y6M15D P7Y6M15D In computing the fair value of the derivative and warrant liability at June 30, 2016, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants. 343824 229523 196558 769905 343824 229523 196558 769905 44394 233017 277411 -522577 -522577 132130 132130 P6M P2Y P5Y 0.00025 0.099 0.075 0.1287 2.80 3.34 2.72 3.34 0 0 0.0037 0.0075 0.0121 0.0149 0 0 0.08 551 111279 These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company's common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol "SCIE". Included in the Condensed Statements of Operation on the line "Change in fair value of derivative and warrant liabilities." EX-101.SCH 7 scie-20160630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operation (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Liabilities link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Shareholders' Deficit link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Shareholders' Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Business and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Weighted Average Assumptions to Value Stock Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Liabilities - Schedule of Balance of Debentures (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Liabilities - Schedule of Balances of Derivative Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Shareholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Shareholders' Deficit - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Fair Value Measurements (Details Narartive) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 scie-20160630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 scie-20160630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 scie-20160630_lab.xml XBRL LABEL FILE Series B Preferred Stock [Member] Equity Components [Axis] Series C Preferred Stock [Member] Series A Preferred Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Engagement Agreement [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Laidlaw & Company (UK) Ltd [Member] Legal Entity [Axis] Convertible Debentures [Member] Derivative Instrument [Axis] Equipment [Member] Property, Plant and Equipment, Type [Axis] Minimum [Member] Range [Axis] Maximum [Member] 2011 Equity Incentive Plan [Member] Plan Name [Axis] Amended 2001 Equity Incentive Plan [Member] Incentive Stock Options [Member] Award Type [Axis] Oncoscope, Inc [Member] Related Party [Axis] Preferred Stock [Member] Antidilutive Securities [Axis] Options [Member] Warrants [Member] Unsecured Note Payable [Member] Short-term Debt, Type [Axis] 10% promissory notes [Member] Long-Term Debt, Type [Axis] Two Affiliates [Member] ConvertibleDebenturesMember Variable Debentures [Member] Secured Convertible Debenture [Member] Derivative Financial Instruments, Liabilities [Member] Fair Value By Liability Class [Axis] Conversion Feature [Member] Commitment In Excess of Authorized Stock [Member] Convertible Debentures [Member] Consultant [Member] Series AA Super Voting Preferred Stock [Member] Stock Options [Member] Fair Value, Measurements, Recurring [Member] Measurement Frequency [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Warrant liability [Member] Subsequent Event [Member] Subsequent Event Type [Axis] 8% Secured Convertible Debentures [Member] Variable Rate Convertible Debentures [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Accounts receivable, net Inventory, current portion Prepaid expenses and other current assets Total current assets Fixed assets, net Long-term inventory Patents, net Total assets LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable Secured convertible note payable Note payable Notes payable- related parties Convertible debt, net of discounts and costs of $275,872 as of June 30, 2016 and $430,156 as of December 31, 2015 Derivative liability Accrued Expenses Total current liabilities COMMITMENTS AND CONTINGENCIES Mezzanine equity Convertible Preferred Stock Total mezzanine equity Shareholders' deficit Convertible Preferred Stock, value Common stock, $.01 par value; 746,915,000 shares authorized; 673,176,881 and 431,247,207 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively Additional paid in capital Accumulated deficit Total shareholders' deficit Total shareholders' deficit Discounts on convertible debt Preferred stock, par value Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Preferred stock, liquidation value Preferred stock, accumulated and unpaid dividends Common stock, par value Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit Operating expenses: Research and development General and administrative Sales and marketing Total operating expenses Loss from operations Other income (expense) Interest expense Change in fair value of derivative and warrant liabilities Amortization of derivative and warrant liabilities discount Amortization of deferred debt issuance costs and original issue discount Gain on extinguishment of debt Income on foreign exchange transactions Other income (expense), net Total non operating expenses Net loss Basic and diluted loss per share Weighted average common shares outstanding: Basic and diluted Balance, beginning Balance, beginning, shares Conversion of convertible debt Conversion of convertible debt, shares Non cash stock option expense Non cash issuance of warrant for consulting services Net loss Balance, ending Balance, ending, shares Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to cash used in operating activities: Amortization and depreciation Non-cash interest Non-cash issuance of stock options and warrants Non-cash expense related to commitment of common stock in excess of authorized shares Loss on issuance of variable rate notes Amortization of derivative and warrant liabilities discount Amortization of deferred debt issuance costs and original issue discount Issuance of common stock for services Change in fair value of derivative and warrant liabilities Gain on extinguishment of debt Changes in assets and liabilities: Accounts receivable Inventory Prepaid expense and other assets Accounts payable Accrued expenses Net cash used in operating activities Investing activities: Purchases of fixed assets Net cash used in investing activities Financing activities: Proceeds from issuance of convertible notes payable Proceeds from issuance of notes payable to related parties Proceeds from issuance of secured note payable Proceeds from exercise of stock options Debt issuance costs Net cash provided by financing activities Net decrease in cash Cash, beginning of year Cash, end of period Supplemental Disclosure of Cash Flow Information: Cash paid during the period for: Interest Income taxes Non Cash Investing and Financing Activities: Conversion of convertible notes and accrued interest to common stock Exchange of convertible notes and accrued interest to new notes Conversion of accrued interest to note payable Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Business and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Debt Disclosure [Abstract] Liabilities Stockholders' Equity Note [Abstract] Shareholders' Deficit Fair Value Disclosures [Abstract] Fair Value Measurements Commitments and Contingencies Disclosure [Abstract] Contingencies Subsequent Events [Abstract] Subsequent Events Revenue Recognition Consolidation Risks and Uncertainties Use of Estimates Inventory Valuation Valuation of Long-lived Assets Variable Conversion Rate Debentures Over Commitment of Shares Stock-Based Compensation Earnings (Loss) Per Share Inventory Recently Adopted and Issued Accounting Pronouncements Reclassifications Schedule of Weighted Average Assumptions to Value Stock Options Granted Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share Schedule of Earnings Per Share Basic and Diluted Schedule of Inventory Liabilities [Abstract] Schedule of Balance of Debentures Schedule of Balances of Derivative Liability Schedule of Warrants Outstanding Schedule of Stock Options Outstanding Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis Schedule Changes in Liabilities with Significant Unobservable Inputs Schedule of Derivative and Warrant Liabilities Number of U.S. patents Number of additional patent issued Working capital deficit Cash and cash equivalents Maximum capital raising Agreement period Payments of transaction costs Debt face amount Number of individual default Useful life Number of shares reserved Options outstanding exercisable Vesting period Inventory raw materials Expected term Exercise price Expected volatility Expected dividends Risk-free interest rate Forfeitures Antidilutive securities excluded from computation of earnings per share, amount Net loss for basic earnings per share Net loss for diluted earnings per share Weighted average basic shares outstanding Denominator for diluted earnings per share - Adjusted weighted average shares Loss per share Basic Loss per share Diluted Raw materials Finished goods Inventory, gross Reserve for obsolescence Inventories, net Less long-term portion Inventories, current Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Long-term Debt, Type [Axis] Debt instrument, face amount Warrant term Exercise price per share Number of stock issued during period for debt offering costs Remaining balance of notes payable Increased principal balance note payable Accrued interest rate Warrants valued Percent original issue discount Conversion price per share Convertible debentures exercise price Variable issue discount rate Debentures outstanding Debt payment term Debt subsequent issuance premiums Proceeds from notes payable Amount of principal Number of shares issued upon conversion Balance at beginning of period Issuance of debentures for cash Original issue discount Issuance of debentures for forbearance Debentures converted to common stock Debenture exchanged for new debentures Convertible debt Less unamortized costs of financing Convertible debt, net of unamortized costs Convertible debt in default Liability Class [Axis] Balance at beginning Liability on issuance of debt and warrants Change in fair value at year end Elimination of liability on conversion Over commitment of stock Balance at ending Face amount Accrued interest Number of common stock converted into shares of common stock Number of warrant issued Warrants exercise price Value of warrants Total unrecognized estimated employee compensation cost Outstanding at beginning Granted Cancelled Exercised Outstanding at ending Exercisable at ending Outstanding at beginning Granted Cancelled Exercised Outstanding at ending Exercisable at ending Outstanding at beginning Granted Cancelled Exercised Outstanding at ending Exercisable at ending Outstanding at beginning Granted Cancelled Exercised Outstanding at ending Exercisable at ending Outstanding at beginning Outstanding at ending Exercisable at ending Outstanding at ending Exercisable at ending Stock option exercise price Description of valuation of derivative and warrant liability Total Liability Liability on issuance of debt and warrants Elimination of liability on conversion Change in estimated fair value (1) Commitment in excess of authorized stock Expected term Exercise price Expected volatility Expected dividends Risk-free interest rate Forfeitures Accrued interest Number of common shares issued Aggregate consideration of debentures Net cash proceeds of debentures Interest rate Mezzanine equity [Abstract] Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Carrying value of mezzanine equity, as of balance sheet date. Preferred Stock Dividends In Arrears Refers to amount of amortization of discount on derivative and warrant liability. Non cash stock option expense. Exchange of convertible notes and accrued interest to new notes. Conversion of accrued interest to note payable. Accrued Liabilities Disclosure [Text Block] Inventory valuation policy text block. Disclosure of accounting policy for variable conversion rate debentures. Schedule of warrants outstanding table text block. Information by category of arrangement, including but not limited to collaborative arrangements and non-collaborative arrangements. Information about legal entity. Represents the number of patent issued. Represents the additional number of patent issued. Working capital deficit. Refers to agremment period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Refers to number of individual default. Information about share based compensation plan. Information about share based compensation plan. An incentive stock option (ISO) is a type of employee stock option with a tax benefit, when you exercise, of not having to pay ordinary income tax. Instead, the options are taxed at a capital gains rate. It refer to the name of an entity. Forfeitures rate assumption used in valuing an instrument. It refers the information relating to a signed document containing a written promise to pay a stated sum to a specified person or the bearer at a specified date or on demand. It refers the information relating to two affiliates. Convertible Debentures [Member] Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock. Secured Convertible Debenture [Member] Refers to warrant term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Stock issued during period shares for debt offering costs. Remaining balance of notes payable. Increased principal balance note payable. Debt Instrument, Issuance Discount Rate Debt Instrument Convertible Conversion Price Per Share Refers to variable discount rate. It represents as a debt instrument subsequent issuance premiums. Amount of debt issued for forbearance. Debentures converted to Common stock. Debenture exchanged for new debentures. The amount of financing cost that was originally recognized at the issuance of the instrument that has yet to be amortized. Custom Element. Represents the inofrmation about the commitment in excess of authorized stock. Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing over commitment of stock. It refers to a consultant. Series AA Super Voting Preferred Stock [Member] Number of common stock converted into shares of common stock. The number of expired made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). The number of exercised made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). The number of exercisable made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). The weighted average exercise price of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units. The weighted average exercise price at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). The weighted average exercise price at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). The weighted average ererciseprice at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). The weighted average exercise price at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Description of valuation technique or method used to estimate fair value of derivative and warrant liabilities. Information about warrant liablilty. Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Amount of commitment in excess of authorized stock financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Forfeitures rate assumption used in valuing an instrument. It refers to the long term debt axis. Information about secured convertible debentures. Assets, Current Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Derivative Liabilities Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities, Continuing Operations Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations Payments of Debt Issuance Costs Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash and Cash Equivalents, Period Increase (Decrease) Inventory, Gross Inventory Valuation Reserves Inventory, Net of Allowances, Customer Advances and Progress Billings Convertible Debt, Noncurrent Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExpiredExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisedExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityOnIssuanceOfDebtAndWarrants Fair Value Assumptions, Expected Term Fair Value Assumptions, Exercise Price Fair Value Assumptions, Expected Volatility Rate Fair Value Assumptions, Expected Dividend Rate Fair Value Assumptions, Risk Free Interest Rate FairValueAssumptionsForfeitures Interest Payable, Current EX-101.PRE 11 scie-20160630_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2016
Aug. 15, 2016
Document And Entity Information    
Entity Registrant Name SPECTRASCIENCE INC  
Entity Central Index Key 0000727672  
Document Type 10-Q  
Document Period End Date Jun. 30, 2016  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   715,742,635
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2016  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Current assets:    
Cash $ 27,860 $ 127,493
Accounts receivable, net 950 7,061
Inventory, current portion 159,731 111,887
Prepaid expenses and other current assets 213,232 284,305
Total current assets 401,773 530,746
Fixed assets, net 316
Long-term inventory 150,000 150,000
Patents, net 1,104,998 1,185,472
Total assets 1,656,771 1,866,534
Current liabilities:    
Accounts payable 1,114,495 941,106
Secured convertible note payable 500,000
Note payable 137,982 137,982
Notes payable- related parties 35,000
Convertible debt, net of discounts and costs of $275,872 as of June 30, 2016 and $430,156 as of December 31, 2015 6,193,715 5,744,604
Derivative liability 769,905 620,321
Accrued Expenses 1,674,716 1,411,333
Total current liabilities 10,425,813 8,855,346
Total mezzanine equity 30,850 30,850
Shareholders' deficit    
Common stock, $.01 par value; 746,915,000 shares authorized; 673,176,881 and 431,247,207 shares issued and outstanding as of June 30, 2016 and December 31, 2015, respectively 6,731,769 4,312,472
Additional paid in capital 36,111,807 38,166,818
Accumulated deficit (51,643,468) (49,498,952)
Total shareholders' deficit (8,799,892) (7,019,662)
Total shareholders' deficit 1,656,771 1,866,534
Series B Preferred Stock [Member]    
Current liabilities:    
Convertible Preferred Stock 25,850 25,850
Series C Preferred Stock [Member]    
Current liabilities:    
Convertible Preferred Stock 5,000 5,000
Series A Preferred Stock [Member]    
Shareholders' deficit    
Convertible Preferred Stock, value
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Discounts on convertible debt $ 275,872 $ 430,156
Common stock, par value $ 0.01 $ 0.01
Common stock, authorized 746,915,000 746,915,000
Common stock, issued 673,176,881 431,247,207
Common stock, outstanding 673,176,881 431,247,207
Series B Preferred Stock [Member]    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, authorized 2,585,000 2,585,000
Preferred stock, issued 2,585,000 2,585,000
Preferred stock, outstanding 2,585,000 2,585,000
Preferred stock, liquidation value $ 517,000 $ 517,000
Preferred stock, accumulated and unpaid dividends $ 106,931 $ 106,931
Series C Preferred Stock [Member]    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, authorized 500,000 500,000
Preferred stock, issued 500,000 500,000
Preferred stock, outstanding 500,000 500,000
Preferred stock, liquidation value $ 100,000 $ 100,000
Series A Preferred Stock [Member]    
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, authorized 0 0
Preferred stock, issued 0 0
Preferred stock, outstanding 0 0
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Operation (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Income Statement [Abstract]        
Revenue $ 950 $ 950
Cost of revenue 868 (6,000) 868 (12,000)
Gross profit 82 6,000 82 12,000
Operating expenses:        
Research and development 194,155 157,329 388,162 332,009
General and administrative 306,213 344,811 614,054 726,265
Sales and marketing 101,214 94,098 180,627 133,960
Total operating expenses 601,582 596,238 1,182,843 1,192,234
Loss from operations (601,500) (590,238) (1,182,761) (1,180,234)
Other income (expense)        
Interest expense (208,347) (147,041) (579,299) (291,543)
Change in fair value of derivative and warrant liabilities 624,873 277,361 (262,621) (400,223)
Amortization of derivative and warrant liabilities discount (94,735) (233,187) (236,296) (523,296)
Amortization of deferred debt issuance costs and original issue discount (62,920) (84,576) (125,450) (172,390)
Gain on extinguishment of debt 245,908 36,641 247,074 119,369
Income on foreign exchange transactions 13,616 4,691
Other income (expense), net (5,077) (2,221) (9,854) (4,634)
Total non operating expenses 513,318 (153,023) (961,755) (1,272,717)
Net loss $ (88,182) $ (743,261) $ (2,144,516) $ (2,452,951)
Basic and diluted loss per share $ 0.00 $ 0.00 $ 0.00 $ (0.01)
Weighted average common shares outstanding:        
Basic and diluted 668,866,352 197,124,162 640,797,803 195,747,368
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statement of Shareholders' Deficit (unaudited) - 6 months ended Jun. 30, 2016 - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance, beginning at Dec. 31, 2015 $ 4,312,472 $ 38,166,818 $ (49,498,952) $ (7,019,662)
Balance, beginning, shares at Dec. 31, 2015 431,247,207      
Conversion of convertible debt $ 2,419,297 (2,136,665) 282,692
Conversion of convertible debt, shares 241,929,674      
Non cash stock option expense 80,002 80,002
Non cash issuance of warrant for consulting services 1,652 1,652
Net loss (2,144,516) (2,144,516)
Balance, ending at Jun. 30, 2016 $ 6,731,769 $ 36,111,807 $ (51,643,468) $ (8,799,892)
Balance, ending, shares at Jun. 30, 2016 673,176,881      
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Operating activities:    
Net loss $ (2,144,516) $ (2,452,951)
Adjustments to reconcile net loss to cash used in operating activities:    
Amortization and depreciation 80,789 82,887
Non-cash interest 31,364
Non-cash issuance of stock options and warrants 80,003 100,369
Non-cash expense related to commitment of common stock in excess of authorized shares 132,130
Loss on issuance of variable rate notes 84,434
Amortization of derivative and warrant liabilities discount 236,296 523,296
Amortization of deferred debt issuance costs and original issue discount 125,450 172,390
Issuance of common stock for services 700
Change in fair value of derivative and warrant liabilities 262,620 400,223
Gain on extinguishment of debt (247,074) (119,369)
Changes in assets and liabilities:    
Accounts receivable 6,111
Inventory (47,845) (5,599)
Prepaid expense and other assets 71,073 40,576
Accounts payable 173,391 108,753
Accrued expenses 274,152 219,661
Net cash used in operating activities (880,921) (929,764)
Investing activities:    
Purchases of fixed assets
Net cash used in investing activities
Financing activities:    
Proceeds from issuance of convertible notes payable 300,000 820,750
Proceeds from issuance of notes payable to related parties 35,000
Proceeds from issuance of secured note payable 500,000
Proceeds from exercise of stock options 4,500
Debt issuance costs (53,712) (76,780)
Net cash provided by financing activities 781,288 748,470
Net decrease in cash (99,633) (181,294)
Cash, beginning of year 127,493 223,529
Cash, end of period 27,860 42,235
Cash paid during the period for:    
Interest
Income taxes
Non Cash Investing and Financing Activities:    
Conversion of convertible notes and accrued interest to common stock 88,550 157,839
Exchange of convertible notes and accrued interest to new notes 42,896
Conversion of accrued interest to note payable $ 15,000
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Nature of Business and Basis of Presentation
6 Months Ended
Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Business and Basis of Presentation

1. Nature of Business and Basis of Presentation

 

Description of Business

 

SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The “Company,” hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (“LUMA”), Spectra Science International, Inc. (“International”) and SpectraScience (UK) Limited (“SpectraUK”). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the “WavSTAT System”).

 

The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.

 

On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company’s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.

 

The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.

 

Basis of Presentation

 

The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the three and six month periods ended June 30, 2016 are not necessarily indicative of the results that may be expected for the year ending December 31, 2016. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

 

Going Concern

 

Historically, the Company’s sources of cash have come from the issuance and sale of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2016, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

 

As of June 30, 2016, the Company had a working capital deficit of $10,024,040 and cash of $27,860, compared to a working capital deficit of $8,324,600 and cash of $127,493 as of December 31, 2015. In December 2011, the Company entered into an Engagement Agreement with Laidlaw & Company (UK) Ltd., which Engagement Agreement was amended in July 2012. Under the Engagement Agreement, Laidlaw agreed to assist the Company in raising up to $20.0 million in capital over a two-year period from the date of the Engagement Agreement. Subsequent to March 31, 2013, the Company has engaged other agents to assist the Company with raising capital and has commenced raising capital on its own. During the six months ended June 30, 2016, the Company raised $811,000, net of transaction costs of $24,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

 

The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of June 30, 2016, Convertible Debentures with a face value of $4,882,276 held by 79 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Revenue recognition

 

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

 

Consolidation

 

The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

 

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

 

Use of Estimates

 

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

 

Inventory Valuation

 

The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

 

Valuation of Long-lived Assets

 

The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

  

Variable Conversion Rate Debentures

 

Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued in 2015 or will be issued in subsequent periods at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

 

Over Commitment of Shares

 

Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes-Merton option-pricing model (the “Black-Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.

 

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

 

All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.

 

As of June 30, 2016, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2016, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP and the Company’s prior Amended 2001 Stock Plan of which up to 22,727,003 shares were exercisable. Awards under the Company’s EIP generally vest over four years.

 

The fair value of options granted are estimated at the date of grant using a Black-Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:

 

    Three months ended June 30,     Six months ended June 30,  
    2016     2015     2016     2015  
Expected term     None       None       None       5 years  
Exercise price     None       None       None     $ 0.01  
Expected volatility     None       None       None       210 %
Expected dividends     None       None       None       None  
Risk-free interest rate     None       None       None       1.48 %
Forfeitures     None       None       None       None  

 

Earnings (Loss) Per Share

 

Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.

 

For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

 

    June 30, 2016     June 30, 2015  
                 
Preferred Stock     3,085,000       3,085,000  
Convertible debentures     247,559,219       101,009,574  
Options     34,168,800       39,718,802  
Warrants     132,875,170       99,995,693  
Total     417,688,189       243,809,069  

 

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2016     2015     2016     2015  
                         
Numerator:                                
Net loss for basic earnings per share   $ (88,182 )   $ (743,261 )   $ (2,144,516 )   $ (2,452,951 )
Net loss for diluted earnings per share   $ (88,182 )   $ (743,261 )   $ (2,144,516 )   $ (2,452,951 )
                                 
Denominator:                                
Weighted average basic shares outstanding     668,866,352       197,124,162       640,797,803       195,747,368  
Denominator for diluted earnings per share-                                
Adjusted weighted average shares     668,866,352       197,124,162       640,797,803       195,747,368  
                                 
Loss per share                                
Basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.01 )
Diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.01 )

 

Inventory

 

Inventory consisted of the following at June 30, 2016 and December 31, 2015:

 

    June 30, 2016     December 31, 2015  
             
Raw materials   $ 257,114     $ 216,704  
Finished goods     52,617       45,183  
      309,731       261,887  
Reserve for obsolescence     -       -  
      309,731       261,887  
Less long-term portion     150,000       150,000  
    $ 159,731     $ 111,887  

 

During the six months ended June 30, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount has been included in raw materials.

 

Recently Adopted and Issued Accounting Pronouncements

 

In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, which amended Interest – Imputation of Interest of the Accounting Standards Codification. The amended guidance requires that debt issuance costs related to a recognized debt liability, which were presented as deferred charges (assets), be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. The amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which provides guidance for accounting for leases. The new guidance requires companies to recognize the assets and liabilities for the rights and obligations created by leased assets, initially measured at the present value of the lease payments. The accounting guidance for lessors is largely unchanged. The ASU is effective for annual and interim periods beginning after December 15, 2018. It is to be adopted using a modified retrospective approach. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s financial statements.

 

Reclassifications

 

Certain reclassifications have been made to the 2015 financial statements in order for them to conform to the 2016 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liabilities
6 Months Ended
Jun. 30, 2016
Debt Disclosure [Abstract]  
Liabilities

3. Liabilities

 

Note Payable

 

In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest will accrue at 20% from October 1, 2015 until paid. The note remained outstanding at June 30, 2016 and is accruing interest at 20%. The warrant was valued at $1,659 using the Black-Scholes Pricing Model and was recorded as additional paid-in capital and expensed to non-cash interest in 2014.

 

Notes Payable- Related Parties

 

During the six months ended June 30, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remains $35,000 at June 30, 2016.

 

Convertible Debentures

 

As of June 30, 2016, the Company has issued and outstanding Convertible Debentures (“Debentures”) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share. The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through March 31, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to March 31, 2013 do not contain such an exchange clause. The gross amount of Debentures outstanding is $6,232,345 as of June 30, 2016.

 

During the six months ended June 30, 2016, the Company has issued and outstanding Convertible Debentures (“Variable Debentures”) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company’s common stock based on the Company’s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $237,242 as of June 30, 2016 which includes $11,466 of principal either added to the original notes or issued as new notes related to forbearance agreements as a result of the Company not having an adequate number of authorized shares to honor the noteholders conversion requests and $109,496 of variable rate notes purchased from previous note holders and consolidated into the holdings of one new noteholder.

  

As of June 30, 2016 and December 31, 2015, the balances of the Debentures are as follows:

 

    June 30, 2016     December 31, 2015  
             
Balance at beginning of period   $ 6,174,760     $ 4,496,602  
Issuance of debentures for cash     300,000       1,970,250  
Original issue discount     -       145,263  
Issuance of debentures for forbearance     29,712       -  
Debentures converted to common stock     (84,356 )     (437,355 )
Debentures exchanged for new debentures     49,471       -  
Convertible debt     6,469,587       6,174,760  
Less unamortized costs of financing     275,872       430,156  
Convertible debt, net of unamortized costs   $ 6,193,715     $ 5,744,604  
                 
Convertible debt in default   $ 4,882,276     $ 4,313,199  

 

Secured Convertible Note

 

During the three months ended June 30, 2016, the Company issued for cash of $500,000 a Secured Convertible Debenture (the “Debenture”) to an accredited investor. The terms of the Debenture are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company.

 

Derivative Liability

 

Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using a Black-Scholes option valuation model using similar assumptions to those described under “Stock-Based Compensation.” The time period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the time period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.

 

The assumptions used in determining fair value represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change, including changes in the market value of the Company’s common stock, managements’ assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company’s common stock, the Company’s fair value estimates could be materially different in the future.

  

The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company’s stock price, which is subject to significant fluctuation and is not under its control. The resulting effect on net loss is therefore subject to significant fluctuation and will continue to be so until the Company’s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.

 

In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Sholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock. For the six months ended June 30, 2016, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 341,000,000 shares

 

As of June 30, 2016 and December 31, 2015, the balances of the Derivative Liability are as follows:

 

                Commitment        
                In Excess of        
    Warrants     Conversion
Feature
    Authorized Stock     Total  
                         
Balance at January 1, 2015   $ 764,958     $ 296,881     $ -     $ 1,061,839  
                                 
Liability on issuance of debt and warrants     -       1,306,372       -       1,306,372  
Change in fair value at year end     (704,538 )     (469,906 )     -       (1,174,444 )
Elimination of liability on conversion     -       (637,874 )     -       (637,874 )
Over commitment of stock     -       -       64,428       64,428  
Balance at December 31, 2015     60,420       495,473       64,428       620,321  
                                 
Liability on issuance of debt and warrants     44,394       233,017       -       277,411  
Change in fair value at year end     124,709       137,911       -       262,620  
Elimination of liability on conversion     -       (522,577 )     -       (522,577 )
Over commitment of stock     -       -       132,130       132,130  
Balance at June 30, 2016   $ 229,523     $ 343,824     $ 196,558     $ 769,905  

 

Debentures with warrants attached issued subsequent to March 31, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Shareholders' Deficit
6 Months Ended
Jun. 30, 2016
Stockholders' Equity Note [Abstract]  
Shareholders' Deficit

4. Shareholders’ Deficit

 

Common Stock

 

During the six months ended June 30, 2016, holders of Convertible Debentures with a face value of $84,356 and accrued interest of $4,194 converted their debentures into 241,929,674 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $50,595.

  

Warrants

 

During the six months ended June 30, 2016, in conjunction with the sale of Convertible Debentures, the Company issued five-year common stock purchase warrants to acquire up to 15,000,000 shares to holders of the Debentures. These warrants have an exercise price of $0.02 per share.

 

In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black-Sholes Option pricing model and was included as non-cash expenses and additional paid-in capital during the six months ended June 30, 2016.

 

The balance of all warrants outstanding as of June 30, 2016 is as follows:

 

          Weighted  
          Average  
          Exercise  
    Warrants     Price  
Outstanding at January 1, 2016     116,875,170     $ 0.08  
Granted     16,000,000     $ 0.02  
Cancelled     -     $ -  
Exercised     -     $ -  
Outstanding at June 30, 2016     132,875,170     $ 0.08  
                 
Exercisable at June 30, 2016     132,875,170     $ 0.08  

 

Stock Options

 

Options outstanding as of June 30, 2016 are as follows:

 

          Weighted Average     Weighted Average Remaining     Aggregate  
          Exercise Price     Contractual     Intrinsic  
    Options     Per Share     Term (years)     Value (1)  
Outstanding at January 1, 2016     34,168,800     $ 0.02       8.03          
Granted     -     $ -       -          
Cancelled     -     $ -       -          
Exercised     -     $ -       -          
Outstanding at June 30, 2016     34,168,800     $ 0.02       7.54     $ -  
                                 
Exercisable at June 30, 2016     22,727,003     $ 0.02       7.54     $ -  
                                 
Weighted average fair value of options granted during the period     -     $ -                  

 

(1) These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company’s common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol “SCIE”.

  

At June 30, 2016, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $253,326, which we expect to be recognized over the next four years.

 

Series AA Preferred Shares

 

On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.0001 per share, designated “Series AA Super Voting Preferred Stock,” for which the board of directors established the rights, preferences and limitations thereof.

 

Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Value Measurements

5. Fair Value Measurements

 

Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines

required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.

 

The Company’s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:

 

Level 1: uses quoted market prices in active markets for identical assets or liabilities.

 

Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.

 

Level 3: uses unobservable inputs that are not corroborated by market data.

 

The fair value of the Company’s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. A Binomial Lattice option valuation model was used to determine the fair value with similar assumptions to those described under “Stock-Based Compensation”. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.

 

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2016:

 

    Fair Value Measurements Using  
    Quoted Prices in     Significant Other     Significant        
    Active Markets for     Observable     Unobservable        
    Identical Assets     Inputs     Inputs        
    (Level 1)     (Level 2)     (Level 3)     Total  
                         
As of June 30, 2016                                
Derivative liability   $ -     $ -     $ 343,824     $ 343,824  
Warrant liability     -       -       229,523       229,523  
Commitment in excess of authorized stock     -       -       196,558       196,558  
Total   $ -     $ -     $ 769,905     $ 769,905  

 

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended June 30, 2016:

 

                Commitment        
    Warrant     Derivative     In Excess of     Total  
    Liability     Liability     Authorized Stock     Liability  
Balance December 31, 2015   $ 60,420     $ 495,473     $ 64,428     $ 620,321  
                                 
Liability on issuance of debt and warrants     44,394       233,017       -       277,411  
                                 
Elimination of liability on conversion     -       (522,577 )     -       (522,577 )
                                 
Change in estimated fair value (1)     124,709       137,911       -       262,620  
                                 
Commitment in excess of authorized stock     -       -       132,130       132,130  
                                 
Balance June 30, 2016   $ 229,523     $ 343,824     $ 196,558     $ 769,905  

 

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

 

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2016:

 

    Derivative Liability   Warrant Liability
Expected term   6 months to 2 years   5 years
Exercise price   $0.00025 - $0.099   $0.02 - $0.1287
Expected volatility   272% to 334%   249% to 283%
Expected dividends   None   None
Risk-free interest rate   0.37% to 1.05%   1.21% to 1.49%
Forfeitures   None   None

 

In computing the fair value of the derivative and warrant liability at June 30, 2016, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Contingencies
6 Months Ended
Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Contingencies

6. Contingencies

 

None

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Subsequent Events
6 Months Ended
Jun. 30, 2016
Subsequent Events [Abstract]  
Subsequent Events

7. Subsequent Events

 

Variable Rate Convertible Debentures

 

In July and August 2016, a holder of Variable Rate Convertible Debentures with principal of $85,800 and accrued interest of $551 converted their debentures into 42,565,754 shares of common stock. The same investor purchased $111,279 of previously issued and outstanding Variable Rate Convertible Debentures for an exchange amount of $174,043.

 

Secured Convertible Debenture

 

In July 2016, the Company issued for cash of $100,000 a Secured Convertible Debenture (the “Debenture”) to an accredited investor. The terms of the Debenture are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company and is shared equally with a previous secured party.

 

Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Revenue Recognition

Revenue recognition

 

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

Consolidation

Consolidation

 

The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

Risks and Uncertainties

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

Use of Estimates

Use of Estimates

 

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

Inventory Valuation

Inventory Valuation

 

The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

Valuation of Long-lived Assets

Valuation of Long-lived Assets

 

The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

Variable Conversion Rate Debentures

Variable Conversion Rate Debentures

 

Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued in 2015 or will be issued in subsequent periods at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

Over Commitment of Shares

Over Commitment of Shares

 

Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes-Merton option-pricing model (the “Black-Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.

 

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

 

All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.

 

As of June 30, 2016, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At June 30, 2016, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP and the Company’s prior Amended 2001 Stock Plan of which up to 22,727,003 shares were exercisable. Awards under the Company’s EIP generally vest over four years.

 

The fair value of options granted are estimated at the date of grant using a Black-Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:

 

    Three months ended June 30,     Six months ended June 30,  
    2016     2015     2016     2015  
Expected term     None       None       None       5 years  
Exercise price     None       None       None     $ 0.01  
Expected volatility     None       None       None       210 %
Expected dividends     None       None       None       None  
Risk-free interest rate     None       None       None       1.48 %
Forfeitures     None       None       None       None  
Earnings (Loss) Per Share

Earnings (Loss) Per Share

 

Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.

 

For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

 

    June 30, 2016     June 30, 2015  
                 
Preferred Stock     3,085,000       3,085,000  
Convertible debentures     247,559,219       101,009,574  
Options     34,168,800       39,718,802  
Warrants     132,875,170       99,995,693  
Total     417,688,189       243,809,069  

 

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2016     2015     2016     2015  
                         
Numerator:                                
Net loss for basic earnings per share   $ (88,182 )   $ (743,261 )   $ (2,144,516 )   $ (2,452,951 )
Net loss for diluted earnings per share   $ (88,182 )   $ (743,261 )   $ (2,144,516 )   $ (2,452,951 )
                                 
Denominator:                                
Weighted average basic shares outstanding     668,866,352       197,124,162       640,797,803       195,747,368  
Denominator for diluted earnings per share-                                
Adjusted weighted average shares     668,866,352       197,124,162       640,797,803       195,747,368  
                                 
Loss per share                                
Basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.01 )
Diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.01 )
Inventory

Inventory

 

Inventory consisted of the following at June 30, 2016 and December 31, 2015:

 

    June 30, 2016     December 31, 2015  
             
Raw materials   $ 257,114     $ 216,704  
Finished goods     52,617       45,183  
      309,731       261,887  
Reserve for obsolescence     -       -  
      309,731       261,887  
Less long-term portion     150,000       150,000  
    $ 159,731     $ 111,887  

 

During the six months ended June 30, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount has been included in raw materials.

Recently Adopted and Issued Accounting Pronouncements

Recently Adopted and Issued Accounting Pronouncements

 

In April 2015, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, which amended Interest – Imputation of Interest of the Accounting Standards Codification. The amended guidance requires that debt issuance costs related to a recognized debt liability, which were presented as deferred charges (assets), be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. The amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.

 

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which provides guidance for accounting for leases. The new guidance requires companies to recognize the assets and liabilities for the rights and obligations created by leased assets, initially measured at the present value of the lease payments. The accounting guidance for lessors is largely unchanged. The ASU is effective for annual and interim periods beginning after December 15, 2018. It is to be adopted using a modified retrospective approach. The Company is currently evaluating the impact that the adoption of this guidance will have on the Company’s financial statements.

Reclassifications

Reclassifications

 

Certain reclassifications have been made to the 2015 financial statements in order for them to conform to the 2016 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Schedule of Weighted Average Assumptions to Value Stock Options Granted

Management used the following weighted average assumptions to value stock options granted during the three and six month periods ended June 30, 2016 and 2015:

 

    Three months ended June 30,     Six months ended June 30,  
    2016     2015     2016     2015  
Expected term     None       None       None       5 years  
Exercise price     None       None       None     $ 0.01  
Expected volatility     None       None       None       210 %
Expected dividends     None       None       None       None  
Risk-free interest rate     None       None       None       1.48 %
Forfeitures     None       None       None       None  

Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share

For the six month periods ended June 30, 2016 and 2015, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

 

    June 30, 2016     June 30, 2015  
                 
Preferred Stock     3,085,000       3,085,000  
Convertible debentures     247,559,219       101,009,574  
Options     34,168,800       39,718,802  
Warrants     132,875,170       99,995,693  
Total     417,688,189       243,809,069  

Schedule of Earnings Per Share Basic and Diluted

The following table sets forth the computation of basic and diluted loss per share for the three and six month periods ended June 30, 2016 and 2015:

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2016     2015     2016     2015  
                         
Numerator:                                
Net loss for basic earnings per share   $ (88,182 )   $ (743,261 )   $ (2,144,516 )   $ (2,452,951 )
Net loss for diluted earnings per share   $ (88,182 )   $ (743,261 )   $ (2,144,516 )   $ (2,452,951 )
                                 
Denominator:                                
Weighted average basic shares outstanding     668,866,352       197,124,162       640,797,803       195,747,368  
Denominator for diluted earnings per share-                                
Adjusted weighted average shares     668,866,352       197,124,162       640,797,803       195,747,368  
                                 
Loss per share                                
Basic   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.01 )
Diluted   $ (0.00 )   $ (0.00 )   $ (0.00 )   $ (0.01 )

Schedule of Inventory

Inventory consisted of the following at June 30, 2016 and December 31, 2015:

 

    June 30, 2016     December 31, 2015  
             
Raw materials   $ 257,114     $ 216,704  
Finished goods     52,617       45,183  
      309,731       261,887  
Reserve for obsolescence     -       -  
      309,731       261,887  
Less long-term portion     150,000       150,000  
    $ 159,731     $ 111,887  

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liabilities (Tables)
6 Months Ended
Jun. 30, 2016
Liabilities [Abstract]  
Schedule of Balance of Debentures

As of June 30, 2016 and December 31, 2015, the balances of the Debentures are as follows:

 

    June 30, 2016     December 31, 2015  
             
Balance at beginning of period   $ 6,174,760     $ 4,496,602  
Issuance of debentures for cash     300,000       1,970,250  
Original issue discount     -       145,263  
Issuance of debentures for forbearance     29,712       -  
Debentures converted to common stock     (84,356 )     (437,355 )
Debentures exchanged for new debentures     49,471       -  
Convertible debt     6,469,587       6,174,760  
Less unamortized costs of financing     275,872       430,156  
Convertible debt, net of unamortized costs   $ 6,193,715     $ 5,744,604  
                 
Convertible debt in default   $ 4,882,276     $ 4,313,199  

Schedule of Balances of Derivative Liability

As of June 30, 2016 and December 31, 2015, the balances of the Derivative Liability are as follows:

 

                Commitment        
                In Excess of        
    Warrants     Conversion
Feature
    Authorized Stock     Total  
                         
Balance at January 1, 2015   $ 764,958     $ 296,881     $ -     $ 1,061,839  
                                 
Liability on issuance of debt and warrants     -       1,306,372       -       1,306,372  
Change in fair value at year end     (704,538 )     (469,906 )     -       (1,174,444 )
Elimination of liability on conversion     -       (637,874 )     -       (637,874 )
Over commitment of stock     -       -       64,428       64,428  
Balance at December 31, 2015     60,420       495,473       64,428       620,321  
                                 
Liability on issuance of debt and warrants     44,394       233,017       -       277,411  
Change in fair value at year end     124,709       137,911       -       262,620  
Elimination of liability on conversion     -       (522,577 )     -       (522,577 )
Over commitment of stock     -       -       132,130       132,130  
Balance at June 30, 2016   $ 229,523     $ 343,824     $ 196,558     $ 769,905  

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Shareholders' Deficit (Tables)
6 Months Ended
Jun. 30, 2016
Stockholders' Equity Note [Abstract]  
Schedule of Warrants Outstanding

The balance of all warrants outstanding as of June 30, 2016 is as follows:

 

          Weighted  
          Average  
          Exercise  
    Warrants     Price  
Outstanding at January 1, 2016     116,875,170     $ 0.08  
Granted     16,000,000     $ 0.02  
Cancelled     -     $ -  
Exercised     -     $ -  
Outstanding at June 30, 2016     132,875,170     $ 0.08  
                 
Exercisable at June 30, 2016     132,875,170     $ 0.08  

Schedule of Stock Options Outstanding

Options outstanding as of June 30, 2016 are as follows:

 

          Weighted Average     Weighted Average Remaining     Aggregate  
          Exercise Price     Contractual     Intrinsic  
    Options     Per Share     Term (years)     Value (1)  
Outstanding at January 1, 2016     34,168,800     $ 0.02       8.03          
Granted     -     $ -       -          
Cancelled     -     $ -       -          
Exercised     -     $ -       -          
Outstanding at June 30, 2016     34,168,800     $ 0.02       7.54     $ -  
                                 
Exercisable at June 30, 2016     22,727,003     $ 0.02       7.54     $ -  
                                 
Weighted average fair value of options granted during the period     -     $ -                  

 

(1) These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company’s common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol “SCIE”.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of June 30, 2016:

 

    Fair Value Measurements Using  
    Quoted Prices in     Significant Other     Significant        
    Active Markets for     Observable     Unobservable        
    Identical Assets     Inputs     Inputs        
    (Level 1)     (Level 2)     (Level 3)     Total  
                         
As of June 30, 2016                                
Derivative liability   $ -     $ -     $ 343,824     $ 343,824  
Warrant liability     -       -       229,523       229,523  
Commitment in excess of authorized stock     -       -       196,558       196,558  
Total   $ -     $ -     $ 769,905     $ 769,905  

Schedule Changes in Liabilities with Significant Unobservable Inputs

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended June 30, 2016:

 

                Commitment        
    Warrant     Derivative     In Excess of     Total  
    Liability     Liability     Authorized Stock     Liability  
Balance December 31, 2015   $ 60,420     $ 495,473     $ 64,428     $ 620,321  
                                 
Liability on issuance of debt and warrants     44,394       233,017       -       277,411  
                                 
Elimination of liability on conversion     -       (522,577 )     -       (522,577 )
                                 
Change in estimated fair value (1)     124,709       137,911       -       262,620  
                                 
Commitment in excess of authorized stock     -       -       132,130       132,130  
                                 
Balance June 30, 2016   $ 229,523     $ 343,824     $ 196,558     $ 769,905  

 

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Schedule of Derivative and Warrant Liabilities

Management used the following inputs to value the Derivative and Warrant Liabilities for the six months ended June 30, 2016:

 

    Derivative Liability   Warrant Liability
Expected term   6 months to 2 years   5 years
Exercise price   $0.00025 - $0.099   $0.02 - $0.1287
Expected volatility   272% to 334%   249% to 283%
Expected dividends   None   None
Risk-free interest rate   0.37% to 1.05%   1.21% to 1.49%
Forfeitures   None   None

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Nature of Business and Basis of Presentation (Details Narrative)
6 Months Ended
Jul. 12, 2012
USD ($)
Jun. 30, 2016
USD ($)
IndividualInvestors
IntellectualProperty
Dec. 31, 2015
USD ($)
Jun. 30, 2015
USD ($)
Dec. 31, 2014
USD ($)
Number of U.S. patents | IntellectualProperty   34      
Number of additional patent issued | IntellectualProperty   28      
Working capital deficit   $ 10,024,040 $ 8,324,600    
Cash and cash equivalents   27,860 127,493 $ 42,235 $ 223,529
Debt face amount   4,882,276 $ 4,313,199    
Convertible Debentures [Member]          
Debt face amount   $ 4,882,276      
Number of individual default | IndividualInvestors   79      
Laidlaw & Company (UK) Ltd [Member] | Engagement Agreement [Member]          
Maximum capital raising $ 20,000,000 $ 811,000      
Agreement period 2 years        
Payments of transaction costs   $ 24,000      
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2016
Dec. 31, 2015
Options outstanding exercisable 34,168,800 34,168,800
Inventory raw materials $ 257,114 $ 216,704
Oncoscope, Inc [Member]    
Inventory raw materials $ 40,000  
Equipment [Member] | Minimum [Member]    
Useful life 2 years  
Equipment [Member] | Maximum [Member]    
Useful life 3 years  
2011 Equity Incentive Plan [Member]    
Number of shares reserved 40,000,000  
Options outstanding exercisable 34,168,800  
Vesting period 4 years  
Amended 2001 Equity Incentive Plan [Member]    
Options outstanding exercisable 22,727,003  
Incentive Stock Options [Member] | 2011 Equity Incentive Plan [Member]    
Vesting period 10 years  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies - Schedule of Weighted Average Assumptions to Value Stock Options Granted (Details) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Accounting Policies [Abstract]        
Expected term 0 years 0 years 0 years 5 years
Exercise price $ 0.01 $ 0.01
Expected volatility 210.00%
Expected dividends
Risk-free interest rate 1.48%
Forfeitures
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) - shares
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Antidilutive securities excluded from computation of earnings per share, amount 417,688,189 243,809,069
Preferred Stock [Member]    
Antidilutive securities excluded from computation of earnings per share, amount 3,085,000 3,085,000
Convertible Debentures [Member]    
Antidilutive securities excluded from computation of earnings per share, amount 247,559,219 101,009,574
Options [Member]    
Antidilutive securities excluded from computation of earnings per share, amount 34,168,800 39,718,802
Warrants [Member]    
Antidilutive securities excluded from computation of earnings per share, amount 132,875,170 99,995,693
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Accounting Policies [Abstract]        
Net loss for basic earnings per share $ (88,182) $ (743,261) $ (2,452,951) $ (2,144,516)
Net loss for diluted earnings per share $ (88,182) $ (743,261) $ (2,452,951) $ (2,144,516)
Weighted average basic shares outstanding 668,866,352 197,124,162 195,747,368 640,797,803
Denominator for diluted earnings per share - Adjusted weighted average shares 668,866,352 197,124,162 195,747,368 640,797,803
Loss per share Basic $ 0.00 $ 0.00 $ (0.01) $ 0.00
Loss per share Diluted $ 0.00 $ 0.00 $ (0.01) $ 0.00
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies - Schedule of Inventory (Details) - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Accounting Policies [Abstract]    
Raw materials $ 257,114 $ 216,704
Finished goods 52,617 45,183
Inventory, gross 309,731 261,887
Reserve for obsolescence
Inventories, net 309,731 261,887
Less long-term portion 150,000 150,000
Inventories, current $ 159,731 $ 111,887
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liabilities (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Nov. 30, 2014
Jun. 30, 2016
Dec. 31, 2015
Debt Instrument [Line Items]      
Debt instrument, face amount   $ 145,263
Accrued interest rate   10.00%  
Notes payable- related parties   $ 35,000
Unsecured Note Payable [Member]      
Debt Instrument [Line Items]      
Debt instrument, face amount $ 100,000    
Warrant term 5 years    
Exercise price per share $ 0.09    
Number of stock issued during period for debt offering costs 50,000    
Remaining balance of notes payable $ 115,000    
Increased principal balance note payable $ 137,982    
Accrued interest rate 20.00%    
Warrants valued $ 1,659    
10% promissory notes [Member] | Two Affiliates [Member]      
Debt Instrument [Line Items]      
Notes payable- related parties   35,000  
Proceeds from notes payable   109,496  
ConvertibleDebenturesMember      
Debt Instrument [Line Items]      
Debt instrument, face amount   $ 84,356  
Warrant term   5 years  
Debentures outstanding   $ 6,232,345  
ConvertibleDebenturesMember | Minimum [Member]      
Debt Instrument [Line Items]      
Exercise price per share   $ 0.0745  
Accrued interest rate   10.00%  
Percent original issue discount   5.00%  
Conversion price per share   $ 0.01  
Convertible debentures exercise price   0.02  
ConvertibleDebenturesMember | Maximum [Member]      
Debt Instrument [Line Items]      
Exercise price per share   $ 0.1287  
Accrued interest rate   20.00%  
Percent original issue discount   10.00%  
Conversion price per share   $ 0.099  
Convertible debentures exercise price   $ 0.1287  
Variable Debentures [Member]      
Debt Instrument [Line Items]      
Debentures outstanding   $ 237,242  
Amount of principal   $ 11,466  
Variable Debentures [Member] | Minimum [Member]      
Debt Instrument [Line Items]      
Accrued interest rate   0.00%  
Percent original issue discount   0.00%  
Variable issue discount rate   40.00%  
Debt payment term   9 months  
Debt subsequent issuance premiums   0.00%  
Variable Debentures [Member] | Maximum [Member]      
Debt Instrument [Line Items]      
Accrued interest rate   10.00%  
Percent original issue discount   10.00%  
Variable issue discount rate   50.00%  
Debt payment term   1 year  
Debt subsequent issuance premiums   50.00%  
Secured Convertible Debenture [Member]      
Debt Instrument [Line Items]      
Exercise price per share   $ 0.01  
Accrued interest rate   8.00%  
Amount of principal   $ 500,000  
Derivative Financial Instruments, Liabilities [Member]      
Debt Instrument [Line Items]      
Number of shares issued upon conversion   341,000,000  
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liabilities - Schedule of Balance of Debentures (Details) - USD ($)
Jun. 30, 2016
Dec. 31, 2015
Liabilities [Abstract]    
Balance at beginning of period $ 6,174,760 $ 4,496,602
Issuance of debentures for cash 300,000 1,970,250
Original issue discount 145,263
Issuance of debentures for forbearance 29,712
Debentures converted to common stock (84,356) (437,355)
Debenture exchanged for new debentures 49,471
Convertible debt 6,469,587 6,174,760
Less unamortized costs of financing 275,872 430,156
Convertible debt, net of unamortized costs 6,193,715 5,744,604
Convertible debt in default $ 4,882,276 $ 4,313,199
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Liabilities - Schedule of Balances of Derivative Liability (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2015
Debt Instrument [Line Items]    
Balance at beginning $ 620,321 $ 1,061,839
Liability on issuance of debt and warrants 277,411 1,306,372
Change in fair value at year end 262,620 (1,174,444)
Elimination of liability on conversion (522,577) (637,874)
Over commitment of stock 132,130 64,428
Balance at ending 769,905 620,321
Warrants [Member]    
Debt Instrument [Line Items]    
Balance at beginning 60,420 764,958
Liability on issuance of debt and warrants 44,394
Change in fair value at year end   (726,216)
Elimination of liability on conversion
Over commitment of stock
Balance at ending 29,523 60,420
Conversion Feature [Member]    
Debt Instrument [Line Items]    
Balance at beginning 495,473 296,881
Liability on issuance of debt and warrants 233,017 1,306,372
Change in fair value at year end 137,911 (469,906)
Elimination of liability on conversion (522,577) (637,874)
Over commitment of stock
Balance at ending 343,824 495,473
Commitment In Excess of Authorized Stock [Member]    
Debt Instrument [Line Items]    
Balance at beginning 64,428
Liability on issuance of debt and warrants
Change in fair value at year end
Elimination of liability on conversion
Over commitment of stock 132,130 64,428
Balance at ending $ 196,558 $ 64,428
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Shareholders' Deficit (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Mar. 31, 2016
Dec. 31, 2015
Face amount       $ 145,263
Gain on extinguishment of debt 245,908 $ 36,641 247,074 $ 119,369    
Total unrecognized estimated employee compensation cost $ 253,326   $ 253,326      
Series AA Super Voting Preferred Stock [Member]            
Preferred stock, authorized 3,000   3,000      
Preferred stock, par value $ 0.0001   $ 0.0001      
Preferred stock, outstanding 1,000,000   1,000,000      
Convertible Debentures [Member]            
Face amount $ 84,356   $ 84,356      
Accrued interest     $ 4,194      
Warrant term     5 years      
Convertible Debentures [Member] | Common Stock [Member]            
Number of common stock converted into shares of common stock     241,929,674      
Gain on extinguishment of debt     $ 50,595      
Warrants [Member] | Consultant [Member]            
Number of warrant issued         1,000,000  
Value of warrants $ 1,652   $ 1,652      
Warrants [Member] | Convertible Debentures [Member]            
Number of warrant issued 15,000,000   15,000,000      
Warrant term     5 years      
Warrants exercise price     $ 0.02      
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Shareholders' Deficit - Schedule of Warrants Outstanding (Details) - Warrants [Member]
6 Months Ended
Jun. 30, 2016
$ / shares
shares
Outstanding at beginning | shares 116,875,170
Granted | shares 16,000,000
Cancelled | shares
Exercised | shares
Outstanding at ending | shares 132,875,170
Exercisable at ending | shares 132,875,170
Outstanding at beginning | $ / shares $ 0.08
Granted | $ / shares 0.02
Cancelled | $ / shares
Exercised | $ / shares
Outstanding at ending | $ / shares 0.08
Exercisable at ending | $ / shares $ 0.08
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)
6 Months Ended
Jun. 30, 2016
USD ($)
$ / shares
shares
Stockholders' Equity Note [Abstract]  
Outstanding at beginning | shares 34,168,800
Granted | shares
Cancelled | shares
Exercised | shares
Outstanding at ending | shares 34,168,800
Exercisable at ending | shares 22,727,003
Outstanding at beginning | $ / shares $ 0.02
Granted | $ / shares
Cancelled | $ / shares
Exercised | $ / shares
Outstanding at ending | $ / shares 0.02
Exercisable at ending | $ / shares $ 0.02
Outstanding at beginning 8 years 11 days
Outstanding at ending 7 years 6 months 15 days
Exercisable at ending 7 years 6 months 15 days
Outstanding at ending | $ [1]
Exercisable at ending | $ [1]
[1] These amounts represent the excess, if any, between the exercise price and $0.004, the closing market price of the Company's common stock on June 30, 2016 as quoted on the Over-the-Counter Bulletin Board under the symbol "SCIE".
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical)
Jun. 30, 2016
$ / shares
Stock option exercise price $ 0.02
Stock Options [Member]  
Stock option exercise price $ 0.004
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Details Narartive)
6 Months Ended
Jun. 30, 2016
Fair Value Disclosures [Abstract]  
Description of valuation of derivative and warrant liability In computing the fair value of the derivative and warrant liability at June 30, 2016, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member]
Jun. 30, 2016
USD ($)
Total Liability $ 769,905
Fair Value, Inputs, Level 1 [Member]  
Total Liability
Fair Value, Inputs, Level 2 [Member]  
Total Liability
Fair Value, Inputs, Level 3 [Member]  
Total Liability 769,905
Derivative Financial Instruments, Liabilities [Member]  
Total Liability 343,824
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 1 [Member]  
Total Liability
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 2 [Member]  
Total Liability
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 3 [Member]  
Total Liability 343,824
Warrant liability [Member]  
Total Liability 229,523
Warrant liability [Member] | Fair Value, Inputs, Level 1 [Member]  
Total Liability
Warrant liability [Member] | Fair Value, Inputs, Level 2 [Member]  
Total Liability
Warrant liability [Member] | Fair Value, Inputs, Level 3 [Member]  
Total Liability 229,523
Commitment In Excess of Authorized Stock [Member]  
Total Liability 196,558
Commitment In Excess of Authorized Stock [Member] | Fair Value, Inputs, Level 1 [Member]  
Total Liability
Commitment In Excess of Authorized Stock [Member] | Fair Value, Inputs, Level 2 [Member]  
Total Liability
Commitment In Excess of Authorized Stock [Member] | Fair Value, Inputs, Level 3 [Member]  
Total Liability $ 196,558
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2015
Balance at beginning $ 620,321 $ 1,061,839
Change in estimated fair value (1) (262,620) 1,174,444
Balance at ending 769,905 620,321
Fair Value, Inputs, Level 3 [Member]    
Balance at beginning 620,321  
Liability on issuance of debt and warrants 277,411  
Elimination of liability on conversion (522,577)  
Change in estimated fair value (1) [1] 262,620  
Commitment in excess of authorized stock 132,130  
Balance at ending 769,905 620,321
Warrant liability [Member] | Fair Value, Inputs, Level 3 [Member]    
Balance at beginning 60,420  
Liability on issuance of debt and warrants 44,394  
Elimination of liability on conversion  
Change in estimated fair value (1) [1] 124,709  
Commitment in excess of authorized stock  
Balance at ending 229,523 60,420
Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 3 [Member]    
Balance at beginning 495,473  
Liability on issuance of debt and warrants 233,017  
Elimination of liability on conversion (522,577)  
Change in estimated fair value (1) [1] 137,911  
Commitment in excess of authorized stock  
Balance at ending 343,824 495,473
Commitment In Excess of Authorized Stock [Member]    
Balance at beginning 64,428
Change in estimated fair value (1)
Balance at ending 196,558 64,428
Commitment In Excess of Authorized Stock [Member] | Fair Value, Inputs, Level 3 [Member]    
Balance at beginning 64,428  
Liability on issuance of debt and warrants  
Elimination of liability on conversion  
Change in estimated fair value (1)  
Commitment in excess of authorized stock 132,130  
Balance at ending $ 196,558 $ 64,428
[1] Included in the Condensed Statements of Operation on the line "Change in fair value of derivative and warrant liabilities."
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details)
6 Months Ended
Jun. 30, 2016
$ / shares
Derivative Financial Instruments, Liabilities [Member]  
Expected dividends 0.00%
Forfeitures 0.00%
Derivative Financial Instruments, Liabilities [Member] | Minimum [Member]  
Expected term 6 months
Exercise price $ 0.00025
Expected volatility 280.00%
Risk-free interest rate 0.37%
Derivative Financial Instruments, Liabilities [Member] | Maximum [Member]  
Expected term 2 years
Exercise price $ 0.099
Expected volatility 334.00%
Risk-free interest rate 0.75%
Warrant liability [Member]  
Expected term 5 years
Expected dividends 0.00%
Forfeitures 0.00%
Warrant liability [Member] | Minimum [Member]  
Exercise price $ 0.075
Expected volatility 272.00%
Risk-free interest rate 1.21%
Warrant liability [Member] | Maximum [Member]  
Exercise price $ 0.1287
Expected volatility 334.00%
Risk-free interest rate 1.49%
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 6 Months Ended
Jul. 31, 2016
Aug. 31, 2016
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Face amount       $ 145,263
Net cash proceeds of debentures     $ 300,000 $ 820,750  
8% Secured Convertible Debentures [Member] | Subsequent Event [Member]          
Net cash proceeds of debentures $ 100,000        
Conversion price per share $ 0.01        
Interest rate 8.00%        
Variable Rate Convertible Debentures [Member] | Subsequent Event [Member]          
Face amount   $ 85,800      
Accrued interest   $ 551      
Number of common shares issued   42,565,754      
Aggregate consideration of debentures   $ 111,279      
Net cash proceeds of debentures   $ 174,043      
EXCEL 48 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 128 229 1 true 44 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://spectrascience.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://spectrascience.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://spectrascience.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operation (Unaudited) Sheet http://spectrascience.com/role/StatementsOfOperation Condensed Consolidated Statements of Operation (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit (unaudited) Sheet http://spectrascience.com/role/StatementOfShareholdersDeficit Condensed Consolidated Statement of Shareholders' Deficit (unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://spectrascience.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Business and Basis of Presentation Sheet http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Liabilities Sheet http://spectrascience.com/role/Liabilities Liabilities Notes 9 false false R10.htm 00000010 - Disclosure - Shareholders' Deficit Sheet http://spectrascience.com/role/ShareholdersDeficit Shareholders' Deficit Notes 10 false false R11.htm 00000011 - Disclosure - Fair Value Measurements Sheet http://spectrascience.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 00000012 - Disclosure - Contingencies Sheet http://spectrascience.com/role/Contingencies Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Subsequent Events Sheet http://spectrascience.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Liabilities (Tables) Sheet http://spectrascience.com/role/LiabilitiesTables Liabilities (Tables) Tables http://spectrascience.com/role/Liabilities 16 false false R17.htm 00000017 - Disclosure - Shareholders' Deficit (Tables) Sheet http://spectrascience.com/role/ShareholdersDeficitTables Shareholders' Deficit (Tables) Tables http://spectrascience.com/role/ShareholdersDeficit 17 false false R18.htm 00000018 - Disclosure - Fair Value Measurements (Tables) Sheet http://spectrascience.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://spectrascience.com/role/FairValueMeasurements 18 false false R19.htm 00000019 - Disclosure - Nature of Business and Basis of Presentation (Details Narrative) Sheet http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentationDetailsNarrative Nature of Business and Basis of Presentation (Details Narrative) Details http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentation 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Weighted Average Assumptions to Value Stock Options Granted (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfWeightedAverageAssumptionsToValueStockOptionsGrantedDetails Summary of Significant Accounting Policies - Schedule of Weighted Average Assumptions to Value Stock Options Granted (Details) Details 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share (Details) Details 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) Details 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventory (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfInventoryDetails Summary of Significant Accounting Policies - Schedule of Inventory (Details) Details 24 false false R25.htm 00000025 - Disclosure - Liabilities (Details Narrative) Sheet http://spectrascience.com/role/LiabilitiesDetailsNarrative Liabilities (Details Narrative) Details http://spectrascience.com/role/LiabilitiesTables 25 false false R26.htm 00000026 - Disclosure - Liabilities - Schedule of Balance of Debentures (Details) Sheet http://spectrascience.com/role/Liabilities-ScheduleOfBalanceOfDebenturesDetails Liabilities - Schedule of Balance of Debentures (Details) Details 26 false false R27.htm 00000027 - Disclosure - Liabilities - Schedule of Balances of Derivative Liability (Details) Sheet http://spectrascience.com/role/Liabilities-ScheduleOfBalancesOfDerivativeLiabilityDetails Liabilities - Schedule of Balances of Derivative Liability (Details) Details 27 false false R28.htm 00000028 - Disclosure - Shareholders' Deficit (Details Narrative) Sheet http://spectrascience.com/role/ShareholdersDeficitDetailsNarrative Shareholders' Deficit (Details Narrative) Details http://spectrascience.com/role/ShareholdersDeficitTables 28 false false R29.htm 00000029 - Disclosure - Shareholders' Deficit - Schedule of Warrants Outstanding (Details) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfWarrantsOutstandingDetails Shareholders' Deficit - Schedule of Warrants Outstanding (Details) Details 29 false false R30.htm 00000030 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfStockOptionsOutstandingDetails Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) Details 30 false false R31.htm 00000031 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfStockOptionsOutstandingDetailsParenthetical Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) (Parenthetical) Details 31 false false R32.htm 00000032 - Disclosure - Fair Value Measurements (Details Narartive) Sheet http://spectrascience.com/role/FairValueMeasurementsDetailsNarartive Fair Value Measurements (Details Narartive) Details http://spectrascience.com/role/FairValueMeasurementsTables 32 false false R33.htm 00000033 - Disclosure - Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleOfBalancesOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) Details 33 false false R34.htm 00000034 - Disclosure - Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleChangesInLiabilitiesWithSignificantUnobservableInputsDetails Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) Details 34 false false R35.htm 00000035 - Disclosure - Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleOfDerivativeAndWarrantLiabilitiesDetails Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) Details 35 false false R36.htm 00000036 - Disclosure - Subsequent Events (Details Narrative) Sheet http://spectrascience.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://spectrascience.com/role/SubsequentEvents 36 false false All Reports Book All Reports scie-20160630.xml scie-20160630.xsd scie-20160630_cal.xml scie-20160630_def.xml scie-20160630_lab.xml scie-20160630_pre.xml true true ZIP 54 0001493152-16-012406-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-16-012406-xbrl.zip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a"#B5<\_2<_VTY\T.YU"ZUI5YQ[ MRS!75.:C]IY!KLKLPVYOT-\[R-7"E$&[,]H"FM$FQ&@4&)B%JQ_HNZ9>?(OY M/I20\79T.SAG S5_]]2DVX*RFA/;A=!B6#>4E?-X_;[JY]8&9-4@NJ,>R*^- MX/-LJ9R,+W2HHPO5RNYCKM9YH-?JJ4U"*R_S;1@Q[R;@[;^V:QR?<"GC5LEF]UF!0'WB5,USMMAJRUP!>Q0"SWUF;N#MF MN[XU4/> =P96)7;K61A+[1JJREQF]3HM-4^P,["JUK,,V@-KL Y<+-ER!KYM M=;L]U?(4IEAG_FIZ:CBT"HVA-YJ],H,,NIVVFN_:>/IJC #N>'O4V]K\CSN' M3SA]3[8=WV3V)6WV]@#)?/>Z%3S@BC(B1Y:EVJ_MV',H/O739*ZP=U6I?:R# M10[6$S-O!]#'Q;LI@#ZI"1H$Z.,Z8QF@9\4S Q4A_1#:*?K>H35EZVK/QSVL1-=<]?UN&0L M.X0X&ECM;J$TLH'K>D20EJZK-^@..FIA]7;618:6'[%XDT9X^),N7Z0S/#Q/ M$U,64\G9Y/F:K>0CA^W^0I_4=0':Q^K63%Y\$I.T[S'TNGW MU4+#P\7":@[;4S[C$I"Y6JB599>9<\ZX?74/83.@]XN"?.=1;-3@O<>R%V:L M[$&NW':HNW 2_@#P,U#P,RR''/'W;DX=5(7^R$%;/Z M\&H:K8ZT;KO7[PUZ6^\8R;<9<8%LT?EODFY::Z2J?:'UP*E>N #2%JR16@@<5(_CQ M[-.$Y#FO)XS?AM$UB^X\!X0TNO1M;[J=PL .1+'J9]#:E_))?!?U889!N( M'ZP0P9;/OG70MX"^=X$3,5 =;QC_WW=*W;T2Y&\EHXGG/ J7IZ\T]18AKJIH MYX\I; UB>4OV%^8P^'[^8N9U:P'P#I_'H%V<=EN@[H03WP6860FC+?%?=S#L M]AY#CS+?QL!5/@/0*YZ.VPBVSQ&;@=D\)MX& ;;T27#86O4+I92;0#2[A=86;G@MJ8:.F]W M@2 P,C_F_)EZ$8-QX>7DX;,/41)H*+SFC7KDK$FM)Z_YW0B +3@02_")EC/> M&0_7#]06, 70.(RY,8XX=^AD*RFBA4Z^2Z?;$++J6;76H%<+9'-;AX.5MPYI MKPXS.:OL&J[21;FF%>YR<[3,W>FVU$8&:R[S"Z-KCS_;H*:VQOWS5S4LGVY3 MT+:L"I0<&V?";:%D\0*%)R;="I1;QHZRMQI?_6"1X\5K[UON9-[*V8W>,IJ4 M3KG,WO,LH)KIVXH_V.L,K+:ZS[!TM@T!J]P"KC\8MM8";(DOD!V$WKV3/1A: M[>'P21=T18AVO[[*M.D.NX/6KM:'0X$?B_^#ONR=[2/A>=)V/NC:SEFQ4;^C M&+DJ\V\;]NIGI(#51MWM "\W#G$K:=Y[O7Z>Q%[ X?L-B)_)FH@P$#S. !_(9/@>M2M;K*P#[V@&U9HE+X(P@B487[TID!_XP/@23NW Y#^8!EX\,WEE M3.WHQ@M>&JU7!LYV9OO>#?P3Z[:\R<.S_[Y)7N$$8_S#.C<^VACJ&>'$D"LR M[, U:"'PZW__E]5YI2X'OWTQEJ.\F-%?^!+_KQV"+G[T I?AN*WSGA?PY=C3 MV:O_LOJMVD'*L.GA'PHKJ/@DH#R-L1QCUS/F))%][7AX>91I@)$\-^[MV/# M6D:S,,* FT#Q B.Y90;=VX,X_> %@-(PL0W \0?[P>B:AC4:=@SX^&]_&!^8 MZSFV+T9\%QB?G"0&;5-Y0W#Q1Y'Y&E"#.=!0#(#_RBD ML80#WG#S[N8&FTS"*.&BPK4W'R6PI\Q(0J-TA5]A)0+SW<$K+!&R@P=3_C)\ M9=R"V@&/> +JAP O50R& %$ ^+L..O];>C[#T9X'P 8<3J./=>S:4/T?3JU MC7=3^P;K#"\%;I$_G^> O/_VX2('XA=3SF>("0W2AX'-2SW%6I3O"X^5@0A. M!+$(O_'\VS]^,=Y[4P_/GRGCB->^_4,9X]RX]O ;H%_?)%80:#-N@>*"0D@[ MX#H/41!(,N&"\?U_V7?77R^^$C 822/Q7WOA+'XPKA_BA$V-YTF!+N(#\52% M18LO%]^OC -[. .L )!O> .+-$="!5S;H/0#V\>@*QV8H2*AIPA? 1BV?Y; TC@<(4J\K)DRQBRY9RPP.$I,F)R=.9@NB,(4K%YD MY/]PF.^#A'G);9@FQ%$!@Y7"@!&;A@@8_ 0R]V]@7GI9PC !"T\/QZ'[((&8 MVM_Q;><6D 920V!CA,N50Y'U#-[) E8U?C!0+V&E< C0QO:$&3Z$9Y'AXQ%+ M!*8,'40.&X3RX2\FH.+*@P7@T4@!F=T^Q)[C 7TD?/"G%V")< )(LV^"$%T! MEPJC#!:X(6C.V0,H'4 @&#S (SZ89%@SN5Z:@$:GPD#FFCCTF %?&=YT"AH8 M@.,8 2I1-;D& M@E86A6X*5(&9^>K&,'CHNX:P*I(Q"91O 7Y)JP#4D)I((@\\1J S)8!Q <8 M,!#+) I2+R:R-/^3!@R!:A?5%"-?$J>$SVUBPL@;IZ2#[1M 'JT>V8M[6EVG!AU3K &1"^MMHUOE@L2>=.3$4B20/C%\((G\T9 M82[Y@B$%H.?\JUO;S4 V%'!)<:!"9!"T@"^"+"E62)H/O\M4KEG0N<;;-Q>Y M>H7%P&. -SB3:I2@$4(-"@/$D;L&,=QP7YP93^O496/9SP5&6?,(KD(91&P-HY"&^GH<<=S MXJC!G8RSQ1I$&=0]H2@%!,[''3GCY#BQR=AO>GQMO*$Y#NPEF M#&B!2"(W"5TC?"_W>E5_%J F**;R8HO'Z"*!B\19'7JQ'!M2]%"NP%63FE>= M&I&;4@QZ0W>XD#U4I68.!*T.QL*BR% MG,UDZ0CGA'*B XN!QX!0X%Q"VA-X _[9Z1H>/QCV[?SZW)B!$@V$7FT/,XG' MT>@)*C,?-!!WDC3IYS(.,DMC+&1H=+YA3E10-$AMH7)+ SMU*?Z0;:132*)AN,+KCZ8XP99EAYRETZ&C1RT38*L\'E#Z> 8 ;&G?D .M=KZ)O# M.'JCB2SGD!3X:*(X38 M!W]%05).1_+-$3C," CU!TQDW]!CD\"W\T.MQG.AO(0)Y"Q(,)#K0];TAH"Y._81K M)Q4PNA18.V27KW+ M/ @Q$S<+4_L!PR7V Y,RG%DR3TFZ, A>%H\)_Z5/A@$LO;+>&$)GB+K&.(5- M= 6\_3L-A-V2#%R**^[=\@",>(E'L-SSQ'4I]FN9-W@1!&B?OA"/HQ\D1>,? MAL1HB5[/PMY.E$C D::6XDH',(VPN4!-'?0:6$$<_0F,OX- [3 MR&&9[^O8\2U7#KB%G.>3/%':PA6 [9, BZ@VSMNHX%,W*^4K>.[JI+<99'S" M,$TF?GC/H5"MGDRQ4L85Y29KM&K86?6&$$>AN.A>4%/U]D'A%JYGS-80*X.< M&V_]%'W*/!18+MSW8?2=[!9O/F"X*27@$P@UX5?7FTP8]L[F9@.3Y;1*"IAG M,H&/O[A>/(;05JH=/PXA.)X!4-E'7 7[&-:I41!7D61R8?$IV%2@OCL0)K6W2;W)!Q>R+ MG'2*:T'&NR?S)WR@PFI@BIBQ[RJ;"#Y>!'P.M'",P;>4>_$55QV8FAQG^*7 MGT538=C19G(7"TT77B_ ML&!0BPAYF!>D#@M>XOSV&D\(V8L*EB&5*6_SD]4R6^VNV>JV M,C# M@0=-%=P([]^X*"3@C?>VY_KVO=@+[ Q?96/P+]S_*!4 =-N2?IX:X M6$S<%3B'6(_2<;CO4/*AF%>$ &2SO"]G]JM\Q9$ M%+Z/_C2ZUP+!X1W,:!O)?7A&#BZ/$7)/PA6[ZLN .C?R\P,XT0>TYQ+Q'7,A M=8J;@8S& =V(6AT60^:T?#&$=+&<#&8D/XY#E@?4I[OP!JX1S=Q](/.K&2!9 M.%0:!Q7Y H>%-WX: L.T6O!*P'@V6LFI.52K3!S=Y2^EDHJ@Y;/]&_!8_A[> M@XF(.$Z\)XS@G%J-*96 +@OS4=<' 6ZBJ2,X,H""%__-0I I]\%XPMJ)?.Z" MX8 PRP7-+/;L28,*O$8<)^H/9$@>-R ?LF@:9O$]=L=D9C&SB 9:3ZJ@F%"^ M6.Z_E; <8-M! XV<)&)/$P&90REFO9#![A%>N3(.O2VW&<"K K]3>M.$Z'GK M);T)Q2M9QVS9"3[*S1:>[>3Y4FFF"(I'3%7&/X5I-_=7. X51YI[(;29FCSJ M?H!2)5P1Z1;!*F.J%1B)<\129FJ.Q=Y_PO(V]%TL +>5>I"C?QT%N,Y$ZXF-C%H8[Y![R7X*QYH.$ \!/4AX/ M]C M]M[C1MY._41N/]%'*-/C- &NSH8UET"0Y>^(#Q%:43U!HYHRA6C[7//:O(*3 MYTVQPQ6YZ62*9!:)ZW1*'VY4>HI+<.6W,:WC8D- M 7JV0?=3UQP.VV9[T#=NF4]IT,&(4G!WGIM25A>/H=*^*N6TY +/C8\49$R$ MR$7OJ2W=*"C+22YD1L1^ &:]B_;8 M&./^C"GVR:G\%T)Y7JA$"5<,J^V2$@-L'!9/A!,"CWRE48&2%A?K!N\@BHG\ MLGR1.P*E"=7Y]#W632CY;Y(2VK(.!8P.>I&J37-\].4F8E=.VE=9:\%=7'O* M+Z] MV[G(]C$^ASXZ#W&3*[W;Z,M/IXA9(("R#"-?!Z] $HO1==Y+T]]?A'.%L@%X MU'NN3Q6)"D3]Q3+'-*;R08($G. XY36>#"MR F[)L&H!RP=%@$ 5/3'FDGUX M,^*Q)H4*I'HC,H74GBW7S!'&@.1L\&I M)$0.$R\'_R3K 035$I6K.R$5- @ M%9Z'(-MQB"]AR!6C]W)N2!;(0FF9AU^2I1:EB#&.EV]U9GAQ>34E.% *))$7 M?R=MB93H3 MKE.&56EP\XI-&#W$-K!,V8%7,@< BHHH"8)@+DK3$%.,<=JY*D8)MVT$=&4* M54C!L.#UB?1"ML M$I@PCLUO@4@X)-*WU$*TQ%O*:LMYO3K "B]*,R@KJ<6!$]IT3L3]$M,92\@; M-2$6 FL9D*6*V$WJYT59D3WSW+P0FF_\TPFVI24"2LH3' LN0OG\JC21RX*S MI"JY3:4J(-,'9CXL_J, D"F!EF6G(H/#N2FSO'POAI=K0[@8)9GY STB#W_0 M!K<* ;D!67I*.EDR6H@?$V*1%8IY]8AB M$7D525EFAIL3+*'$P&,K]:2R3E*FH$0-0BSVAK*-&UFRR"1Q^=$QB':F,U%0 M2MGZR82$7DGP\,+1'(*E17QXX!8B&!5XR***>\I%--7^0@ MXZB8T536)9P,$\'%2@A4(W2V-TN\R?25#\_/?#I#(S)9N<8 +0;ZD1*H_)E9 M0 T51&%\0MG>&/M5T'$\>/;8BSQCC]=Z"-<(OQ.U\?/85XZ@\>,3RME!Z< O M'@EQLY[89!S"@!.C)')95/H$T[*4_ 4O^)<%HWQWDI=:R8@XC!5NTLIT7IF^ MRTY58)-Y'5D\J4]CKM(\$LSL1$J2[3#[X3V/E'%[A^^.TL%B$@@S#\5%FCZ& ML U"'^=TO3%[($\'J;.AMO"HJ(+LS58<.>I)8I44,WRFK68^;Y0W0[+]_!] M=#/@)5Y>( L6PS&8"'' 3%0]N[*:'^N\A"RY\K"4RP"I[N*.?Q;#),I193PV M1KM]5'?);O#D7[8NVB:/H$/6; M2U)R-Q'FU3@; I2B#PS#^MQ2>,6J'%',)\&\]6[0-RV,)K)Y(FF4L3"=))>9 MP ;IQ,952V<092[)XL)2?7LW.^(E2 MX3GGY]S(^T=[6!D=11XO"R!U1M]@J8^X)PLU[IW(ON9*#%RA2+>95N%@\S6[I7/\4U;9T.B/R4O%6+A4&U+[<4O!_ MP;=948K6;P)8XN.)J]8YFEK?NI35/(%P/'4CP8[U-HU5D"0) D(6^:!Q]EA?21%MD'$ENQ E&RD MEX8<:#:P"DS6R^'A-FZ 9+14+"Q?=#E0&BF*XO&9W)/!X=6RK0P8 ;)('Z6) MK&SC1_I!M[@W60@G$9%%)5Z A?L49BE!5^$."DL.!Z=R9&M8G>QYHT0)_LUA(+_#-$_!)T- M+R*MB!MVS3;O#33TO!6Y=,-03V);D0H*/TR6+<_$F<5Y_+XZV@YUS&9EBQET-V)[E'J8"4,*)" M=L/[X-Z.."[P!#2FH8R9;SL\'EQV'H]2,G/:0ASPR2:*J5\*@"W+G$B=*_W$ M7&8#@N.9!UY,G+<3$SM1&%N14U$L[ OH,!GFJ.]8(8"S,1+&I7+@:)5S5D=N MIHFSK7&!VM2N2Z:%A/^5%V-Q]V+*[" 6&:3\0S)T%$[+&E!Y6(W9CCQ_3#;X MAHJAR37C)]WXMUFM@_A:GF.4*;CY"0-7Z5DR5]BJ'&S4VF!.EWY"#P(O#/82 MV6"%7_RK->B"!LWD;UY?<>Z4'CD_];&6 L4P(%"+3)[T*WC[. D&UOQC3:0J M)0O VBFX^A$)U_B!/%YZ($K(YQ2U3$[DYU.D$R8/;L2YT\_+C(LG^\2D\KP! M#A6. ;G">:32G2SSG 8LNRLA1YHIF\,).9?I\F+:.C:F:4P.J] [::R>]GD- M"OR[<>W<8IK*X-.H([OX1[F:L#]S'QLQ@K MQG/8I!TY-419D1UP;:Q5T;PJHN;=9W0CLJ%>B:PUT6.Y[H(%)\[B9[E%UD:Y MPSH[C<;SU;&4O[<7UZ^-B^M+XVLX\QQC8 U-0ZEG4@C!5]VS.*D*1#)R*BE= M6G%4&$]M&,M]N\(&(S_K 7$Q"'N62E+J97FF7IE+'&SBZ5[?5Y=MV.B[B?T] M4#I80Q\^,-GB *:CVCB1_8ZY2Z?DR[-]L:P'VDU$O2WA\=Q1_FPO<7%#K00@ M,9H\14FCW$&R,W]7JG30_;0X_R'OZD)5E7$BM:+TS^*,'%GRB @;8S,\46B; M>>2/IY]X%Z%R) .M)Q -<&^/VQ$\ YGA4C -\+78^6Q@3?!)A(I[WR8 MC]3MHF>^2E%3!AE6+CA[6Y%2DI& MNN7CRM91?("L@6>X['W1Z(%W^1(%(Q0HBZ0PY0U!CJD91<30XQ';8%P-Z_.5 M:OL#L# R_(PS[2[=4"0"^78$3 GB%XQ0D?=YO[4Y"J,DW82HIM3#"AG=^4F\ M7 CEC=SY+H+N]-+ZU:112 H"UT=8TBR[(@N#)6CT0' V$).$^C,ZVV:/3< M,Z7= &IE)>S(4RD2LLR:B*Z.E,I@!+]$15U8V2FXI*N$.!+:"R,8ORH%YHDGV<6XT)ZG/N]0K"N7Y_6U(>0%J0@5!:.;B M_D+*AN8QGAA8%6I>E"$'H4Y1F G@.)>5&_#G'39WCTA!"?SQX^=26W&OLYC@ MX#M,0*KK3^H&4U[C(L51E!SF13FY(<0:.(G6$IYQ56W M?GYEC.EC+1G,7MIR+^>Y0 A+)&UZS^7*8W$K6]46#9@.?CM6?_9&C/ &$B 1;9ZG)^$ MJD+N+NV:1?#B8!F;U(F28T/T];+F9#6CF?Z,3E2\VAG5A>;A"X2%TF:2==X# M6M)AG:*&W2%?H,TX:DEK)LY[&N>:ST\ YW7S^1KF!=Q 0-!-!)&[BZY@&+TT M_NOR\NKJ[=M5+4_F >\ B5?9=AF+IA6QV3ANK=?GP>YUQRCS31FU9MILOC:- M]*K]IWM^?E%P_Q$ MN-+90G;KD&=,S^09T[PQG_I5X73XN?'&\VGJ(E0$A@I9[$T!B A!&)>M H^_ MSY*\]3,0(Z0[84+J ^,%#O:E%BT%E,KXS]2[LWT\ZRM; M'G(4X++<_!I6I8NUF,V+#,:O+<+6X #I639X<^1FOX?5WXH>&8^=;B9(%DXX MFW.'KIUEU!)-!QXCE[SI-N?PK#MN1D/1[1N;XS24DNL8$GW06I_6HH\+;02. MT4$^%.3K,W.U![1U!D@'MK C0$U=J5!A\GK=&H^^?(X8OW^>MV&JJ#H:7][? MKJ_FNF.VACULR'5L.-0$.6 SN D"+TNO##CP?/,.BTF[ [/7&YEM:W2 .#H4 M+%LM"V1Z9/8&W7I3O0>]^_E)-(D[/+ZLR5;D[2T/#T4'@^21B9CGMD?=9JO19ZT M_R)'?N:SB M8E1P:M1J=SO@GXS,5G^7U"K1+KJ0I&QS]VMA@U;<'T:[JDW]H>0FC9?(3M75&D:OT^VQ-XC=M=P4;4P M;;S!KD7H"+!ZTJ+3P.H573%T$LVU-.T2A4T0M$FG[J;4.SRGS>.J)5-/DW$3F'[13'7@ M3#7H=LQV?_M-XC57G3)7M4VKVS5[E;-VQSU#D5?'6%4K[J: MLJQF8V=SKP5J=4I58F:64Z26=9U_C2[G"B[K.?3 M':(CM]5SH#H#W(R%:=1HU)PD:HXONGV3MY_4N]8-6IA&C4;-2:*FB7[G)@KV M7S0:=M(5S8;Y;O5BA^&CUKZ;8+"/[4GZ?;/3VV7WC.:.4%,;B-' M-K8#$9C M>8>\W&V9 \#TL+7+'@[-':$N7NZ9@^[ [/2W=-'0Z04#3^QVG1T@]^[=M6GN M"!HU&C4'B)JZ8H5]]BJZ<'%T4,+RUI(LD. A1.V*^-0:XQQV^'%JU#KL,.;4 MJ'78X="I4>N4PRKMFC5C81HU&C4GB9JZ8IVZXIKWQ6L4#\_Z[YTCFCN"1HU& MS0&BIC[/<'*?H MXRE[]M3>\/(++2V'("U:KVI.T9RB.45SBN84[:L]Y:OI2Y_*+GW""3S\XUUP M!\"&T0.!X>T#H.5H*V*K;AQEJ#&<,(@]*HT+)W2I579?%D%B)R5W6+UA#IN. M661T++-I%UH]B5=]>]6JVP='WMF_P-<5-;]&_J91^;P*J9D :V0^#JL(JIGM MZD]DF5O*JZVP!RJL3J];8]OH+_8]F&<0.<_VJU;.[ZHW9@-B&0E-_^>Z8I9V M;V!:5K?9)#AT>K;G16N']+3ZYJ!5$SVWI*,:4PKWU@N\^!;BF)LP=!MRH&>5 MYKQ;G:,>/NVUS;XUJ!W%FDA5B-3MF=9PEP="ZG-R&N#1[;]<;Q->Z+1&YJ"S MI?2FQG"9Z>Y;YG"X2YUX;/;Z"XM9=,>H14(X!M7(8@CDG8:T #]2HW"('2!I;/$@>&CT&$,BYDHO6(3 M%$F8P++AZY^Z9+#.C:^W7FS84[ 1B0'0&&/& @#&\5-<@A<8D;K3>UXWDIM* M=YS XRDL+#WQ'XP+-YQ14[G -=[%<0I_7C@.XE76T7V.P@#^[; I?,%WIQI6 MD"@7-8?Q,7GK1?8@0/,.(_>:VS_;4=N;+P.X7^,YV\O MKE__8GCSM##R%[_-7.!LX_G%];=?C(_A.4USUNH B-YTY@,44K@_1RP&;-D8 M[Z#\O&'CA,@,L*!(QTG,Y1QB-><6!(JK@'=8E<3BQ! 8[<%:WTUG:3Y0]H8H MO2R%\S)TO0DX>/@1BBS+)KA)/9= B-B?J8>-T)-;.R%(7 31DR Z""*\Y=O( MI$EHV/ /)[P)O+_@W_2N[]ECS_>2!]/@J[@'R$"/T,J1LV-X;\*B"/X&S17= MP&S/[3AF2?R+"8I#>=4+N+JYQ2[M/@$0WS*6X!BVX0*@#EA(YJ8.X2'3;XX= M181SH9$(*78R!Q]'@0"?!D"AFS([3B,2K@PM! 4UX"U!A@VK"T* :3(!< #J M\0,!0;@E&47]EZ""3(E1%-33+/" T;>>R&%/O!B\<..!V1&P.0+E(7F]*<$Q M@[]"H.:]!V/BP&',YCX9,Y"(@! P@0_S*EOD?F1.K8!SS?"6C:/4!HN9VU84 M^4SBK[\1*$*N^V>MMFF\!R9!MOT:SCS'&';;OTAF!WMYY[GP+!,I,INY..(_ M??J<\T$ T"^*GT/6W4-!#',)RZ2!BPNQAF1G?!?'QL?D(/+'X1@631(/@T;, M%@Q*$+AB'!/X"P:P?; _@OWA44)#"6$T[FP_18,&"W=G##7/XE8'E1#NP@2('*B@ 8@OD)BJ>X?'ANO"/I M A2"6K&%94UC^@2<+-2&\$/$DBB,9V)B>P8DM)U;#I?TLF 4)P6513::(3+L MS&*0WP6O.0G7,D0@G$SH9A+]#!_WGN^#BP0SA8'JR*G^UR0S3C&H>&[HMTN?0]]S0)5^!>R]]D/G^^__^1\8\/YZ M??GNZB6\%X%->)^KW#=@=_T0-6;V!2X?D?^%37Y[]A9<$FXU+/A/$O*_^V>= MUK/?:Y&4,6T"G1L*S(2,<>/$9%PB)GN!LBBX'T-P[3_;#Y2CT IF)9?J8WC' M+3&P>[>8KN!>5>90.W9\2XD$JT69!##VX!K$S"$?)$#KOV!FZ MN<8]./D@N^0'XV?L!XL<#WV2R',HM_%3Z[PURGL:9NZ13)EP!3,!MQQ5%<^] M9Q=!3= 'FX)2B1,0:NX-X'95+$,L HYB&XR!A"/$UP(." [E30!XC_RMS,FT MAMP#Q^6 W\7]*7H+Q@3_##T94WA>'JBW&=!$QCZ%B6WIU\!;$??FX-\_69V! M.1JV,4+"[(Z3A.01Y9-R5PI#1?)$;%)I! 6X+NW6SSR*FO\0M:-/JQ%>*\( M41)8$CSOE]^:990>\\/D$$Z$+V3S\_GX>(*8//8%V,G=)"?T)\OL]T;":\/E MO\;TZ-FUWCRSO@0NHR[BO@Y>LR1RX--/(J'5L#F\(,, =?-O$1X MENS'C 4">T$8G"%'$A@9G/ !\G&#'+#&R7Q!6\9279X97T2BX+,=999'Z\_M MYH+O0TP]@&VW$Y8I)ZEN;?<.58*)CI-.5TRO,E/W6$#D/% MRD,UTI\ TAF!1"!8H"\@7)IZ&-\]D%80H6")SHJ%PHBSP>=UA1:Q%43L,@QH MHQ9MXALV!L#32(O62CB\(/DHL%S1.P&O@.M^GONA!(IBV\I1;SR781,28%' 0T!#@0M<&SS@;RB[EK$R9ZU%3%LP ^^JB+S*U M'P@&AR\> 0L+OA%^+A)(!G\IQF'(#8N+,Z-'9I&?@JZ9XIMQI:'@E!PK009$ MG\A%)S;H(D0_^H%\Y:C*,,%D_)T CHU_<5^"Y[ -&WL0* LB3$L/D%#.G4-8 M-5\-:CD&TY!F%=Z@?6=[/D4 "$8:8,1+B6:.$^:JH..D"^[H AK: @U6>SA0 M\0#NL_18RCSGW 'F1)&+O[A![S-;.OL3,V>"RH*@?-OF<&PZW5/,57H M7&Q2W M\%0LB3P'9!IB[&'?A1&A&0:067M)F%L6%/3,$S"?JR\(U,$28B Z$SXTK*2( M1,,-:9<"DQ.8_HDQ Z,NUO'M-!9R>!-A,_C<&5"F4\$$K_ZGOMGNM,T.$-HN M*-?,0VF033_8/7[<45_;)/UA1YX]YRP\:9L(D%&I;:.T MQ"*5?LBW4 2+$@AW$GC%L)3,FX\*+-AMG?5RK5>2.2P8KS&%SLO3C/QE+M[T M01+9A/DRI8=6N6>X]D.,"<\[+TQCD1 5P'/Y*B%))I@S)9C"9/;A( &0.ZPQ:'*U01^F.UD@DJ#0:9>.EV@2T^&Z*I2D)F3 MLH7,:XAV9V"VN^TY_WW\;T\^\$\S(R@4#YZ0H5Y:]]16@/-,EI5 M<,1R$VJGH,@CW/OF#,(M*LQU&P8BV81@2,]#96*D0BPVZ7ZR6B.S.Z*%9QQ/ M/A]?1%[C0T3)6(NR,')P&$CZ:52T:O,==($Q?(NNC,7$>, R#/&OFZJD&Q\^ M+#2QDAIW5PK9=TWRO=]VH7PMB,\P+-; AU M(LM<@[LVZWO5K[/OU6N1'0>_.Z]B0J^7G/:*@GS\C9.L^AHG]4UKT#4'_:J' ML'0KK&IXJJ^U61:.4),$=WMFNW\ G>4.P1HK MZ>T#9-F:>K6,S(%5U1%L GH.!<&GUW5J$VP5M_]$)9 ZN-$^P2Y3#X.>.1P<8N[AE*C4[;1,:UM!Y8FZ M!B:$&E1*NZ!MFJ%@= /(1RWKJ&,.*A>3-59/:6(_AVS7[E:\(.W8TZ M6I_ZP!9V!*@Y?FN.IQ]=-K%3O_Z87VOTRK5NPV';; ]VZ&V!VK _[: MJ%[SK=MUTP1T#.U:-*I2E2:VP"&H=#>.E0]$%SIAK'0D6G9#4'N(]60/,:., M+MG&F/$B^:M +!I%7,]?I+RCL5)&)T30 O=P/+1\TYCN";9Q'>A M,X9L4&8I#:6W0 M0<_&\6,&T1OXY,ZF;K"R;>*#EN@5,'CM86E:B9@JU"/@B[TNS/G. M)KP-H")-HBL(]>7(3I+;V!0T)KDO:>=!,.0M/? @MS%)Z6&6#*>6 *OU[V _ MO)B:'M^K0.9[[29O 2Q;D_)V(@1#X0-E31)4,8%2Z3=F.%&AOUW>T5QM8$[- M\R:V%_%>>G.-991#^@3(8QT)EO=@R'HGI,'W(+P/)!)%:X05.S!PO$A(L"E9 M"2J*[9C%&K'%#XN9\00:XZSG<[%WH. U//QSX6P,53 MT8R!SM,C\8'-G,@;8T=I:IR3&Y1K7-;9:T(.0LR"F,8_SPT,;R<)\B6.?!DA MP"QD0<49,0GV:1QGS<&I0DRTH.;"EE-9HCQ#"#9>Q(;6/SR\?,-_R/LF<60E M.P6CC!34;\?[07B\QW/@TNRC)<_[9#1'R^[7U?S*+7G&?FG,[U-Q&2HG+Y!B MHR _8K)I.TQIWU";B\+M+N@NP/\32^!M 6DBY"C[$;V=$&GC!=B5%(;""T>H M<31U-Y*L [SEB^[-! 70O7S.?Z?N#?YV;ESD[3:P_REPC9-@;WBNI$VAPE'Z M^"]27R*ROK.DR& K]&LQ%8CB_$5RC^)8]FSE#5?#L52D9!(*BO^!:S6WQ%!@ M5\2LE[0Q\5,GX0HEEAH-AP>$PH]R=!(\T4E&K$RVIWU"7YK+7E)8(">D$Z:^ M"R0G2.0%/+ 8UYM,.&4%>'Q9C92[_4M@UC8SQ%M7N-U1\"UYG]OJS'E4['+" M6\J!:.*&&'8/XOI6"I)P420M^DP ('7A M0B*B@@1M3^X*QG+4^TCEAP 84'92Q6G0C4N*L3$MF7--D3DDT]QCPSE$OT+0 MK(\TU^X9HW&&*O_$9>*31JJ-?2B+@I,=9^'0?--%+JKQ0N/%,C< MGQ:I/;4?YMTR?K1/]G>D)G]8_2-[\1(P4F?)#I=9)RML5TZ$Q@>BN=2E8Z7)'GGM.7M/\,\+,UZEV*S,*6=FXI]H<>$6\H;KPMZT-T] MA:BCT[4P,ZXWB%JT0CU4%'/OZ:E9Q$"A>R:A,*SFMY/9-G,:T-94;O2FE[D2?WKM?H*:+QOR'^O^+-.S4C?8=V MK1GG*YK9MU@O4R_SX):YAJ[8K-EV=[B?9MO_8P?\%MZU.N:?0%OF5FUMF0?] MKCGJ#9M- DW/E2%LC_KF<%BUZ9&F9U/I6;4]DJ9D4REIF:V^90X[5<^)'5$# M_$-Q#YMRK+FY(VC4:-0<(&KJB[!JZR>6E1J%07Z1*&]+GA3JP2J:G;?P^;?)GKJF^#L,CM$HQR8L!-^%SD+JMZK M=SK,]GS0ZIJ]3M5DW X@T;WTE_?2[X_,44O?=]!@&FF#N$/^MZCI<[>[I6Z% MNY& XXOSKGP/CYW1T2B([GPU['.6UPQIMM4J8>H1#1]-'V:0I\^Q$WM+65W-)$.E4C'%YLJ ME9UJOX1U:CN;P.TU\5D+^&R7-VY(BX;0\&9M1BYR MPW3LLT8T]UH%S)IR,>V1V6L?8A&:)G5%R#O=CCEL'^(.L29U51LVZIN]RDU3 M-:D/D-0#:O>PRS+V$G?E!5V^5_BI@3<$[O1"1N7F5;J4-[]E-$ELYQ9O](WC ME/'+A>-T'+,_4\Q4)*'QP8Z<6WD H6.XGDL7H.+EPWA9KTT7L?+-YUD4WGFQ MO!;YGN%MC8X#7B!>U8GW9^;WE.*]KLF#O(XTG-"&M7A(0, <3"VE4B[C_?7% M]>6[JY<7CA,!R+(8RV/Q&R]V_#"&97X%/+SV0^?[[__Y'\A/OZ;QV8UMSU[2 M31'B_MH,P@ M\O"/2W[7=7[9B-9,P#*#><7YN%"[#MHO7I./0,2O<**S>:9Q?L6SV[24[&['ML^4B661P[D08$^^.G5'AF2HZQBP%3\(&^2N6Q,NIF=O!)QW?4[;(DYES MB?YCS*([#R\))T\3&7G\ -, W\:IGY"7B+ 1^3F(2FPAVG\9)G]7MNDV^25 M2^9SU_0UAD=GU\!Q,-$GN@J>> B?3T.7^<(MC0$\QT])G\?@$P=GCAW? L S M%L3"JI!-$M8"2#*S/?<,!>0G\VUU!1 G'#;( C?//ON:WQR.];=_/E4&8 M)C'P!5ZPSNE1^=@Z;]5TM>Z6E,Z3)Q!$/N;,9Q.!AOI4S]_0A%:.EYM0=E.3!NG+]/0! MHJ@!^J$VG7 MTFMX'WL4Q5<8O+<][4R.*K3*B>C W9)G%/P!&16I7[Q/Z6C M.H>H0M:F3YU*YA0(7)\?LJ_,QZ&>Q-KR+/4=&UPO.])8K:2/76PU<=)$'TFW MO3Z\A1T!:H[/]EXI]9C:]FK;JVWO,=G>6L\['DY)>T9*.B5"I[A$>;<^/+* M)X$8M8#:*"F>YD75>,YSGQ74)U\H?0A%+ =1?--$;&QB?&11M+&?4M$3PZ[Q MA4UM+\##)AK/VZQSOKF)V(V='$#IF=;2FK_7WG\S]E%?>>2XO827(]M)4MO7 MB-TF8M\!7KT@]ARME$^F_EL-EX]?D!J#]L\LXHU\-.+K1?Q7%DV-Y]C)(J[: MK5_C?D/<_T$-')Y;=2-^#?NRV7F3;G&[6'==%-D$80=QLJ1J%?DA$[/1XC4\;U7M\*QIL9VJB ,\+:4/1AU5N;T^ M"Z&)HQF_42.<4/U=309&'[<[(4G3)J;!Q-&,WX@1CL7$-"6"T0NFX/VP&Q5KLEI M@MR=C.^D0P<=.IPP^^O0H2DC[-W3:>X(&C4:-0>(FH,.';(.#;;HT#"QO2B_ M&S8476YN>,6O>A_K#,8(=8'6"6P!:G>HP<0Y)$W9W!'VCIH2(U)KE[HCZ1#V M"#7F+7$2SK)9VMW9CYTHFLU.Y^ZRP^E7NO7=GH(+DL1&Q&81_!O&0M/.?C@L MAK>]B6$'#Z8Q9LD]8X%X)EJQX(WOC&YZ_ZEUWFIU37KL^"'=$P_\]ITEXB5^ MR;QQ&4YG,)[@J6[_55R\S![^*%X\;L?&GVF(?D?()_\$1#R#/\XN$6P6&:]3 MWP?F"8S7H1VY!KA3\"/=%O\P'8>^(><:O+J^?';M$ M%)\4RIUV/KR8RS #X<,$1DZ#B#GA3>#]Q5R"A,$W4QO)QZ8S/WQ@#.D]8T%L MHU<)_X@3X#R?7DE"(PB#LSOXB+F2(>:\3^"F,,(WDUL[,5SX#N^F_ZG=ZYB= M-L!Q?^LYM\8],NF,.0D! 6^/F9%#9H1W@D4"6)\Q"=/(H/X%YW4CLZF=+7$" MW@$4/H&Q+BZ,SQ&;L"@"[%&7#=T.=+$=:&!< 'OZAM7+I )XC*LET']O/&#! M)(QB J>H$ T[36[#B+C3#D GL\"=DBX.E^G-"[1E/J-^H^\")XQF841"9:+2 MI!%@L.?X=:X"EWZ4Z\5?3(+/X^IV MC!EVWC$HWG!,QG0MK\#8L! UR*21:5 M%>"'7ARG>(0'WTUG?!T1B#^\E,9H,IYW\-JX7XR8V(G/$0#Z8V(YB:-9QG:D M#TQC9LO8E&Q.R\(HE ]B&JX "EY7U'[&P]Q<*+UC!"9 M*QMP?!OZ:+(QU:#4/V9L09"L1D/\R/=1V<,RO<3G-B4$0S7U?!\Y];DE[RO\ MQ;@#MR(F6C,$@R9$*,KG(C#FY[ME?N:8H'T!'B&3A(/B;RX##V7J"3&!L8F) M^8+C I (#&[<$BA3QFAY!QH0A,HG"* V?IFER6 M.'(13%0^LRB\O 1V%U'CF_S=.'L9 M/(H N>T+F_SV["T@ !7Q6/3'R3>BZW*8&:I)RJ*$684.VZ.7. M&$X@>HJ5;TQ%?8/<@*B P;P/H^\D$WQ *3;%=*@=QRR1FMT>>[Z7H+9(*>2Q MC5N/17;DW#X0(/$#N+)3D]X60.P%AQ$# 4/!5[!R;KQ+(%:S80Q< -IP D99 MKA<+O8$1'!GY^S %C<>]:>;=<=T50Z1/7@NBQ@#\S6R/'B3@M,>@<@ O$E(:6: MCQL;8R0-Q++:Z IF^%KN3XYMGV0+) *PBVK4]@(N3T J[PYLV!T/]N_M"*.Q M O]S%S"29A#=V*0@.4!U?)9&)%=C._9B;KS(+3SSV1WSZ5UN*S,Y0H'D0&2L MBV)8Y-+#[*R_4RJ_)X1:+T$SL2R'HJ9D4)ZXMG2(LOP9=PH\7 QFRJ2Z@]\4 M:FM1*B"Y+9 $P#Y3WQ>*!H,FT_ JFP8NS. BQ MCR*!YN!1.7B":#Q%PR^!:!&B>O"=.)?%<3H5>4K*'!J4X41YS*!QC/,-4N:(T1*O),*)H@ M7A?;+-RW%O3(T*40694ASNHH&2+86<6_0J'A?E7)K42'Y"@U:X/Q\;J>W98O M[JJWL=5M7G/C)4D3XUM<_^4Q)5N"Q\D(M5^1\$\>F7S.0I)Z"7ODV+V&"<@3 M@N\_X>Z#1N^.T*L1NT>XM7K>V;5B/#GT(4\.:4;?)GX_93&PQNLV\?I-R2YH MS&K5W%!";,+B[[(D_04EZ36;;Q6[E)'4.-4XU>KXL-5Q8Q):S\6>K+XF;3^( M;VO$[P?Q'8WXNB]EQ.,8-2.]<:9E=_;\J5-9AW+T42]3+U/W1G@L_;FX<5Y1 MJS:!I_9^M+FY(VC4:-0<(&JVI%2?;+@EKU_N__S*J.E>EC>+%5 /%77N3BX4 M;=:UO]W:KIJMVBBE9N0?.B6'FI#'00BUZ MO$!T2Z/V 'D7'&K=43O/ZLM%FRW/FCZ:/DVACS7JF[W>4%/IQ*E47TC8D%*' M'3'':E<AF74MYH]XIK.L6FY1BUY>FM@[Q18_-.7J- M,]XZXFXBAUHD?1!P:VPT'1O;R=Y6-&TG@-?#/8S6S$4VANG%/KGF^-U4*VJ\ M;A.O[P+C2FZJ:M:)>;NRR<:)>R%.U MO^5A\=!&GG37[(RJGG)M GH.!<'M3L=L60.-85W@>H"X;0\&9M>JZLEK][VA MK'!@"].HT:@Y2=2LJ;2(5!)QS&'[W8U=P2-&HV: T1-?7%,W>>Y]WOAK&Z3VKC;4S2I M&T+J]:YJTZ0^0%(?V>T8FM2ZS_5V&BCOM/7U<^L7XUW@^"FVG1;MK2]#!#RF MWDUVPC"GR]M?AQ/CTXQ%HJR;OXQ4,<1RN@.E?$,IVJ!CFUG+;.7PIMH^^UP. M,JP=$TWM2_[!#NP;PK^1(CF20I]RWE"<($E"@6E\XTT1U?*^SO=*IW+9>CSV M?AQ&X_$GZ7!(7<8W3A4UMB7:6HG"6MK%&LUJ!=@8#,UKA^7HJ2_\EZW=YKO: M[/3 TH\9<[#6$! ]K<@BNV@PU)E?_ YYH"]M )B1MO' [*AJ4X5=8* ]K \# MO2=6O27>W^I^P&;<6;@GZ/Z*V-K M7&B;K])J#Y>?[#F^#&ZFMN]"'^S\7JZCKXG([4'[9]30G4[WYZ-=8W=$:VP/ M.\O7>'S*6/"PZ]UY$/FX];>MWM&J7^N\;8E5@B(^&07\-HPFS$M2X.)CI:S6O W; M"-AO8OD==F&9SM*$[KO$K'(A65^\XY) *DO:/QAV4LP8FS!YEK+.SV_:1K_U M,\2:X3AK S.!']WP/C!()1@3+[ #3-L:[ Z_A8%M'ISBJQ3?]#(X;(-[B> ( M%P9-;N$S]L.+:5E!F##C-O1A(>)J3O:#W^6) ]]Y/KO!.SO#U'?S)[!R0$0V MALO& TJAF++280$<^@!T&#).^_D6T/P'8OF-%SM^&.-7 M7X%&K_W0^?[[?_X'RM"O\N6\HCZ^"-Q+8 , B0&66)Q_GGV-;760W%_8Y+=G M;Z-PBO0X:UGPGR3D?_?/.JUGO^^]GJ:JH<9JIKCD^J MD7Z><:[3<?C''W;DT4[7%U"L*%WD M;N$/;S(U1!!Z>%<_<_J?] ^ODBO8$GPEK9PD#@K7<(R2KHY;8$3 B(XPS M0_LT[)G#5HO&MQTG2FDO781%^+S7LT3;LX1OXX*14>P&O!L:W;;9Z_?,0:]+ MH,2W-CZ"K\%23\/ H--3YP;>51W;4XR[[F!X,$*S- +KA?O#/UF69;8'(_QJ M%K$[+TQC6#:V3T8K#-"%:1(G\ <:MY5X25HZ.\B-I#T%F\T79@VZ9JO;.=>< M-B>HU\P!_+GE:-42NDQ"N5CR(I3IS XRY@4>)$@<.[[EG-=JF2V4.>-15!O/ M<;"\/B6G059M\@OZDL#?*+G,]1(27BY;7-QP2S"6?G$^ +FC$1/%%)@*H4TD MU"IYB\.B$VL9,U V)-I<6<"L09 ""@M9%'Q]^+.0=;&Z[ 4OQM(;V_>ETD*H M[#AF20:CQ!U. :_3?.#D_@D3 8Y)?]F9@LAFF-E1\J E67"DXI502!(;M_8= M,\:,@2;$2 DC&X%_B&%N;GG4A-03P0R $6?U4P9Q"@0=+L<_ODR,RPMRD%)7 M4K^2]Q>Q]561<8&HOV#(B.,./)1;%A DH&WBU(ZQ_H71W@)71:AV,$J5@3J&NP" MRWQX,WH 3@=5X@!SHEH [1:SZ ZTF"H"$=:+P6.NK+F2 U4S\7[P3UR&6A,$ M 5,M,G#']Q!D.P[QI0=48:B&S@W) A-@2%ZE9OML3K5)[=U_%6,* MP$T=$#$8#X(D%I&6R_#B$CJ,Q$L42"(O_DZ-:<,X-A) 13S!- $8 IS$ 5R' M4Q;QQ67J__[6P2;;R2CPA33K22L;/)W=!)A=()T-OT(O>,E#NB"D:BB_X'Z8JDZ?U)++^:% M JH1L[>FT3.5,TN>[4//%DU 87U:^9BH7 MM8*O)3J)\_)T1^6-36+=,39CXL_J, D"F!1K-'Z2.RM!'GILQ* M$R0BJHQOP?IEII+R4.2=D1-7@(!W&A. M!F,.SJ;<_I&7Q_.XP)N*4P_/V2S)#T1]"R@K1*>AR&A>@#-'1T5X2!!!..[) M;*FR PI2.;6_LVPGE*M@#'2F,R['I$?LR81D^%:F5C$NFH61 D%Y2B' FK%L M(Q'F?F074\!-/\F 39;]!5=&S MQUXD?YLRYL(#PN^4#+CZ9<1\ M:@=_R4DP%0A_ISZQ-VY-NQYP1R2#X3!6N*E4-Q85GE2'UY?OKEZ^"S!?!'KY M#TI?'40^*(/9R(#6&O(Q#1ES)>61J$GQ[V.B%N3D4X_G>6>O=H/-8&$VDYD0&*&-A/,69I?4*6FXU/3;O!+Z#<;T(3=>G MZ(T7ST)P1C]-WH-M>H^FZ8*L3_-U8;9<9+KWN67E\&NU^(A:5/EYP2?A&XL@ M6![?K@?.@Y HX0*+KMV,IR4#=]%G.3>NLA<@'G3L*/)PX(3K++$#YS)P7(5W M@!$AS^YFF@H\F$G*(YN0^YWZ)N/)(RL6.&50T&2#7H9F7[ M";PU\#K^4F% %2G32@M++ A8V$!&$_J8%))X)CGA;G?J-+'QJBQ@)=\:1@_\N"R%(ZEV"^N M2DQ!"RKH)C>$E\"7!DK/O 3]74S34Q8,AF W&,4#X;ES/O'(K$T86_0/PS': M&9YHIKGHHFOX'ZHI!*\>(?6X6TC1A2N,9\(HSXV>8L:HM)/BX#;" NO-$1UG M*%GZI)AU .OK>^Q.&$<509(D(&R9XQQG^\](BFQ+ARW9,R#3R6A]2CGH8J2 MMH$AS&+_%3A'6!D9Y#A>Y*13+&AQR/3,^Q4HC13\Y!4KN(N"PY,-_?_;^[;F MMI%DS?>-V/^ \)F.=4= ,NX@>V8Z0I;D"9VU+1W+/1WS- &110G;(, &0,F: M7[^9A0M!"KS@7@"JSYEN200+F5]>JRHK"^7XD"$F)CE>Q%F'\6++&@^6@9S_ MWWK^F,Z\$B#2R83M0GB+VQ]OYDI9QY/@3C<=HN2$EC,L(%W:V?UYBT\69["1 M1?X[WE!E/7CK<%M(D/]M4A3\*V00<9B&]V3 SJ*[O8^"X%'@(LW$T2+] V32 MC"**N'2++7>F4B8J;\UGD@*F2R\NML!"ILV$J@\!/:[ NMS4B]!B+%[,=Z P M([3\,%H_P'(A?5LSZ3&#C:_TDK([&K+G.T5\8'@6'8ILG8<.(O\+'B.9%- $ M//H,_/'&8+#6)[ONNME4C,KWHI51M#=BTZ73>"$B)AVM[,5V'+2ES2?!IO($ MO+OMS0/TZ7-"5A#V,Y0])]JS6VT4QV$LKW^Q_ @+B+AT?UU8.=8LFMSM2?>C M%9,=KQ#&7C%Y$68Z+I(]M,?LDVP5 M0OQME#-ZU&2%;/>%;BJ;C%C?//=V4E3,&>[.D#Y[EILI.H^>9M!CWF(^D+EJ M #/D#)V-)"D]]3K!>@/.V,8WZKTW9 M-3H?0B*+]1X W#@5W.YDMG831.89T,3T#%!DS MA4XZ8PJ\)8E\8"2-N*S'2@K/\S*X7*_QYC0*(OH1BW]0)L0-*!T11Q?N_"9Q M^'<.O)M9QW./()Q1-H0L']SO'%J,WHK*5(_.:!E8O.*R@5&(O%!41N8]VT%B M;9\N[C\*%_>7PG=O9<\$4YZ(0J92*".(B&M=CD2U)21A(Z7WFQ0%1X7Q,H7@ M40G8]IX>I0GL I.G=!DH4YT:G]#8O(O\6-$Z +H>ZSA9M@4+\[%X2PU<#%FN M'.^5D&0K#X;%9"A>G@ZB-"WO&LP@R1$>Z8%,W '=3H3 M4SIJ%!S2U13JD,YBAW3V!6(%\DZM^&R5^"5O3IS=BONM+PI?\)$,Y!'96_MK MN/.927JL-(=-'#AX>LH1Y\M,$R5AK0ZWAK)ET*R,_W[068#EWBR8X<;05&.]V' MMP.Y!RKN@6)3 $5R0:4WIFG3DR$056FK>)H0[3@E7=+/="GCEW!).'R-H\6= M]1HM&L'(7V'DZV3DC5,2MKT2I2T:=,M2?J,^$M^;O'%OII.W;YUF)=M("'DH M4*TER2)7,GO-'Y>NS,Z3MK!@?82NXGG[GB<4'< 5K"RN4XXFO_&"+EWS SM> M>G0"A?E-O$\5N6&Z3L=U/=+U"X@PR90R2+U[DG2B$&@F1XG) ?Y-$-K6?2O( MD3!:TJ.';BI[-""5^\/K=LFUG]:;)E4Z\+4TNA54$4CWZ1YWEL=XY>2-X2;S M;S]N;1Q'@O0,0&:S=&79\S-<4(X6]:E7SDPR-LLC"65I-+%6*\A8H[6)W'"2 MKM)DBH[B$T-ILH^1BQ;NTV!R!)N$[9S5B*AJB.XI4!JXE2160DUCIU5%5DN? MK$@W/9=L^<9$F[:=Y JF*G'&&B6+=D@+O6*_&<_UX"VR$(4"(9WE"#C-V4V1 MKF_NLHX^333@[YOZBJ1G\@$DYO[VR";WZ*%X"G :,%N[]>^ M_L_V]S;'9D!1(=<+TR]O@N9B[3AG-.G96.#[ER>/K@)83N#AE#--<7^FSH:^ M1S@R<-:HHZJ)9!"1.B;(!B/,D](*^/$9K )7%?%T=(2?'SG'V%M%6>?V!APWO@:7 6AK6?= M:"M(K+-^:9*1)J%J4"%00BI4:/PM+CL/N.C5^\Z=2RH_Z;D)$Y(AXC M1/T774U?KZ+&*Z)L3/#(>W;-) T^&T*1OH3GW)-;-DCH8AGU'E1YFR(R'DQTK792J<3!^K1%][:CT7 M7>Z?<3YNA^% XM(6<^F'C1J*P43R3CWJ>3QLYLU6@Z MX\--:S&JP<)#>.GN>'J*6MP\F]DVR'0*%;<\8,8=6"%NZ$>>B>QV9Q1>;>+L MGH=#_X;K>5M ;$W>T'VGT63+\YX+A_O\O]!N60@KHD)W;#,%Q+D%LI2,1#[S MM9_,:Z-J$60K[?R?IBLY%P#0)W&CBJ&; )P2-VCTZ7* WM\! &P#RN[?WQGO M2KS!J= ([CO5[MS[+"B]73?]'PS0]_NN#6D99J=X(\KAF)>22IV9RR1*7)_( M,:^.>=&+M#CF7,_[B'G;>EXBO##>M;O*+3?,:2M#7889Y;=/H[8L&Q;N#1T; MYIWSR]2HS5VO>NPVJ^KZ7%-D/'H#0'(3W.Y58,S>C=7$16ARL7O02KR@Q;OF M2KB-UF#H_PMZ(\A:,>4"XI96Z0558"YZ"_L^36@N'<"^P^U8ZH GS/VX7Y!/ M$\8V*I\V#Q[SSOEE:M3FXJ0B2_580Q4BQG/K7K^N/>6>9&RC\L@Z>,P[YY>I M49N+K V;P_"FG3V\79D[A+&-RK!'X/; [:%/ 5(^UR9\[LEO?.<^I#QAJ3&U_TOF!GC/#/V4NZRS>_6JW@=:UY6.?X.".^'0T]ON:)A0+[S][ M0?"S )1';?HH2HQURTJ(WA%S)U12BD!;[%ET,^7FMF#L+4Y[$M,.&Y00NFZ. M)SOIH]:S93OTG"-M>AJ=_<[TL$CZ8"N>QY=COI,)5<.[7-,AZ#I]_)W!<3?^7->[.'T&-Q M $1@R>>T/R6>)_YS;3];#I[J35H91A @6_/-]::97M/QVVQ?(-&=0-C &R@] M2P=GQVZZ/9;^*>Z&<>@<,Z7DS5EF<>=X]6R?M.+V H?$E=P@N]'PM+=M*L.X M)S>]\9M-23K\2#7;>1/+Y[*V&@8,,17N"_C\=%SK4]]VCADL%70?SA?Q*>]75JBA-=&R]-30,N4!Z' :K 'B9>Q5 MSU>6&RP;U4Q1UZ>B(D][B%%?4)8E&6QZ*NJFUNZB;J_W.6_C=G#]T\N68L6F MD67_(.H-R%,1KVV82 K[ELM0&/X];M?>NF8>7]UHXQTMA155$2>F+LIF'SW MF"0UG8K3J2X:4Y5]+W(T_L=KY&<.6<0(M#?U_^Z%EL.&4U'.%=2CN;>&N49C MRKKSEG;459--T9A,1'G2QUG!V*2E:"KD)U-1,IJ45HYWV92,]&S_K_F>X^D& M;7SS)XDN\0F?=G=A*4W>(JXXB&[2RJM62&]0X%VP^99M:[N&'77!_N+1]LS7 MJ,X%71K']VCSZP[1+9&BHD7! -5#:Z@=K\1WA>UY]!P:,8, M34T.ELD;"KZ2,-K:B&]2MV<"24[<;LYF%O/"3540ERY1J )0E9[; MQT5+IHZ+L0I-/W.EZKE2F9HJ*D;][>"Y5HU9JQ11UC11+[S*Q?6*Z]5AO=)T M19SJ??%7 YS59U/-I*RF;=I/\EUKAACCT'!H M1@D-BWEG%0?[.QT-.^G&S8:CW>JW'88'[7VK(&A@>Q+#$%6]R>X9[([04AN( MJ2G*"C:#X2@WJ,N:))J ]$1JLH<#NR.TII#;LC<&@X-#V$IJVY0I>]BB[F.#HXX>36DG0B$4TA6G?$8VN,T^_IQ]BD MU>]IS-BDU>_IT-BD->9I%4_-V&",0\.A&24T;7:YH$3OUNW3JE$59GM<)2R=UW4E1Q4R>#TYUQ2N*5Q3N*:, M3E/X\92.,[6KJ/R"6TL?K(7[5:XI7%.XIG!-X9K"<[5CN=KFTJ>_?5@'9X^6 MM?KE.JXRO2/^/>X)W'F./7O]#AA^=+S9'[_^[_^%?/PM>?S&?29NZ/FO.\\) M,R !?OE&%G]_]\GWEMA[_$R2X?]#+_K9.%.E=[\B'8W>X80OL/&'E%3*NIV" MPL0]2MNFV?8]5RDT*+; II5NWH+>495>?T4IL<*<*ZFNR(PL'X@OJ++(VOU4 M1W'EEU&=NALP\$;]6WI=T)%S\*M.LG==2,L"*+&0T:^:)C:[SX^$S9J6R4[8 MTHRCCJZUV 7ZF_4"X1E,SK:/6_.R/F<4WKMUOJ.=O145T1# M-EN'F NIB) T790G39[O:"_)82"CZ[[ZKHHNJ-)4--6:5BLYPGFAVY#%R:1) MGSBT>/V-!,1_)K3C@?< KI$$,)&?,=+1>Z!!H8\-)+A\F'(@/%[S>-U_A'F\ M+HK89Q($@N.YCVDC[U MW<>.9"1Z9AX]$R.@&7\-P.&[?_CK53B#X7UO1@@6,]'E%8M2$7HAL W?_HM& M ]:Y\/W)#@1K"3$B%( :X8$0%XB9.6MDP78%/[O3>[X!>5,]N*\<<+=L$'"^ MF,WP34#4G>^Y\..,+.&[0?1-]LL)OQ$L-'%>A8NYMZ(=X=RYIM!BAMCY8<)4SLFU F5<46B<+'R;8<6 T7&\LEV+7<&JK<+[SWV[K;\>2!\ M]. _POM/%___2Q\]<[I:\XD%4BTERL'J$A, M^P&K>6*/(14S$ +&G 0!I%5P\QL]@3F$QG\#=8@D2 48D1UX/5F MN5IO!DJ?B LM<^F\].;V M(Y_!(:*$E?\+BVYY0$G_RYMK&+>?ADA922.9)H M)R3.D$1XRK%024-/L."7F??HVO^!W^FSCFT]V(X=OHI"Q,4+4 9>@W*.FAW M[0%T$0DT\'0*-;$BM8^]2X4E@H%;1[;@X8 M%G#G>D#38@'D -4/KY0(BBVU4?1V(;K#-564#/3T+? !H=^UXQ7KA1U SBV\ M$LL'-4>B;!2OO:1TK. G#Z3Y8L.8.+ 7D)VO/!"P")<"L( O;FIJ4?M1.<_9 M<19=URH+G\B#O[8@/FXB*9I\:O'WOU%28KN&V*"(PF=0$E3;[][*G@D33?DY M47:(CL_V'#Y+38H&R8TYXJ\._7JD!RY0_];\9C26VVB(WL;"4FN(S(6J1J+. M^"R.C1_3=##ZV'L IJG%PZ ^L6(%I13,XW%$T"\8P'(@_L3J#Q^%=*C8&(5G MRUEC>I"20$<05M8K5?%8IS=L;K'OD"#P_ UW4&#A_= 'NRW$1A[P2I^ ML;4"$5JSIXBN)*>"469K<%DT1A,$PTHC!LVRX+%9&'D9*B!\6>R;J>FG>+S8 MC@,)$;S)<[-I6S;;6J3!*0 7'P7ZW RI:.:SFSG= 9K^'<44,A 'U"$-$%&3 M6ASJB@0SWX[883)SVJ*;9T2GP'=)_-#")'P7O4@U,5FGA"RM.4'[047%P)&K MFAC?Z(0U<4!+_ JH"ORZS'S;2+Q)G('X+\PR&W"WK Z2.Z5223N$$T"'H52#:^ MXXRVX@PDE>LJ?->9YGRQ7.LQ2H_6R1PS/=:3=K2.SO?$7:T!U/5R%0D7M"$* M)4&(.'CQGQ]]BV9\\\VT-WSR84**SC^= "?N?V<>O#D\Q-AY(7CI0X[9/QP2 M'C]"U,4I%B.WPK_!,RK?J7;G+^L46VOC0!\$^G[OZEF[,)?89QF.>3%X2(P? MS.L$\[;/XG',N9Z/0<_9W,:O N+UCU6TGHHE0:UO-7=N U6@^^JY14N=.^>W M3Z.V+!L6"B?&AGGG_#(U:H/'_:(]JP8MHJ;(>+16-EY@T28MGI:__D'\F8W[ M,+Y=^'1+4\>KFU''=/VJV!M:=ANMP=#_%_1&D.PV,N "&H(AM =SV:XCNYK0 M7#I0HN]AMRTJ6)PP/WN.%=(2)SYMYM,$=D;ET^;!8]XYOTR-VF0W)P8:2?^T MEX2VYMRMA]:YC=6=;@<]H#JW >Y)V!V51];!8]XYOTR-VEQD;=@P][_H+8 MX1HB*X^IW(>P,RJ/J8/'O'-^F1IU2)/.W18[FW\Y)YTXW)R@+'<"/>U_<+G:OF!O"&"AS0!!"J*F'"0&-=,YP]MJ*^)X08#OCKX%]. ) M=GC.]N.C^M%)?/S, K&=)7)CJ+^$P\]@LNUH63[(P:]Q8P1\?IRF]5RWS=RI M9XP- )JV5DFZN$/NSD_ZB]UCDXF"KH/YRE^EO7),590F>HD&Q,QCR 72XS!8 M!2W9GG)0V] GHJFC" K[%LN0V'X=\O'CF_\ M*M5&PXJJB!-3%V6SCQY@3)*:3L7I5!>-:0_N5#T:_^,U\C.'+&($VIOZ?\=[ M"-AP*J?=*E+S6]I15TTV16,R$>5)'V<%8Y.6HJF0GTQ%R6A26CG>I8D]YKIV MA_?O/^]^Y:,5V+,+=WZ%;R7SP33R_;ZU41QM>=*N\@O/#Y]V=X,I3=X"X@&@ M0;>;YQ$>NWO$20]ZWKZ7;QVWMGO94?O>+Q[M*WN-ZES0M7)\CW;M[1#=$JDR M-Z;*&_WJR)HDF(#V1FNPEP>X(;>FR+IJ:*:I&37>AC&\R<&2WZZR'VMMY:L/N M"!P:#DT/H6EKKM!ESZ2+.8X.3OAE=R(132%:=\1C:]#3[^G'V*35[VG,V*35 M[^G0V*0UYFD53\W88(Q#PZ$9)31MS77:FM=\WFI,V,/HW[E&L#L"AX9#TT-H MVLL\NUQ0HAUS^[1J5(79'E<)2^=U70U2A0Q>3\XUA6L*UQ2N*:/3%'X\I>-, M+;[3@%M+'ZR%^U6N*5Q3N*9P3>&:PG.U8[E:$Y=/%;H::O\-4S?N,W%#SW^] M7/L^_#28*Z52QI"'P*9%9=Z"7@>5WC1%*;'"G-N?KLB,+!^(+ZBRR-I54-O> MA=_[5-#CCJ@G_I9>%_29'/RJ\]E=%]*R $JL&?2K?(C-1N\C8;.F%:D3=@_C MJ*-K+39<_F:]0'@&D[,MIVC->5-=)1F8!234&#^UE>TKNBG*LL:V"/HN3V77 MM!J4IVR(IM22/&OR4%;E5T096FHJG6M##($MO)"#^,Z'-!;P'<(TD@(G\C)'FV0,-"GWLU<#EPY0#X?&:Q^O^(\SC=5'$ M/I,@$!S/?3P+B;\45AYPX+D\6C=YR%J71*FNR@\>LWLK)1ZY>250<:WL:PK! M15U4U'('N4P355N'RZUVR[0N/9?Z/GCFBCP,IS;K(L!2K,-55Y02+)L0:U0KQ0BU>J-6$,;*1X+)9 MP302-MN;6<51QVBS4.MCE!8(5B@\$ C26!*/*<(*GO"*GB4.KA,D9;.T5]72+N"\*R.#4E4=''M\!;!;5;$(CM6HY@@V$386X',Z T[*&> M]G_CG]T16K)@31<5HP>ED'V(QO"_!V+Y5A>56GU1.&4JFG(?>\[W!>#QE4E5 M02NS&S"+]DS(7 @]^&6Y]%P8TIO]T4-E;:FCPD035;WHLG,#A+3??:,W(M)4 M$V14=&6Z51D-+4/(^!3R8_9DN8_@4S _<.%+FY2A=9T=4^&1-A4UE +\+7"_9O(&C&5-0;K?IA=P2V-VG&O') J\37KK7$\O#_$-SW M#4):E[2P7,7RP<@Z546S<#$9LWZ*"_M MQ#1U#31*-S7IN]IU&!SZIXQ-@!HAA_- M!=N%_RZLM=/^G)][],*U;I.)(BIFDPDL%S8SPE9E%?*U:;OAN[[S90?/B>WO M_7T%"#Q;H?U,/MO6@^W8H4V"B_"39?O_M)PUX>?-LN?-$JR$!*Q7?O*,GSRK MX6 (LW1S-%A'HUI^NES:X9(4+ED= :XMTEUBXL,=XE!=P-#Y:]G%W;C"]8\9 M[M=Y"^[DN)/K6CC,''G_W?)]RRV\C\1QKV5-,,CK*O?@"Q^V#*3T2SX1"RL3 MN6S;E>W%.GSR?+I'>U^BWISC7Q'_[UYH.2V#WF!<8V/OC%IQ-SF;OV"SA M*ZHU8M$FW31B^6_+75O^JU"NF]((6G9(K;7L, U-G.H3MD7 Y7EZ[>O4$">3 MH@=BN#Q9E6?1HS-O%JTA&%!SI+ZDAZR4O+$[ H>&0]-#:-J; M8;5VUBPM-?)>L5 85_U>B>4+Q"W:E#115XLN MQC5 ">^SM+_/DC$5IQ+OA<6PC'A ;%#_9=H01--J.LG:C 4,;YYW[=A+V[7P MNDFO='Y M) R)W;3P'5/'ICXZ$2X?+A]6Y&/ O$FI:76'"ZFO0AK>W#13V5GUIDP6M+TE M/9- S_B=54UV!M=%S6SRQAMV1QB(JV1WA)8 5B1159KL;L_BO'"PJM SQC@T M')I10C.\#)U7"59/)S51G3;9OI?=$5HZN:2JHB3SNSSX^F ?L55,4]3DL:7J M51#C98)E:U(5332E)EO1LCM"2PBKICAMU)C9'8&'HKYCJQB*:#2ZM#R\"1(O MK^/FS"BV[W5%$76SIHE1%4IX>1W7?Z[_O+R.E]=Q)\+EP^7#F'QD51%EM8\E M-5Q*?'9Z:NO$[!5%;(1C?G'8@;4892KJ2A^+T+BH"U*N:JHX4?JX0\Q%732& M30U1+]PTE8NZAZ(V:;N')LO8<]*5^NY]+'N58W(EY/WES75FD.16D-MU&(26 MB]< #N8*R.^;.QUQO<-RG+0H2O V_%)BK)SK(NV@VYL>]RPG\2L@>WMQ1B_H M9A&-*@[_=SH:*5I^PO ](0,5,E?YNE3^ O3+>FS[.BBN\?VAFT4TJFC\]0_B MS^R JWPG0F;F0C!^R6$WN-_Y]JP'ME?MLV$=QK#>Q2.=22Q=>U>1TCM8%Q>LQ9PY9Q#"TYWK^@2&T M\'R9A<7PECR((4J2A/_K(40,^(?6?$(/>KR?D'UTZ0HN\6\Y59' MF/5*O!BJUH43%G,DWHRN?XP- )KAQ=XXX:=E8CSV\MC+8^^08F_U*N2BU<-) MU?';ZN7[)\LG'ZV S"^]Y8JX 6W5<8]GDF]7^&-P,0OM9SM\'4P]3>F*AFRK+D:$K?"-+RW;QG ;' MNNM*Z*(T<>#87L+#OC4+UY;#@:T3V!O U78# M>\:=\FA*I^-9X4@,B1G8[X@OT#4(#GR[P'\G_E)XCSW!@Z+M)SGV%;&G?0&$ M]W+;P)>(+]6.:FA:,Z7P39S*4-@]3]!>!;^JB;(Q$2>%:ZJ;X+LMB50!K!>' M,HH68/=9F$R;U^1<*MJRC,NBGH*"'AXTXF>*!E6ISH\1<.%PQ6=JA!&5KK44 M8/A)M1%9&@\Q# N'*SX3(PPEQ+ R@^%G(;FM\B U%.'P(,7$"$,)4B?,@UK8 MC>*G=5J]':+DCA4+=C>:D-5P%R!V1VCI,H5SO8_WHXQ&_7O0>>+H_(YAA>E3 MIL/N"!P:#DT/H>GUU($?]._T#D'15$Q1*ER3PX+=C29WXE,'/G48L?KSJ0,K M(W2>Z; [ H>&0]-#:'H]=4@[-%AQAX:%9?O",SU:Y"T$+^YR\QA5_ KSM8_[ M$^$3$58PAL<+M$:P!X(G4.3$T1V&[PYO$/8T0YA!Z2Q&XE# M;Y6^1=%6/QIQ--5.YS;9'/3[$PF(8"TA!0D#P2"#A"R%N_%G!U^> Y0O(N\Z_8[##Y;?+7\[U2.<$0M_2_ MY'WO93LF[O9@3"^(SUP;_X58P=HG\UOW&YFM?:A MU/G$JAM0P<=WQ >4'% \4 C[&IT?>UI&W==STBY U]AI&H*\0HJX1L8M84K/Y+6B_ M(5^)27,_%:'UME/_$T5,VBDM$&RW9<$.'-U[>(&] .6$[]]"O/$YO W!RX'M MD&[NGAMKU3JCN>@7.C_"GN#<@]1;1O\0$/^93M@XKC7B^IOK<619H)N[YL8: MMN)$&M$3+H( G#-7\UK1=5=KCBG'E+OCOKMC9A:TWG^FB[&M=T#EP$? *QSX M;H!7.?!M-[KVPM;O1V NM#07SX=RSRMGD[/)ZTT/+7_F7)%8S*NRH%.=EXNQ M.P*'AD/30VAJ79ZGRLI83A=\O'XWZELX5^)91M M1@ 6D.'8LCQ"6SUKIJ*N#*AAS0@1;FO&VM:5']YR:8=X($&PW?@$&BX56NOP MR?/M_Q DR)O]T;K.\H;M;-LSEP^7#RORD:>&J.L3+J612ZF]*2$CI0X-*<=I M;2/;7,M@I^_D8&(!%S(7\JB%;!I3<2KI7-1@H$XL[)G-FN)O#2AQR]?S@DN:$T.NEK_78OZ.9HL(Y& M/0O+!:/N"'#M[SDY-IED1NGC+7RN\FL9.VIEKI!!9O@;$TG7O0RF8>07GGT$NVO%&V]V2\=JI1):Z(Z'="5 MT,P!K*BJ*,DF1YC7WO806\4T14TNFLGS])U15>@98QP:#LTHH1E'^G[MV$O; MI07BF+0[V6Q^YKG 9P ?]3"Z\[RG[]B^UQ5%U,V:TO8JE!3M(#X>&7']'[?^ M\YE#_Q,==D?@T'!H>@C-.&8.E_2X)6U !2]96GB1%;QKJE^Y4@4Y6 M--&4ICW$IS<(JZ8X;73-E-T1>.;?=VP50Q&-PJ62?,6?457H&6,<&@[-**$9 M2=[.F\=VWU:QC]D3EP^7#RORD55%E-4F,V0NI3Y(B<]C^I]VL3L"AX9#TT-H MVIO'M'V>N]N[<'D'5^8N=N&B9D34Y6Z1XZ+NH:@'=G$'%S7C+;B=OC10;K3U M]7OY9^'&G3EK;#L=M[>^])#P@/9NLD*":[I1^VMO(=RNB!^7=43+()!^)?$SJ;IE^:K?SO1W5+X* A)GAOWJN MO_4&?"H>:_;DVG^NR:9/>X][J'^Q7.N1ZHJP1M4)MWJJ1\W/*26A%VL%/G&U MK1;)M:<90:5MT@/[1S^:I&^;=L\[HE=>UF*V?5NI1^P M'Y[VEBJ2-G2['7@:/5SU8T5F6!<)0"\+JD@3S9#47>8;U $CB0$01A3AE5A^ MT08032"@3-I#0#_"=4VZ7^O>135M)_[,#O!&%GM6M.UWJU>F1..IOR!VN 8M'JID MN>?=OVE1PR)XI07J9-G[_O+F^I>O:VR"?[NX V?JAC=!L";SK17LB^!VD5FU M%M:N'7UP \\X#F02:\OY]YWOK< 07]\)*!Z]_R-"Y6J-2G8'UN#- MJ2Z"J=!/@KR-#^5,,I.-#_JSK/Q[!J[56_[[VGV,-QLN'B&NXP]?Z(T,R0.? M+7ON6"\7[OS26ZXL]_6W__LYG$?/'&10D:)_-H9S$OVU,9VSV],\TQ-9+L\R MU824HNC)5L7YZYWRKU@A=\C8ECC ?Y]21N8A39$9OSB/4;/>%/YJ'3+H;D5<6Y<.OE>4X^+WZN7YLWP M_[Z![X R^\&;,&A.=\+@&Z+>V%X<4>\<"VS&G5__N;97J-F_!62Q=C[;"W*J M"28\I4/$EI?\_8OMVLOU^$9_ MM#=AMC"M;T(N/@X)+*$.E[@!S6$O<,LP/Q%[UXL7RY[.N>1P9 (^8P$K!R$()\6SX5)0B< MBBE):A]0HO_Z)[8P2K)GN6"&>9)F_7JG_:L&.'*H[1D2R;/I1S22Q&).P9*E MEM#"S,F%S.GUF_7RQ8*DS@8U+IN!*[HIR]J&\-S!2U-P2L*MR(8I-4;!CKAO MW9D7S"#9 5F>DE%OYQ$GD4;E^G!<] ^[HL^NHJV7D78E>V+?(74_5;5!%]^H M8B/T=,ZY-D[.]0SG^M@XE]]RKG?'>1D7G_^FJ!#I#NN03O;E=TDR\R.P?W%M MY^_O0G]-W@D?NJ55/TCK3N(EG4MR#7'S**$-0Q(IRC_3ZIMO$!Y.]=<;G"#B M8XIA/9+695J @3=NMU<,Y'G/OC'PQ@GF,[ [QSF7ZY@%GDY]*X!=Q=5"/;6X M$\AGV=Z.D<^XM9U _HFVUBKY6'7TR2?D)JXYZIGN%R"?1=T_E7Q&=;\ ^>7B M#*9TVJ2A2)-'_=965JUORY1$-6-?79!OTC.E:-KT-NUB%EYG9Q;?FN[3X&\ K*3,[.\TFZNV]O33:-R42>9/;' M:R&P-:X/"V;?YH"F3J2I9/26ZT/[Q7<^61#?)W.ZJGWRKI(TT;?61H<#R.GE M#'O5Q=3UJ2(/4EVNERO'>R79/9#R.Y'#@24^/WPJ%+*J3$Q=-GN+18X?';=' M.01(98\B2[(D3753&R(Z53S*U)3!HRA#A*6@1YG"/[HQ51N&XBL);]R9MR2? MO2"X>+9L!P\1?/?;3=@S1=.5J9[9)2A(1#,\')A% MY?" 2;/"$@>')U4Y')B:JAA,">%P+I^G2+*FZ;+1 0]7:(0^EB/)"GFCL)7ICBN9)S8EREAEF2J M1F;YL1 A37!QP"SV<&' /,DP5%UAA8O#9K%7%J:LP)R/)2Z*+_X8FF1.S4FV M-+1^+F(;>C/"Q1P/_-+.=VU;R'&2FN6L.:OIE+-&+:EKSIJSKN*<[R/P?GC&OP_3$S*EAWQJ\/ DGG:G5 MY8E:FH1_^# #*2X,YZQ;6.V_")^/'/IQR_EW=.'3=![\YQINV-)?@VUJ.V*?:$8?]HIH2'4O9?4N1MQ\XM7@(HV9>?.)6YI[=J\,TV;05Q"]11PB4 M5OS,@9,F-0CHU/QM^KCX3>+A8$/]K;G*D>O[*' M-3U*$\I1N\7K-[*T;)(:=9B[N8^L;Y@Z3-86!S?NS">TWA8X MG-DKRXF_@]_H@@_5G.*FY,G$'4Z1LD7J]+ZC^:;T][3,^V"9O;PWWSGTXGI) M+H_^0=84!EBK,00S+\8:@_$@Y"K7(=C]\Q'&F2TC60:UN$C"=5B0DSIX2Y*7 M"W?^#;>XLOM8C2].&'JF'/T0)56I/E@9G5'#8.V$>Y+"M[0KQ6BGX7M'4'%K MMRL[F.$ZP)M3;RT[?4F/LXSC9';$55DGP!97M3ERQMEJ25KY7C!#8O1C8'LN MG9O)#=O8R9U%3B:X9X Y[LNOZM7-?^+ZD@T)9B*0=MA5Y]';-9ME(I)>GLW$"=P_>7Z8 MMKJ.:LBR!6.%CO=5W&?/M >6BK M9='[*6^'W<)2JN;+CK.;R/_.]V:$S -DXMC"_@%3AV&6=A!@&0D.LLWH]Q?O M8K&@5]"?6.0PU::9TH%]-!ZVIFB7PY[%73;2]?6VG)@L:\;>^H=]Q+7"4L$] MPMU:OX,E**NY,]6K[_ MFA]4"Y6E'9+#]CNJTG-2*=74E!2]($'1'ECLHVX7&PO#ZQ(\_X%8_I%['0XG M$GBF(=EI._J6&H@J6-68N.YX_%B+R'SK"%Q9YL_B"JR37E*9HE-4Y$Q33577 M*Y%T_6/VA,V4\$*-K^1E,TA9F+2I9LJ[).U]2PU$E:Q\W7$Q7ST7+[TCY1V( MH1E3/5L*NO<-E4@Y13&.N?&WI.0D/;^YUA+F"?9_0 RV"Q8:US.4=AXFH)._ M_K'O5351=]H=4O"<48JZ!.2TYUA\F2(M?K'#I]]<[P$+MS''NG%7,-'Z1H#* M&2A(J"=DD)( MACQ1IT.%X-1^3GEYC*ZH0X4EMHT2L!B2EJWU&"8L6_-07&?^1*P3IVK:5-?, MP>M-"M!R:8=1O03D8R2 IR[6X9/G8R#,;Q.6EQ1IRF2HB.4N;113*553)XHV M&H#J4"EY:NCZ8'5**^V]30/\T^!QJ6!KRA3[X(X&H)*V=FS>W%D>D[XX&OTS M>2:.NKTR'AM+.C;/>4Z&<,13J=UY1#.*IHQJTG$(P^29*^+;SQ:VNHR752QG ML^B2OO/$>[0'G9H7T= FT!U'EEK52XYBR:V(E^13R"9B3P]G4711O>P;]KR MGL ,WNPZE^S0JIBF)B?;5HU1VAT>V]V0#DPQ94F5=$T^N9,(&ZQ4F!7*JF2H MZ;[42$3?U"21">[&+>Z3;[PPM(FN&)/)D)_GA6>2 M=";MFJZBF5(-Q5W#T;46E\>S@I%S&E)Q)U#2+KBCV+/5D-4XY4T3XN'-/**9 M:!T3,UU1=--L#)V(T,[0:&QEEPE.*B1CAFI.S.8R6P;%WC,76HBY$8NZ\HHN M,W*M>;HU;,?>YFRJQJ7D6Q#CAK[;Q=L3CB7#N*PJLBK5NKB>2VN7F/1AF[82 M,\6LO3?L1#;V!)N?=H^-KV\-;V\X-)R'#+_^)HTFHT?/-3$8$^S MV^2OVQR^N2?AA/L_H\8NV4/XU7AI!QIU;\J1D?V^/L#[H&@8B>OERO%>";D' M,[%G)+D*$EOR+%&SJ)U\]>B-%&1^\6+Y\^"[%UI.]G,\T?_5"_]%0K2O1S !/#,6Y\W=:M(YA6G M*H\"/D.9&F92A52"F[?-^?(POT E>Z1^]^/KYI&X\Q(5Q/6?:YRR;?8):$OO M[T^6&^/^#ZJG-VZT8EHMWAN284KFY 3S,G;MJRT&MV]Q:>RE$!]L'Z7;+*P' MM)/M M!O;L6,.B_:=39#RH=E+HJ@>U;9(/W>AYB&;YZ*4BR7&Q"W>^'2Y6H=X2S-,XH4%C"H\4TEX"_J7>4J& (37B)" M!">I)A:L4/COM4L$51(%'%L4EI9K19@*) @AD("&"99@2#\)*]][2+X(+["$ MN??B"KZWAJ$7R4T' L&K0'%@"[Z (0X>_0O&=)W28 G3GX30$U1M>\#P";Y" M?M@!90XP$ @O=O@$'T5W?."@S[9#'@&I%V_MS#>? ,< 0#K&?',- M2(;Y0%AXON"2EWV?GZ>7.I06X:[ZYGT-[S=T/*S<*M3G*U/MM6FEM5,UD7=* M;/?JQHKG&8\9+(, %@0G&+GN0>B4!7-;)28533"&CL/ MC]5$&SL7R2!$#5KMV&&LR9";:>/:5]L>J*XH@^:N3%-LIA5TM(DQ3T;JA&4\ MKKT!TV^BJ^FMNW7]<+A9 "K<<*&VUEYMM=D]P/L (&_"XJ6 M(>GLTH$3%"WQRS6_^3N\)%@0/_A*"CFW!O9PVWS]9(JR$8F-.B)OSD"3)FSHD- (>&-^@&@!#KG4:*X#(^0(RP65Z ME)[,0C+'0J*BL!1=#4F^]\5V[>5Z&0/XZYWQ)2=J[*&169ZL'UL\*?_JGJ?# ML>77.[UV&@L6OM:C0"<7R4I*WF6,^QA@B^,M]3J5XVE>-_A6^#VH>A7E:'8F MQ1.Y*B,K69GDY<[5V(K,]Y^> QJ'A'ZSPL*GR^NVT3O@ KYI/9*WY[W.)WD] MRX^RU ,P]JC$ 3#4L\RFE*_L9WM.W'D+"J].(-^5 MC>EIS)]H[%GZF^;[U.EX^UQ]LX,_/OF$)#T2&??EF&^I1R):'DO,0U'!85G)N^^F'PR7DK"L'*YF>[&/]LW$,U&G M=-<]K*"9PI'3&-G7)/C.>L6EJLNU[^,YH/SITN1D%O]I^3:.AZ\OVT58US/> M)I_.76[N?&]&R#Q "=U;#KE=7#Q;MH/? !7 OVQZEA[HAYP5:[L\R[*LF!F? M4Y2A!!#'=O_X9>%Y(9[(^@R_"#_HG\+7%?G[.^ 87E_,>#[YQ[_N,'!>+]!_SX S[X+AX^>8'CS;;&A=^MT/.389]\9/*_ M,C?;17\'\HF37G/U;_C69DV_W-!R\0F5\=6WB.V/4.W MBZV\'UOY$+;)F%LD@NU[:W#C1>QME[@,1"D9/Y8._-U]!(MVSWZ[?_?K]R<2 M$,%:>FNL;_')"MZ,[AP/E1*ZG2 *]D*PW%=1>"#A"R%N_%FT"A4?_<1SE7^A M#0A$^C'6[N'1S*7E_T'"S?E0_ Q/]L)X_P=#/;9B%@*Z%P,_;)U0%:Q ^'/M MX:E4+WHG]K _@Q_.+I%:X@L?UXY#0ML5/GJ6/P6-E#P4<.!(/S/W^7#\O.7S$4P"=_^X ,V[_@O^'7_P]02P,$ M% @ 67D/27$0SBKX#0 <(L !$ !S8VEE+3(P,38P-C,P+GAS9.T= M:V_;./+S'7#_@1?@L+T/CNTDS3;9=!=N'H7ODCB;N.UBORQHB;:)RJ1+2K'= M7W]#ZOTP+3EVHFM<%(5,S@SGQ>%P1+%GO\TG#GHD0E+.WN^U]UM[B#"+VY2- MWN]]>FAT'LZ[W3WTVZ__^#N"/V?_;#30%26.?8HNN-7HLB'_!=WB"3E%'PDC M KM<_((^8\=3+?R*.D2@A^)LSFXM-]-Z([ M=MWI:;,YF\WV&7_$,RZ^RGV+ER/WP#UAD8@6R'>)#EKMX];Q80NU6[^CWP_0 MQ=7M_GP(@EQ@%V!4][\.+EKOX)]VN]\^.&V?G+9._BPYH(M=3T8#MN;O6JVC M5JO5+H=^0Z45(9\(L'?>!68S^04?G]/!WC'SKMR'Z??SCCVY>?AH]8_^XP]Y)JTQF6 $MF?R_5Y"G;/#?2Y& MS0/@KOG'S?6#AMOS 4_G#F5?B\#;)R"W3;\S!4H+08]]4!J"VB0#)XFU/^*/3>@ ^/91H]5N M'+9#<$\V1AA/(Y0AE@--.NA0*,=I%,89\R;%@MJN:+J+*6D"4 .@B*!6A+<: M*8V@O#K"D%-BN0)+B\+4)C!1)LW0X6&V.V1"F'O%Q>2"#+'G@%J_>=BA0TKL M/>1B,2*N\D0YQ18I13-T:LP8!]^'^1ZTJ+;IE()S0\/?SI07G KND#Y(@-0# M3'+3" JD"?/#4QQWF'W)7.HNU&01$SW.'J+V^STCA!H9^-!CVV1(&=4,MOP_ M,"=1B)Y\Q,Q&/BV4(';6S)))$/33W*G;U\,=%B#=F+@4>"[0?;K?;(C#=0R!WJ2&^/&O!.6 M-VI1-V.<8ABSE=Y6M)(R4G*4GU P#GKC[0R6GD3G6(ZO'#Z3^4D4=YG-<[S. M)%+$D::^FT7:*+>P:Q&D-_S@2!-)E@L()#1$8.TW<*0^EH6]R!?9:,[ M\'? "*=3.5BSH=YE#150U6$NIHMBPBBD_(K-=$WQ@#HP4FB+9(-9X2=9A2=0 M7[%&ER_N55?T=BOGTD7+]2O6]16F0M>@;@A6*M+KIJ_MXBZSOMM9?2LB?I$+ M)17K-<';R#)-P^$NGR,G3C7:M;N87X) M#/&13^!5:[A,DK%.8E(N06D?K9^@H#?ATVO._=.S87)9VH^+.TVJSVW"5Y2-]H9H##M3)K !& V M0FZ#NR0[W9FA;)GH@KB8.O(6"U6I?B15RD8Y7+/QQ2$V-*+9C7+EAPIN!, !APHZY!$%3*($ ME\CEP:*A&44!IRA@-7+(G1M6<(H.=-C4\=3\?2"6)W1&>CFW',\F]I7@$W7: MS/-UU!M>8L& D+PC0F=23_/(#0UN=LYF3]=FRE.FDT 9I/EJF:I>LTN]2VV M0F**!$?<>L,+,@!Y08DR->=0>/@.'N-1=O-IE26E,HJ@C]K? M0\A%>9N:\A/BY*IS/K8ILMF:L$%ELRLZ$/1D.)X793<*6)DZ68]#DN M!VJV:*X>MO1M7&))]BGOK)11?6&6F\A- UB[XT;H/7:O*H<"9H-^998*Z=L> MQ.P9N0+6,L]8GG$G\_*0+X3=)"7.4,1<\-9PMSZL\J_S,68C(KLLH> OU!TG MJD>?&!]((A[5*_0NFWIN%==Z$GVS5^6*7R6\*F '49;RJ!EPE"J8)7E"/E,[ M9RH1K.*-<8?908J>KY65BTDE:9F=)%=N*Q=Z$AM\51H/1B^LU;UF=\B>QEUV MPF %E-F$N0I<[@SOC[W)5_^H2QCNR1#IRQM.U4T"[_B725K@^K^&P"+7ANQ"0RC 07 _F9UGGW\J]S#A@0MF#K M LOLD C8*NO"F;_G"O5;7_UT"O&0'I!W>_<\(99&ABT77)1&&#&B")@RCJ*25\%-R;AJ 40$SB MW9#OWS&CC%Q^\ZB[".7)-]=5@+2Z+^@CM0FS88O<@48L9"A1";BZBMB9P-R@ MWX/C=:LVA MP": ]87:LHDOYY:NI?2&B4ARRUVBO@[H6!:P:W>92R#1=_O\ELQT7RCRVMBU MU8GH[]/[9.Y^<,"CHVE=$KB"M+Y8 M_F5]IVY(8P."1:?AU&*H!]/'YA8YH4!$;W@'!F%N5TI/70(9+"?%?>5SA62TH!"3 M1D1LD.6.;>L=,W9,S"^%>FDQOG#Q%;SB'$^IBYWH.A.?^V6=MH:U*SG% &\M-.$9_^)K3[B@-1.:Z6C M8LU(@WY8Q""P\.M;46=8V-$[DL3G2E=<# G5$3@*8-NC7SW:0:B#?DM-V@U, M-S\@]XF81),LU?3RGJGS=C\^77CJY;,_:[3"E3)AP71[0]C*J]6I=!Q-63!)1NT2EV @D*,OB2 ML'4557E7%\*>T#[B9 9!=(NZW/(-B!]2?5G-\K54%]ZX['V%M=_'QC')MESQT3T(1X'WQ%< MSJ=4*-'319#G'/!'5BYD4%0^KWKS0_[P"E;2^1/[V12<&O+'5;"^!4B&OI2Y MZTAWA@ZG=XK;5W]UAEYZR_I"N@CB;)W,LX2E5VN@(%+7RT1+F/IQC90(Z$N4 M\4R&*<_(CVN,6ZX/_)%E?OE,IBC+QIKUPHW:8;!: 8.L O(?,6<$C=YAJ OY M!;9<#SOJG=-A2O?//O3+O^]:<2(OVI!'1V+ZQ!HS^LU+%L:>0F+=7--5V_W: M5#6B4DZ/I2J^;JP2N:7BD7G$VM8\-JR%N-[399=SBTC9&W8\=\R%JEMNH3ZV\%\**'V9PLNV0C[D3HZ\')#DEMH P"&,55D#GE?^U28S56LWX TUYC: M#I[!7%;+$6:+3_^]=NVT0&:8^LG4@9\VL0]:[7:8L"C;P[IQ!ZZ>EJT<;/UD M+&!6_;?>&4\T ]5/JHC5Y(TQ:9F,(/63J,"3ZB4 M7"ST69RT"$LZZR=%?\8[PZ%>7[,R%';53X+$(9/X/7!:$B/(_XE$[1(BU3A^ MZ5NXU0$JM,?\C%Q"\H!G:(:F>E8)]NO0T7 MS3+?9V>E6M[]?(R?-?UO\^'Q?U!+ P04 " !9>0])C3<,XY$0 #?R0 M%0 '-C:64M,C Q-C V,S!?8V%L+GAM;.U=47/;-A)^OYG[#SQW;IH^*);L M-$W%H'S@!GW*7E_-'C9/W(P<:GGD_OW1U]N>L.;T>7ED<-# M1#P44(+?'Q%Z],L__OH7!_Z\^UNOYUSX./#.G#%U>Y=D1G]VKM "GSD?,<$, MA93][/R&@DA\0B_\ #-G1!?+ (<8OH@??.:\>CEXA9Q>3X/O;YAXE'VYOESS MG8?A\NSX^/'Q\26A#^B1LF_\I4OUV-W0B+EXS0O4/7=.^H/7_=>G?6?0_]7Y M]<097UR]?)J!(F,40AOQ]=]/QOTW\,]@<#LX.1N\/>N__;?F T,41GS]P/[3 MFW[_5;_?'\3D[P*??#L3_]PACAV A_"S)^Z_/\JH^7CZDK+[XQ.@.O[7YT\W M[APO4,\G B87'Z54@DL9W>#MV[?'\MNT::'ETQT+TF><'J?BK#G#M[ZB?482 M[I]Q*=XGZJ)0>EGM8YS*%N*W7MJL)S[J#4YZIX.73]P[2HTO+"M)>ZB'CP=SJTX6H)?8?[PO6/G..]9/V F'=FSG&(:\3KK1Q9]),$0-# MS''HNRAH)%HI99MRBHZ'!4Q\,ILL16S2@%9)U(ETD]G-'$PQIX$'T7&,9[[K MA]IB*JF[LN8(\?E%0!]K?5%)U*9T5Q!C&9[,/D3<)YASZ)D?$/?AL5.&.0B@ M!7XS+JU:-UHL$%L!FOX]\0%$!-'%=6D$X87<3VD L.)Z,./B9[!=ULBF)VI1N1*63P(<:&)8V;K<_ MW''\1P3*GC_HF*FJ_>'[:+M]M$#9.+W>,AYM%@*-/@ME7YW$U+WVR3^Z",#=MA+%&G'*NW*8M26 M0_C"\X-(@'N#W8C)X'?^Y :1A[T+1A=BG2:*O7TR.T>, ",^Q4Q&HZ[,VJY8 M1BV\+9N((BY$D[%0KSO';/98HQ:Z)"([HVS5E2VJ'M!1KM$T%&N0=B1IQD;) M*LQD-L9W8"P8^[@F'+OR.YA.7 C!_ =IT;2EKK/MS[GCW+'QP*_/HF/)L\.H M>+18$(I"NSI$UW0DRG1S9B MTKGTI5$N$P63MMXP7)-/R+7(T1@87LZ1-%WZ0(\_G,5&EROX(0=J) M63@Y'ATK4+X)FI/X!,1<[T_!SR,*3R$<>^(G#E,+#[[SG(23D[!*Q$X%#ZB; M$S80F]Z4Y4%/9)4[VS/$[^3V=L1[]P@MCX4S'.,@Y.DGTCUZ_4&RR_U=\O'O M0\Y!@!%$/Y W?4" [G @'_M[TFZKV;$Y@<6&'SB0^._\CPBZ9R#\>QB.P+57 M$,%E?ZY61)-\6\&,*PV9ZU &V<3[HT'Z',3H,XKN?45UCA=_E6>JB<&$6E3"_KC#]E M>(E\[_QI*6(3.-$$DERF&0NTB/6@.C4*50,K6(=@LE[%(7/%OLS)P-_JP[B2 M2@^S5T8QT]';/K"D8G6CJRVC3I7EGT6_F#*ZQ"Q<30,4)YHP,BY%+J8<9M14 M=@P[E4&L7F'K4-H,DI2X=4&KM+$=XTMM#E!0ST(H0ICZ^Q!(8Y7 ;>)M,L@@ M/U+J/?I!H,)&A]J.@:42+'T#6(=>9C6B=O O:VM!!C-%*S&,:^].BIC8]:8>OP*6XT*6CTT'EM'IUZQ:W#*C-N9GVK2<)02J>'V4_F,=,S M@'6XR=*'I#!"K!J$JVJLRMJ:7;^>8;"N)^6JV?(I;6QZUE!M_.(B=96JUGG4 MB"X6E.A@4FQI>IJ@#4B5DM:A,?0\7^B-@BGRO4LR0DL_1(K%G$H"T],";6QJ M5+8.HFM1ED&PEQ9;0ZH<+2(Y^&^],EA$2X?6]!Q!&SA]0UB'829-&!*OR:!: M3VEZE-+5;0O-?:=Z!I>(FJBI:-B>DY;4=HTNSW__C/_\$T%7P95.)IH56IF. MY$TM7:J$CHW?'6_K]PE^/V!Y6'GI<*Y6['276C'G18[S#YT7O:G/KL@I]$I/ MH0U'A\Z<-4_GQ1>"(AC L?>#P8JXCXQR/F5TIAI\]R#W9\2^X8RFB@5.!8WII%D7KWJ] MK8-JK=HE@803?X*!2B.F9QM;$P2+&FQWIY)AV,KIL+Y*U9YI7>YP10G-ZU4; M$Q0D9@OV,,.\/GLH-#3=56HA*%;FE6G:IF]5K*X,%Y2%_I_)Z2!UKP'Z7!9V M5:S![,C+=!#0!FL/'6V-%7EU+GR"B MF$+,D+H] B1505?1KA>.3S>7SNJ:C\4Z3V]:2FMUR:XJEM#?MR1_&VU@[# M>AV=Z4JNI@CJV<$Z^#:CA'!!X8$3LOE,^;J.!JGI@J^F(&I;PSH<+R@#.4B\ MT>>N;F&TY\@5%DHU^8!GT.86/54CVHB)Z<*PIMCN8"'K4 8/U)FB;S4S/N,H MD[IJ#EO2TLKIN8Y2>PX')G9/-0^?SVTX_MAPPU'L-V:9?^\D[)T7T6;O\9 [ MJL7SZW,*OMYE1U7P="132[94Q2O:(-.4T0$8/@0EXO( M(\ C^&R]+:R.-GOQ_7\\;1YZ6@!R.U:5QC/;!L Q7C+L^B@^M5GI06S"RM ]O$\-9A_K_U$I0%^BWL%QD^OUXEV'$\1C'_U]FIF4EEXZ4 M+<-K,C"^X[,^#+588 N,=5S0#@Y_&V@A<$^CU^.GYQ)OG M[A--C/LXN4&$RZQ*\4LFWSJMHB'>!6G/9IO]?@'F% MY;I_(>K9E.P,GLOR7!>%/8;[.N=1?*F,?/-LHP2_H.P&LP=?W!; 1@'R%ZI. MWXR-IEL\LV6]G6QIG4>D5UMA3]P'!DE*S3IN57M-C)_9XIW:.M:!&;_S_T^? M>&GE:#6096TU07QF*W#55K$.0!E)1&#!WC@2U[%,8<"AGCQF(_XX$UL4G;09 M&TW8G]DJW$ZVM&\N5F$;L>C .]@ZUN9K-,RMXAMQZ=#](_(9KCP"6A7^]'E8 MNNG&^\AI=,/N9%<'^=*B2PMM]@3VGHSV1?)LOZ8.?QRI=]OBU26 MEE.TUW&K#&5?S\T(G5DV$';V]D U[LVXF$[(=M&Y6/':QH3?RK<3 MNC-/TPG?'N;I+BOHSCQ-8Y!U+X!8F7@;(F4G+XV5#,6G>99=O_ A?(.M8 #?7*>< M[(^+A3D:^&YVKS2GV9MMS1)F\E66#3MGP\_9,.Q8K[*-WISP;[>%+]T6[\KJ MFF\1#?H%$Y>](M2YO*6W49=+/-B66- ZDMC)4W=_+WX1=+N1IL9>E9$Y*9T604 :+P:O=@X7S(OWI "_ ::EZ*^J&*A3]<1]% M8\;=JYD)=BI=7BN"Y.&$+8F6*J$+ V[%:Y6'$K\T>*H4*(RK%2'T<"KHY3]C M<5)ZP*]$L86HQ"G7KC#P-LF'G!?)0YSU4VR)"5K:GQ0'] ;1P5K=>S?N''M1 M "[R56;LV!L^0%I_+RZNC!;QFL$ME2Z<74;X**IRQ*J1U*O<8H6$HH'%H'$B MF&B=BN8DLCD9X9R0)CU,RNDN7M:.@2FTE!9%!-1+'9BNL;BI7VVB>=S-MK_;R, M44S6?"?2R",Y5=7=^79&R]034:[1XV<48N:C0$?R?'/3:Z?EAJ^Z/;M,5>N6 MP-?27H@3DL'CQ9W1.LALM3>];ML,FE)E[<7F"H2?TE#B5'KVH'ZY MIYK&FN[:/I"5%K*O;B1K!;T>:U<7K(-B#W"M[8!7E+AU5\.6-K:IR]4"5U#2 MOOVV[)M;6LLJA477W$*E@763S/,SL(R4\9)%8$!]!]UZ) M*H-%Q0NT"9F:RG0L;XJ5C@TL!^X"N;@9:%D*XW4S>P%6U+W[%](W T0B._9N M:>;RZ!(4!%T]F>F"5VTH]-0Y%!Z;,MJ-3!>4P=\[C)CXI@(1'4+3=:F-,-&W MA'4A;4O/4<,<9]1L+G&P7&'[EF1EHM!T;M%2,,N$TR\$Q>="8"]WHF-U2-,B MMBPIJ "EB49:ZR:&YW[%F1//GO21ME3O%!7*06KG4#R>1*6/61.L#KEM5JQY MT9L)%XLRRZM?3-02%'7*%@XD9W1,HI"'B'C@J4I<"W4DY8INE0 D#W$R3S&+ M:L8"V%64Z4.&N9DC*VP_4KM5U'",KBA/+8HTEZX\<4UFML%ZMYXB9I$14 M\R0/+5WL/D1E3[Y\72L_.2TL:1?*V:MSDR0=%?_<(8[AD_\ 4$L#!!0 ( M %EY#TFRG6,:I", -E_ @ 5 &UL[5W= M<]LXDG^_JOL?>-FZVMD'QY:=9)+LS&W)7W.N2SX].%%, I?X+*"_O@G8FW_\Q[_^B\/_^>7?=G:< M4X_Z[F?GF(UWSH()^[MS0:;TL_,;#6A(8A;^W?E&_$3\AIUZ/@V=(S9]]&E, M^1^R#W]VWKT=O"/.SHY!O]]HX++PZ]79HM^'.'[\O+O[_/S\-F!/Y)F%WZ.W M8V;6W35+PC%=],7%/7'V]P8?]CX<[#F#O7\Z_]QWCD\OWKY,N"#').9MQ)__ M??]X[R/_UV!P,]C_//CT>>_3_QI^,"9Q$BT^N/?R<6_OW=[>WB C_\7W@N^? MQ;_N2$0=#D\0?7Z)O%_?%,1\/GC+POO=?4ZU^]]?SJ_'#W1*=KQ P#2F;^94 MHA<9W>#3IT^[Z5_G3==:OMR%_OP;![MS=A8]\[^Z\8*@V/C];O;'8E-/T76! MZZ3@.233V^)"@W**FNZ+)+DR1#[/($Z/DC;.[%:^'Q!?:O7Z@-(YTS$D; M-\;-)0FY(AYH[(V)7XDU*66=?(HQ2@5,T6@R>A33F &T2J)&N!M-KA^X*AZ8 M[_*)])A.O+$7&[.II&Y*FTCCUV;/6%I5$=7)WP:?CD(XFATGD!32*^,@\ M))''/WL9TH@S8 1^M5YJU6XRG9)PQM'T[@./@TCX[#(>LX1/+\'])?,YK%2O M[DJ]U,G_N4?N/-^+#9B4-*U5DQL,IG9&T"GQPM1?^$))Q.TL'1Z+UK/I0K^V/R*KR M;==K^_+MB)VPF_@SJ,HF3Z*-"(;EAJ=]3=43<7I!ZMU,N+55T.^1]1<.<%Y=1\6D1$$KB]#R"CV/3R6#+?MN3L>@)U"VG6=]8 M9*T4'J[]0XWODI;#B80F([)2)XUS+YWE"K-@WM8=Q@OR47 E?+20*S[=(QF: M=$N?;T]C1P\DN*?165#@]WZ2YI/TNANTK0%5^TJ3DA7/)!S/V98U+C( G+3.#WS%$>O[E*\' MWD4X3N[HCNMQ;4?IP4?^H:)>%KUX0;S+F^[F;7:E'33/]^)C.RZ;$J\BT^O4 M+7"5Z)[U?C,"5HGJ^ Q<.JK,UI6K5).B&)'V]LE'/R M,L_\UU[@"<_HG/]OB6_Z$M/ I>Z<<]%A+;D1_->BI[WLGX&SX\RIBC]R'\W) MNG!*?33+OSP%HL3P/N=R<3K-?SYB_"M!1%WQ4\1\S^5__Y+^^ M7?#*-43/^(\+N7QR1_WTV[=Y8UG;702LIP<#!FSG[5997EK),)PSGP\1PWDH M&Y>?QRR(N5V=^.G7^-BF]^*'.6>3D$VU^LQUQY02%!7,&7GCL)#O;7Y],]A; M\N(S;G2_OHG#1"*R#91._DCXD0T6I<&8B 3._E[GT;D=2&2H"Z"Y!['M M7+@M@JF0$(@'=D&\YKM)&AU>\BYI&%(W#3U]R9UL<":$B6YE1KD=H&7''P!+ M/718)?;!\69W-LS8/MH$*BG1[;NN0 6S#T'U#@-4PTV@DA+=?N@*5##[$%0? M[$(UC"*^W1G>17QW-8YA=,KM;C_9 <38/Y>P"P%@=P'*&#U*0G&H80K#2G-; M:,!*EH$A8QJGWRWRUX>!*_XC9H GXJ=N3WQ$PG#F!?=I>!K&R(C<+F8*+-B& MLH!>@]WAE:601%=T3+WTF.2"QKGTBE&FH.H(<%H10(?<*EZ+K![.+8Q/L55' M\%AC&73=K.J?NR^/Q'-/7AY%B)2/_%'\0,.2K# L!L0=07/LD.5_CB^2@<5^6\IJ+"[N1I>8> ^AG)@L."L6[$ M2!ICAP5B&4+CHV4T8A+<>]Q;R>3CMI/EAW-7\S?&W&?/]U7PZ*GQXV4H P3@ M)P1+CV[-P0Y"@4O5P9Y%/1*+='@%KEZ()$ A CNX&%(\8= MH3 6"^L%BZDQ5FJZ+F%F( F(G=V@1)%=&*EBJR[ALL8WB(+=J,)Q0F_8%?5% MMMREN+] ]2$&F*9+"&FD /&R&X(HC/=C>JLO;=PDGA00@1G:C#^L7#8U& ME8*J2WAIY0!1LQNEX-Y/F%"W"F0@29?P4@L!@F4W(E$%I6[#4Q$7R^F31VPZ M]>+T=I10?DF@DI-U#H:AKIDE00 =@TI& V ,P, MOP,JEG$,ZM3N5G^32#:^V/7V:\*&8>Q]NR$"LVEKF6-A?;JJI.VU%)%JDY7M M:,!TR@(37%9;=@D4*>\@(G;W_D/7315(_$OBN6?!$7GT8J(XW@8(NH2/2@00 M)KN;_2M1I2&@[KSV&M\$)],DC06N5!!>1TQ/VR7P#*4!<;0;!UB7N(I'T26< M .XA7"S?P-/Y2IMG,'37^S.2#,2S$!;X97=%Z'/^O^T59)"7ZBI59SC8I#J# M\U.IY[_UU1KZ:@U]M0:YR'VUAI: ZJLU]-4:M@"HK];05VN0SH5]M8:^6D,+ M4/75&CI0K4&D-9T%?/N8UMS[&I I"V/O3^H>>U&:D:M*&M*0HD_T-Y, 0L[N MRE4V-+Y['86IW&X:IIZ_YV!Z6 +1HX>P@A@XG?RR "FWT3")'U@H#-$4OU6Z MCN$F91_T0]#A=19%256L,II.XE1@'73KT6%4*/M?#:@"82?16N4?]!D107;N M<<_+3>O]9G\0(>%*I_]P#QT#42,(A.:F:1M (E.9IV/OR7-IX$9G7%TA):$L M;"CH=&1XL3#F'O3KL21G5'<-#8CQ E=1!@@^NYD[-/4(%49?@JN0+VLWD M6.-:YP@"!-V#Q\ %M)N2*:>7_$0HOWS_85\T6@R>J2AXJ6( M=V9'^\L>'39Q%GTZ/WT-2.)ZO,G?FGY%8L'":*)Z(;XDW?N*T@GABIW_U,]P^D:%/9.@3&?I$!@"@/I&A<^CTB0R6$QD*SI_NH'6MZ2W^ MTU4ISS@G.^!&@@X5)5D#PZMVB/0"@'C9!6SU%H(.*7G[+F3^*#@'UR;+F23; MW;%XCWS+#K",\^2S0AQE/?Z '@DIQSB/-U.KR2)PQXEXS_J2AA[+@MO9Y7?A M-XTFA8OPU^+IZ_3ZAV;\;-HM?H"WE@[GP2D@5V;/]5N#8;]=-8>P%C<^",9O23PR3B,$7B5NXAB3PNXR5?@#AOBF.PG\4KZ5XDXO"\ M#_X_66="F'EWZ>/I:8?BM^4N&S[Y2J93$LY&DVOO/O FWE@\WI$5=Q:K+ >A M6)"M+-C'5<'RSM*3KF5WSK(_9]EALV(5+E#+>?^TRGN)HF&=&QXQ#O;6%"P[ M/VR:W5/BA:G?_842P4D_\$[X>Q#,@$8:W6FN$-.U%QFJ3Y[ZF2L[X 7,E>)-R MBY:35Q1J8P"'X*%3'8D-S:@59=9)9=4WDU8"1)//B>?ZY#DM"SY]),'LZW^= MQRYXY"UH5"2MGWI#9LLJ\ M:NMWSU>7C%]%V=S:BF0CJK&_$.PH0$ M);&_%U7W;O@G=4ES:BH[F8U&VH< @X5'E]]8/V(HUYUF4,6=\UAZG6EY/*O/ M@%02VJH,9#2ZE ]4226!T+-<)$C(-IH,Q0'@?6K;ZG4.:(Y[@5/*B"VMJ,"F M",U5BKSIH.,FW6;.;S[Q=3BHS5+"?JAL(5O-<=$054_SL+OWO!?9Z\!3]6(1I+ MV^)6-,PRSE"$R%P242[^'W%YX(GXZ<> FO3)':-)WP6N*(V79+Z+/E66.4$K[7'JW(]VY"N[>:L&^7^&64Z[:_G M[%;( NSSG/H\IZ[E.6T1W7PFH2O">>JCA)5FN(\0I#)AJWF19L8>$FX%(N6" MBTTR]2WC>8>S99OBRMBTNH(,I^F>G_]AD)5E M6LR2@BGE4F)":NN 7;\:&',/#I2:CQPE7.SO[0W4B0TJFEN9K:#0O9YMT/QM M/V'%^%H8SP3',7Y-HXG:H6@2</5]4UYO6B AZ89_\O7)?39*H# MI=3,TLPOLW"FYA)G%.P+>3'2>;&9K0KN!DI?8Q-<5>VJ_8KZHGS?)>'>0_$V MP.&L^!?-NENA#^0+P>Z;E%]+K!Z21SZ\1G23^N3=1/EBM);[] MB#4QLZ(,$'ZV"P@L7A7*+_UD]=^O:$3#)^J>LO T$67EYOG8,)B5NT(/[682 MX8S(:),IH%R*/!^B\"Y(EHV\1491U4^A-Y1F),:Y]=M8UO1?WV@4+RXW#1JP M(2YAK@^ QUFL:.]?C M!^HF/AU-?J?>_0-W8H=/-"3W=,A7OFDVB=VP]+)B,8GN-_&T!77S*Q@+%90N M=ZS5-Z]PN8,WSAD3K>>L.3EO3H$Y)V9YW=^4/R=GT,DY7%P305(3NZ#P(?^# MZ_E)FJ"X*&YT\C+V$_[M4VZH8M)(LK*^H\G\83L^':1SAE+W:P7;-]9]D4MG MR:8SY],1C#H%3@71G%>',YN5EB[@@."FR]I8[R_I])=TZKBDL]V0/IS).]!< M^6GRH[@#Q2WH&]MV3\ZQ20*MGM+2-:$60#0QFP[D2C<'/N: -CX#P7QJ?LG[ MHF%(7:,'TV6M+9VA&X_*U3"M7 *4 UTR[>.7O<.HP*C6S=9%B0US6>0?7)HS.J_%*KJN] M4TOWMP-+4ZGYZ[/UB6EP=MF!T.6:QTK!!7/ ;FOL6LTWO>3L>U'$/9$+%BL",:*Q MM*VM7;S&[ID)V[5OV@$EEP,^W'BX/Z56M8+"UB-&Y@K7,0^FC+2A=G6%"17) M[:=.*K[(/:3Y3YLFWP&:3S?F(N]KG1^E^K5TMP-+5;O,03"4 72;WMMUG)9O ME9UZ 0G&'O&7WF%4V +J8HH5.[H=_(P9V6V$ J'^N;_.7NL&Q>!.N^6;COV= M=K2ZQKRG^)'OM%MR=ZM>:E@(M6:(%=L5)VF[3VB([?WK,G+M43C6)AZP?YST+5!P4KSWZ; MUA"(8B%$SF=T\L*](2^BEZ$GK4Z3$6KHL -308BZX_G0P:7\O>*L0,XI"X5@ MH\F$BC]!S]:FAX!5^\$.U19"U1W( :"[HD)<_NE#XHNJ1:-)<T'#YB!>OF)![X]1D51_8$=U0( A:NT]ZSQ?78>!>B8HRQ?)<,)@JJH[ MIQ"%'< MAA%;,3'T@85,3X@=B"I20&A\0K2(%1+QLA]%K"S=62@*]1EW@1W-S>0!-\N@>V#II0%A0G L M.,^%S#5B!P[G-5E <&TFZFR1%Z?-V!R[&A4EP4$R&[\XS)D8TK=2-21T(0/GOCB8% M-WA9^T7AD&S5;T?PKT-(T"X*897V2^$4KE,52K4LSCF65QR515L^J,J8E*NR MY%V+'Y>=6ZG0LBYO) 2>7SZ;MU27J_FYLN11)OK\,PN"&8H*UGV5E[[*BT7D M3HD7IL7V#V>+<7'DDTA3H5I#UH$D6B/!L>6-+9@N7]KD?TM(*HD.657/"13T"C/@68>E.CB:I\]CHLBC](G*;:4-Z MR&S>VSQX3,].'YC/.>&+^,0;>['9DPD?UQZ(*/3T5R?O"]GC"?W#L/W#L(VB ME+[GKJ\RL]+,VL&8V>.K,IFPG8'-WP,2U8BGCUQLDJDO%$7VTHJUA[-EFSQE M*)5L*5[@7OHD,'EELYFOV3GIDL.[FB+G" M1J>"CCYWN$PC6VXUKKSHN]H)4%/A]@E,),86!%SR?,3GK)",C8J;J:GL+-E& MVH< @X5'MQ+7CQCFE;%F5#$O>(V]CFWID-AH=%5[&1OQP6ZGWP T6MZJ/?]G M]T2A?_X/Y^+5/_]G)ESM2U0K+]-A?L#)@'><0;S&W )+>^5*[VV9R ".%01O M/>%_7&S&:K&EX9LEN&HG]EJ']E MR-J4V/%7AKC+&''Y54='^5Z@U,S:@W=&[PM)N07G+LM5Q.9S],D?B;C5P::/ M+!!G8)I'AM1DN)<<(YG7D;);1F>%5]TT!C2W]-:0D<*9B0!(5Y@ZT,&\SM2& M(&;'7"2]LD!]XV\1ZEAI:NO<1CU,5N,S,J;!$57W:QTT]&@T'%XG?#K_QF)1 M_(BWIV%HGO MP+2V04^(X=E*(G =LCJ8?N.*BFAI21$C64T$ MT)^SZ\Z)"@6C29Z#.0K3]T3FYKD\G#HBOD_=P]G\Y9&\H6+SNV7'^&&O1<"Z MSY[J>?P0K>JEG#89\,;S[B%:3"KPCS-HU,0S4FC1,N8>PLIN7>63Z://9I3R M'>(3-ROY+84+EAHCS:XB1#\M%]8O1B*PP];)P$VP_:CK\P)OP#R%F]P6M,N>7)!R%V5.' M:2D Q6M,4LDA^JXAJ)8##!38#=W(C-!HR=80=@T\0 0M4)\!T4!BD)%^,7F M:"F,L@[\)[.J%.6*\/./.(6OH*@"WY>KZ,M5-(I27Z["UO#H?(V!OEP%DN2) M[IL2YM2-OEQ%IXNH6ZM6@?:.E58CD$*R)(WE<7XTBA]H>/- @CPNLXCK9&<= M6\PA=;%@*ZW(W'=L51,X$RZ:T\%OZ:[N+,B*Q-JPQS('/[ Y2A314K9)ZK+>VE6V49<_:B6 M:*ZZ(F_Z1[MV6I&_']5B-U%3W:DCN&PW]X<16Z^,P]Y^JRBJ M[E0:;!:<>]RH;5C&8V_%U515>R*1S6T4*C?7D*\?U6"KJ 5/%?%G# MW*F#O4URI](/.?F7@ 2JI9;0:>*2DP;<-F)O3'RY6@8-J<7YJ?3Q/L^LSS-[ MM7EF?9T M<4Z"&V\[MMX3;IN'\5HV?Q;T8) L.XP7Y:.7M7>7V]L!4 M(>6=W)P7\7.!FSF)ZY"XV!,+G 5/3LI4?Y.HW^&]_AW>8DP>SA9/IJ>%4-0[ M/ T9[AV>D)K& =TN M]C5;(.;=-4HKQ;Q37[[J=^H%W GTB%\X4BII1+U_K]B1I5U]>S,2](BEL79 M@VFD.MI"%F6-77EC6T]/M0ZF1@4@8C5#)@IC>FFYL;/@Y(7OV_@F('I_4WPVV_LU46K !;% H.(^" \V 3" [L/P#0% M85$L[%#]?>?>!- MO#$)XK7HJCK_Z-T&^4W(]D$)SK2C;IRS]&E'?=I1GW;4IQWU:4>O)>UHJYP'/ N?N0P^BM?D6I*]._N;+:3.RL">!>.0=T>/:?;?U@Q._OD?S?046@ =;-1+ MJ4$TJ)TEU8 1O,9F41^0V;W#FP8D?(5YU'GI,11BH,J4G_>;E1Q:?M(A@3M_ MGKR4 =0G]_3)/7URCS9@WB?WM O4*TRM0!"&QY,V@3]B_PHML",G WBL%/,A M0E]3"&6N2'OO$?= M6U>D1-%E.= Y655UC=EQJ8 '9G?B"]?E-)GJ0"DUL^0*R"R5\(2]& M.B\VLY6K:Z#T-39!1PC)&=4PBI+IO,"_B.I2]X:&4X,=&D!Y.["$3O6C(:4$ M$'!(MN8EWHW>P="2=A6Y-1&0Q_4D9O>-^=R3%Q[Y%5?%9H.OW$=7P81EP;E^ MJ:0X]IX\EP;NYI@6>^@VHNN2@$X@.CROO.C[:4CYUCNF(8WBZGC*>N@FGK D M$)[OZ@WYR)@Z9>&$>G'"&=(E+E]?WK_:D_OSUEPSR?$?4T=$Y:UQ M!T=5$F)SY5=YU9UJ0NWM1$^5FE:#@OS@NAY<,$=:M\:NU5H-WTCHB2$OG,0C M%CS1,/;X_W*.N(S"UQE26XK :H8&VT@.G'O<_@P.\;E0?P;7G\&]HC,X MHU?+%;L3.1GN.W,768*9R8"()W9ZD '\VQ7&X*M M^L/7(JM+O+]>U176$]HJ9:0>%JRR".!XLNN5K<0Q]2$8D #Y4J26L[[H?F.P MZ*8Z!8FEQ4BCB.C%"O235@R-JY[S,M&[G)&UN*5RC'S=*?+"7XQ%1 MJ&5._BD9T^&4)8&B+@5$@?>RM0GC$#IVQ\W\L/R2S,3:>Y2$(55A(V^/'AD% MVSA'37J;7E2RH>YQ(FY;9&4>KA\(%R/S5,72,)H4O-;4CTUO:ZBB$=OTBQ[G M&L3#&7N]#-F84C+XPYE,6BM\LQ1#3$&P!57M"C_E& N&, M7!5%*6]'#0%=(>H4=C+><>[MRNM\@>_E#)/F_ Y,?1Q%%^@AK"8)!.A[1( 6 M$PB+JX@IFA!]QZ!4B@'A^$&?TI?_7OSKCD24_^;_ 5!+ P04 " !9>0]) M;TM<@CI/ #D?00 %0 '-C:64M,C Q-C V,S!?;&%B+GAM;.U]>W/D-I+G M_Q=QWP'GW3W;$5)WJ]OSL&=F-ZKU\-1-MZ25U/;-.38<%(F2N&:199(EJ?SI M#P\^0!(O5A6!E-H7%^L>52:8"?R0 !*)S+_^Q],R00\X+^(L_=L71Z_>?(%P M&F91G-[][8M/UX>SZ^/Y_ M4E$$:!4F6XK]]D69?_,>__\__@SM-%]A=T'BSQ=^A[G.(\*+/\+^B'(%G3OV1G<8)S=)PM5PDN M,?F!?_@[],VKHV\"='AHT>X/.(VR_-/5O&GWOBQ7W[U^_?CX^"K-'H+'+/^E M>!5F=LU=9^L\Q$U;1-U3]/;-T1_?_/'=&W3TYC_1?[Y%)V?GKYX61)&3H"0T M].=_>WORYL_D_QP=W1R]_>[HV^_>?/O_+#]8!N6Z:#[XYNG/;]Y\\^;-FR/. M_M_V6<+W^OQ\_7(?W>!D< MQBD=IA!_47/15F1\1]]^^^UK]FM-.J!\NLV3^AOO7M?B-"V37V,-O2!)$7]7 M,/$^9&%0,I09/X.4%/1_'=9DA_1/AT=O#]\=O7HJHB_JSF<]F&<)OL(+Q-3\ MKMRL"'*+F +OB^IO]SE>R(5)\OPUY7^=XCLRXA']T+?T0T=_I!_ZE^K/'X); MG'R!*"6!HU*O;SMM54RO70M[B?,XBT[3[:3N)LL*WJZG!7Y(F<9YC,FFS\)>/>'F+F\\Q7?_V MA17'Z[XFE'>6U^H$>6CHDXKB=9B1%6U5'B:\]SG[(L^6EH)4W9=9D?^?KK^XM\Y!WJ/&A[$F-!/ MG.V__OJZ_9!'F)%]&%[BM#S]=1V7&[HI)=O;M"QF3W&AZ@P]CU.HV8C? 9N. M 0[<+*3L XZ3HI86_42IH>",38?CT>9,P>'>G&E%'YHS*3D<$@RLM.(- M\!2&Z^4ZH>X6=((7<1B7>P-2$<;XL';?,W!0A_[/I^E=<,>.%;.['+-_2,%A M(G8!#CN!*3CTE-[!827>X"S7T*.& 9B9N2$?N%C,\IS(S353.PP4M"Z-C%9< MT<9(";VCR$:Z/H@H+1//W_ =T%RFI9QN9%8 M("F%"^!H1*-0D?SL'1QJF09PH%2(DX'R,AYGZ0/.R_@VP2?XMKS&X3HGNW:L MWP0;N=R>V:U4Z)[@M2S>@35.SN'ION$B&^5;LF*MB6# =D,G.(\?@C)^P/.T M*/,U75BOXN(7S:9(S^(2A+06"(K3I<8 M&J&*B"L+-C!8LY>UC[^:\P Q7G:D:[@/$#OU0;)9'^,T7JZ76HO5HW&)-:EX M(JHZ!&#P(Y.JCY2*!IB=NJ*.!XTU$GYWZH7NB]5Q/-<_@AG_OD3]L6>_P[(# MP9/9#G1IG-H!F7@=.R 2@,&!3*J!'> T4U\OS)8LQI+\<,1CD>:DTU.ZG:8+ ME=K+9\?GS-LW1HW&ZV?#Y!TS8R7MXXCRH"K,K.%BNQ!@2PP5B3XST>UY.R1. M-[<2X3J[6.%W[Y#1"#78EU(<4)II[Q DH*4/@#07F7H&=Y>9-H*W%YHZ:N^P ML!9Q<.O-K0^BA!.;$@5^FJ^Q<*&+%;OV4J-'2^X,.Q9"-\C1T,+ C5G /FI: MA/ 8KXH'V*HS>PSRR.!JZ=$XC>62B=>)W1()O$-%)]7 JE":?7H^%+;C(@VS M(LQ6F !2;3)D5,XLA5K$QD ,2;P/MEZN_G WA =T[0!F!:XPB^FZ#/)R(T96 MO-^(O^C\'R,:+;=W,&XM\L 'P\D0HP/EBQGQ/L+_PPC;%Q&@ MGT*,> ,!^^G#C&S$HCA9LPU<3Y>K)-M@ M\8"E#QA0TSL-'3")W0DB4!&#P:9)PL&V%N2I]D<6*JP/..G1N,2,5#P1)QT" M,-B02=7'0T4##1#G68F+RV 3W";XHKS'>?5O?8REDWN!\28-'#7XV!:W3]]PZ<3LON66$8 "E MDV[P>IO2'I:$F$;J[C<82>&2NR1]'A=%EF\8\M5>.06A,\><5M#&-R>E\HX% MHVA](!R]^3>T:NA12AF 69,/67I7VAD3.:E+6Z(35C0E,CKOZ+$0;O# A) > MWKBT(S>/V6RQB),XT%H1*9DS&Z(1LK$@$AKO"# (-GBX^)BAEG3J"^'NJY3J M>8D: 5IR9TBP$+I!A(86!C+, FK>!/4Y7*)$$W6BI_>+$U7,B8X8,%+T$2<_ M!'D<3/1V3(&5:WZ6D@FK!HP%DS/46"O00,?( 0,_MF(.TU+QT['T+2*PC6W[ MBNTL3H,TC(.D?QHUOQ\V!QE(KR-XQ637B'[VYR:UXZ-LT( M;QZ+ R2T! S?9T&UD)OC)"AT5X@&'I?8M1)?1*J6 0PN;:3LHY#R M\ ( Z/VF0=P&,;YICWO^6JR3 M4G43KJ!QN41(Q1,QT2& ,G6E4DF&O"*;_NC.,A;/KMCJD6RDA/JQH^[X9C"V'59]<#)'(?H(8?*CS? M;P2!SW+\ZQJGH>Y%BA6G)Q^*216%)T7%!@^:1ED'V1Y:*&Y/"0II119_LXTP%B;.@(KLUK_OGW&.>DJ^\W M3&0[LZ=E]F3Y+!12&#\-)SQ4VHBK VC#!-X$OAUM M]",8%OQYG M\_ !+[= MT@2^A6H"!=W>C4;:.RA(>S<.:>^> =+>;8FT=U,[PZH'*,W%G-KWI:)TYNK2 MB]IXMN1DWM%AEDWQ-@@ES:4I+*MSO;XMV-&C/'TPI2M6T#I]JZ$3M_-60T;H M'3\VT@T\:0TM8L2P 61Z[J.B]@@B[9,?.2E4()F>_?2A-'VXOB:03Q.[;<,% M(H,82.5:6!FR0<# M:^.$54:'4W9/F#O)0A9U2;/ LY(Z\W21Y4N6LF)V6Y1Y$)8RS>WXG*%MC!H- MU&R88.!LA*2#:-N*%-4G@]E$UBTMQA>]B*GE:TKRM/:W59*[J9^F$ MK(MHR6B\ \8@V+#:(X-$2\O2Z/J#Q3'!:D[CRB/\] ^\42HWH',+#(68763T MB !!0RZ9 AL5,6+4B)#[0$=MQ^CV7J)6]V=76) )54- _ W$R$L$4BX6E,;G M*%_B/,[(6A>=D*V11I<>G>MQEXK9!T"'"!029)(I(<&)R18B0I3K^[0H-4K!H%G1]!C+Y,(FFJ=![%08A\C/7Q.L^IC'$1!LD_<9"K MC8&:U!4"3,+68%#1@<"%0;A!7#0G1YP>40:OQH%O5L[B!.?'1(2[+%=O'GM4 M;K>.4A&[&\<."0APJ.52;!H9*:II/9XGLN4R2UGH+LNZ65RLRZ(,TBA.94N( M#9/CDX:% KUCAX8#$)@LQ%0=2!@G#X\_0)P9"=P^=Z[<'/+-TAGYFZPHN(;6 M]0Y6*6Y_%SL@!($DDW3*W6RU:E6;6L;B'S5T#;7#C$#I!S$#4>5X:<@ HJ4O MFPDK;(>S=Z3L<$M=DL65'>CI)8+J,K5'Y/1.6BI@YRJZ0^$=(UJQAJ^!*B+T M$R.#$KM0B_4A3O&<_%,9MB A](*.@:!2A#14\%#2%TV#%$J*&"T0N,R* I>% MXJ9/1>2T;H%4P$ZI@0X%&'A(Q1KX6:ZO3V^N(4&A.M9;(6) ZQX8"G&'^.@1 M H.)7#J5RR5@/-_!@,UQ4-S/THC^A]94? @2(F(Q*X^#/-^0PQ@+'U8H;\GK M$E:CU!%A9L4(!G9CI!W D##!P-XL#+,U?S:+B0YD%W:.RVJ6J.:;EL6I ;,0 MOF/'-/1@<&4AY& -K%A0WO )038;;">;FA-6[IH8,#&[4LDG+F+!R2''- M P4P)9&3OG/@1I4@GM?,),?.[[,L>HP3M?8VK&XA9:],%V-F/D"@LQ9VL(,* M2IR"LE=TR[V-;I-X/0=P(:7= D'8^0BIYLLJRB)'[+(EP7M 5M]P8_-SV M[$XKG9_'A^ PZK=K+2XCU%30\3U>KLJIVSO$^ ML0^WN%Q@F4.\2PD&1%KQE$[P%:>& 1[A3;)8VU.;[ HG MY 970:YL!8KM-0Q."T09A2\4PM,20T&/D8196!J5K)#E'-6\@?&"P->W70= MAJ !%;&GI4PBL&()$RC!P$DKGJ[@2L3*,:>XI 5RHKBH=DST3B[,BI+5S?G7 MMW_ZP\&?__06!>Q__I]UBM&[-P>(HH!1_NLWY'\>_>&/%<$)#EE^%?3NB!'] M 08ZVQIYPZ.(:I9J6?Q42%0++R^'.*0'@UH+(36%#IM4B3#@14X;^1I'UMC2 MT#L^&NK%[IT.Y<1@(&624')&I/2H"F0 LI!:@\@W>NQ@XQDO1O^[-5JZT0B" M8PH&;-K"=]2M2Y9Y6OL(IR$14+EOT'"XW8D91>]NQY3D8$R16<;!QNSBX\?Y MSGX\/]WY08,B6=U'_-MO01JG6'MWHR=UEI+.(&R3 MA4Y!YQT:%L(-J[]4U @S\DGKY[(S0;?:FNRI@16'XVJZ)M%EQ30EY# @8B6C M[EC7JW?GQG98@-V?K3#9"!@#+Q=*O@U9[MDR[.NM[,AP "@! ..N_)_!)?_H M:WV6]*-B^!)%>!&',9 (_.:I*5T'/RO6X,T9&"0LY'1S]Z8\'?_[S$?,[?_/NZ.#M-W\Z>/OF3S5Y M7!34GE+3)BY2>ZX&K^@"15E8XI![&!,B2.HNBF+[3"I++(([FZ7&PBLD& M0.4!4U$[]2KJ1>[X%.6D8("MEV_@3VRH$7OE%*$L#9QPPVI]<[5 M]U' [@@ RZNME$]^G"S@[OY-X'B1,H#"W"6TCX[^-&(BGE* MCLXL==VG-%C2=_-D1WI2Q4LHK[>-?&Y#""S5Z,81&)C K)>VD@XB"IJ@%W(N M"7NA,3 V#V/7P;Y1<[RGT7LI'6)<^:YL3K,JYG]^4A,"JG=)BI.,* <):XD M4T+E4*F.R\U)&2(L>3HC?PSR?JR@)8^SP Y;\9M(#Q.#=T"-D=*\:Q/< MO_2*:YVRBXBH;A"&]1.N"T>>9ZTX/5W;CCG)6K!Y!^9X6?7WO< .L(-J.<;3 MJY;#$^ALSJT:T65^I2J((6+)NWYM(LD2(?3 M$;76[%B\XLEP)@5=96V$D'IX@3N*SM,P6^*FI(HA8%=)[39'H%;D;EI *2D8 M/.GE&Z;QIM1(J']3,P"I?G.%'W"Z5KXX:W]V&RW4%:H;$\1_ P.(GD!]!%0_ MPQCMXZPH+Q:52$J#V:%QNP!)Q.NN. (!& 3(I!JN*05+VI!#@L/W>584EWFV M4,81=BA<0D$BF@@$X6=8435#P?I(8!1HQ4A@P.!BA?. /G>MG]4;MA0:>I<0 M,8HM D9)#,:*F"3LXZBA;VHS ,FW>(4+3/J0%E-E,.]"^=AGNFHY8*!L^]Q2F9 0A2:1ELH0]!]$@S MQ4Z*Q\>A8P>+.3<[ X*;M Q M. V2-PK>"9974H/!EU'$P7O9(*G*%RUK!AB8&BS\MAL$S]LMJVT6K-VY2CQY MD'LVV&$! PSW+GT@YPF3OB*E%] ,197"IB4#"IR!@,.B,^1T1SNAAD^6 H'- M>99F737J>G#ZXYX%G]O\PY9J=),2&YC K&NVD@Z.@ZPF7\S]S5]5!NMK&,B; MIR4F_60X PZH'%A%VOY-7:+/@L]/VE>#&O+_"],'];#?1(V*D,H9?VS&%N>+1:L".4S\R(40'D9NF$8VVYGG,5ID(9DLT%OJ.A+X.:% MI<(*V+,[36$R4JE.3A-+7BB0WE)N,Y"KT&3ZE)9%59'V<)58GJ7HR>.[F.9* M81%7P%!-EZ2"KDF8K$JG3W3[O(Z+>^JNIC/^5GG#:>9SZA&V5:/C$S8Q@=E" MV$HZ\ L3/OKB&W=8.&JAO/L^RW(#72HW$*(IEX'>"(!,# (A%M4/P,D^,O^1D&&.J,?/73M_=!$8?L M>)2L2^4#'R.72\!8JB!"R, "9G6SD[./,$;%HY(X'<,;(N:(9R9[%LAC:S0] MI!/9U[DQZG+KU@ AU:3R" 2KFGHNR#;(WT?\C^0 <<\>B3^0-?>.NF7X(R6> M2%EXI 0D"K06>,;E/5_3Q,T7"]85PA,L.VN\;6,NH;^;PB+RMVL)#/!W$M]H MZ77HGC)^;MLDLV^=C@M9 >,LNBZ#O-3MXC1R#@<@H6[@ W2+[^(T!1,U9_N\ MUO.;6JN'M'Y?S]IBQO+U[! P!]4J!00X%/O\>?G).B?B73+]67H,7B"C8/7>7IYM/V;3K/EKVK^@.;MVV#8!:M?6@A+[=25-=K,)/5*O3FDWW/ MT\&Z40#S860'6$P(RQ:A73+O19MQ,V-?ZX4B^N<\2X^#XIXI=K&B=S!RU[.) MV%D4CU'@)E)'2>G=SEJ)-W DTAS?A(&GXD 98X$5N3B+_GM=\+*Q-YFB^$P5 M8J1-*+1%.VXK!&VI9K=VT,A&O*-V5\F5@&ZB:XCYJR/&%EE.36&Q3MB52H'S MASC46T$XEQ1NC[FZL9++M&=R'YX< M4]94>B>PBB74\2[)'TVV(GL7M <(L?'=2J^G!&%$+(0?O:YL< M5V1-HTR(<8'+>$4L/Y7N,L]HBMWH_>93@6G^ 542!F3S7(OQ-,_T%3JPA/.!3=;\?J]I6DO3+=AY)F/C"H'R&L M]ET.S[S4M@4#C]SQ\8\XC>KWQ(IND!$ZK7"B%+13RV1 !09'2M$DKJ5#[EJJ MZ& @I0Y]PM%QMJ1^6YVM4A$[O[!7"CSP$ PHP2!'*YX:/8)C4O2Z%^+C5B!N M@WDEZ\6"N:#:Q[S%699?5^[3B_PX">*EZJIR9!M.4U)LHUXG8<68!L#@=ANI ME7"N[HK(]H^7V*%[OFRYC,O:41$*N=[I)A _D=8+^DM;H *4K\SX@I(_2_LQ MCTO2A0OZ-_ZLEU7VP?U;G9LMXQZ7VO;.)A)MF^-I%FPR+P2 MEY.'((\#>L=/3EGD&):5SN^VO.?$\']+M@?A'27$F-+?XR)9A/^QWEKDEYTI M0A?JQ_\L;#2V"!>4M $@H$VOGFU YZ !,"#?1NK!BWUAM>IL#&EHADT\AM,B M0#DFA[L3S/\[%S)Q"<9;M<>VY79<)&B,2KVB03:L3L'Z@//;K,"ZZ_MQ8KM) MJ^9SC[[5WMO50FL?,FLO\G-,;/\'0 +D^&RHZ"_F6]PJ'F!A+7)F&K%?Z_#XA9]$?#WN! ;X@!L*.\SS MQ2DV4/%UF6-:5+YVX=7YQ%.>@V#&++=U?]@UYA>18Q360]6F)?@8'J%%']P5 M:W.1PKP[++D87_&A8KXV_Y?!9JO5O>&#L;3WU+!;URLF^*=>N<#*%7W%R0!# M+U^3*;J%%T;&ZAV "F6,&.SQ 3[V*(650) 2PDMW9QDS>9REY ]K\K>+ICB- MHI=V;11FI+NN [:+>I>U""YEW^ZZR-[/&:-G04\/NFTO]O'@0]L0@&E@H:@% M]#6M@+'L6XLN.](5,$/!R1ZI?H<<_KJ.&UY89V7!LM^>"(1H2Z)_L8%K6VB)]HDD! 9S/[2;G[[L2Z M49AF>B;0C -+!0U +ZFE:@[T[, MHO?1W7 W)WD68AQ5)R1H1<20FGJ[V@YG.X_S*)W-AQJ4,67]!3":_"7I\>)/@40MJCKX,X M_IZ7/^A8D2;!K.6BRL(S%IH-CT?.6W25@L\7'+5JJ# I90()3)VD]N@L."]# M*5RS**3=*TZ? M BF^(5(=\K4 YCBM .F*41_0]U*C\$"9W[_*%,_U9< MT8WCFG )_VV4$\$^AA\6M+>07 ;DJ"*A_E(*:D^O1.3:S,CLS?,-F57L19?] M /888=9C&2?Z( R?L GE-NC^;X.#_&6.'\ $N.,$EX\>IG&5"\2_!V.UN%ZO M5@G+Z!DD=1+0>;K(\B5;$TT)6FVYG;Z-':=2YU6L'2N8,^4X>0?)7 5NU%:I MZZ1V14)S0*X?VM3LM3LDGI+N',G@*/X.!EH2H>P+M?$;>8J9H'H44R>>K9,LUMES)BKC M=OH4LO0#G^CNFYL'*93_&C.6K@#H,5BBD.-R(?E;UE'\CH#[5AU&IC:,L( YDAI]096 M"CMP0247^5V05ND B?Q%EL114.6WOR1B4Z]1)]=@D#3%@4R.F#VU[7+MWVMW MB)N&O33L?99,H M^KI)!G_6$OVKV!8,D%=)'6B^3C)E0XO*4QH&IQYZH^ =S[R2&@P(C2(J\G%0 M9T'- T@R2(A0%3&E1I[=Q5$;NMX:43N%NU2T8)!F9:\:2QK\)M^/ZLG<(E,$Q, MTWY=9;W&,#IS!HQ2I"VR8,/E'4JC11T4R[#+S.S8U=ZIZ$T=&<:*S'HFY^YX MHP+Z4NLBAW>,C1)S6)FY9?H2<39$^>!MUZ3JF6W>%OS^X6BP@*.9@8/4WAZR MRG4-7D\PV;W%0*(XSH(X9^&Q24,;807D:>C!P,V"R$'^1-HN03& M(VSFX)U=99J9#*"!QS?:M(9.RP :;R:#)@#N(PXH"_,XPX#9<5,/D5ZE\L=/ M=S@-1\4;C6O#:7#1-NIU(HG&- &IMM(/;R;;-I@;N1.*].<@QU"VF1*QS8" M#M1:8SNNA><%:Y,Y[K#!0.SU^K; OZZ)7J?S\AIP2#+ M(.#0PUR3(TX/S@CV%3*>G=7T/D&E/QNKB,'"RGQST<,5##!=82+,&E_A,+M+ MV<,==H&R,8'*@L\EN*S5$$%F9 (#-EM)^Z"K^)# " -VG4@>.\3I6=QNTLS" M=[=D:GHP$+,04K+=:EG X"HDQI4G][B*BU^.K(,Y9^>#\)"Y661$D%XL/67KW(7[ $:_?9K<[VJXIIX^0=U"V\U)Y MBW:\XW=FF8WB%K"HEMP4#U M:9#3Y((TK213V6Z_:>1RB59+%41D&EC H-!.SL$[^(H+??4A*XJO$>'FEA0& MY)H#F>791DGN-HF27NAN-B4Y+1A8&014GJ!AX.<3LENGN]Q;8#!YY:"#^^_Z"*=;- LRE:TJ@SU+//$.)TW8YT/P,#X M91YG.4_U3+1(@J)@C]W8[B/Z[W7!=LC"NV)%1XYOQFWYC^V4[%8#&=<&&(QO M*;@$XQU>(/B]#N]QM$YH 1[I1KI*0[:YH;X#8PC+EHTY/3+MI'#GU+152V!P MO9/X@[-3U1CU!?R(X[M[:L5G#S@/[C!U=:Z7O!0.3:C# ['9:0M5A7;0]WF0 M$A9H:Q>]%B*H9P&#+1DJ=87H?)'6U7F@! M!ZWY/<%Y_!#0?;$XE. MZM9W7J<5 6"M1C\&.?6M%!?KLBC)YI5L:K4P'L_N+/1K"Z6:N*\1O-YAN:7 M6I]5N2+$>]UZ=T38-0W),VW?$&">UN57OTV'OJN@F2MW:4BXK%*Y3_,I MJ%-J;&=M.^-LO_,L)^1(Y93S]9B5S"EH=7!QKC[&Y7TGR;+X/<0^"&V:\JZ;+FS>I3DUHCPF"%>?U\_7R%N<7B\N@Q&G)0]]DIT(YG;,3N$[,YJ@M(_(.)9-D M@TH>C)1BXM.KZU=HQ3BF'OVV*+,M#E0FEH+0&5*T@C8 D5+!P(5.M#X<*EH4NI MMD8DSR(BSUX)%4U3^YRS%Y8< EEEG! MXJZ.B5RXMF))]W?OPZ\1:E#.JZ9"*T8&P]IUJ2$VT1A"RN-Z0\,'#&ZD#A1;!.2IHD MI<3YDOYIMJ2/OQ0]8>!Q7H_+)/Z@+)>* 0S6;*24%NE:!"%& 2.;^,P\3Z/X M(8[6;$=.!=4=Z23$SD_*2H$'A^0!I7=<6(FG/AK'#0<]$%$6&,;G,L_(FEMN M:(Z(DAP-$O^CZ*T^U336M5NJ\SC6S>P3=>5DEJ0D* M$D(! W@TB4X5N%"Y%7@BG2M,;W!P=);E9VL:*EFO\JH#[_AV7)=+V$K-?L6$ M48V >RVDJL-:<'X45XU /,BF>D] KECAULWF]:DFI+.GL,\JB*MA&";;BF MJJ/T_K_C/V?3'KK)G-%IAX^ F4Q3:39(3=W%3Q^#,@Y M-PX2E7]+0>LER95,7&F&*Y$0#-ATTJFS0^?!(UK6U##@PZ;$K7G6W/9GC1C9 M4N?(.'U:X9"^6<;Y4FN5)_J@&^@5/X!-Z$X33 MR/7T[7[WV4]>63=./G7%C[[LB2O15#EMHXH6TIET7_U!"[Z=Y1C/4[+-QT7I M:M;*O_ML9ZVN&R>;M;*/OLQ9J]%45L'P<$%H45P1HYQ03Y6.8Y]:GF7Y LI=.F(H[*;>Q74JTA7.>>3'P9Y"*_=5 MYJ.2CT1SJ,: /E;:0>O%>N M:W8$5]RD:8FYN"#7AK^8?O ME=)L&:<4J@8CC@X1;XW\^MB?,'RJP)@>TF((BLY4T/JL"ZJTSU)",+#423=( MP$ZW#"VP&"E,[.@WN4IJG_C1;%@5I& QI-]\]E!D498$;DSJ6VA)1/1B#NX3 MX 6E-@J0%*AT!I1!A%$ZA469ED%B9%E$V9<#[ ;JC9,"0T61:K%XQ&E$B M8?""&*7@4O0,J-T@Z5N.I!3?D34ELL*22M)A(5KV,SOK9+<%^4P1XA1*L&BC MSCDN+Q:S),D>68KJ8W+LRI8XGT4/['_/TN@RS^Y(IQ;OXR2A>R93!VW3HA>$ M;J^Z%,+CFP-J+;=61&5:8UP<$W_4 V9(!WRQ(A!\<6,D(H MR=*[0_IF!*VRG)HM[X. #;V/77?[J)FA[.T.V*NA@6'K:::@>5J4^9JZYUBI M#H6B4DK7^9T4HO:S.O7(P!Q*U++I,F)_:*8IR^O4-E"@GU@;0*H&=K7[$*=X M7N*E:D^@I/:'J8'(:EPUI$"QU9=/FB&L)4<_40;$.+1HFG LQ.QF-Z2+9D^Q M="!D=/ 68ZV40R>B.,,/$&5 /U$6D%/[+ CUD7EJRBT>G:WM$"G]T! MZ?R.&_H#!]D JTH-]*%R3X?AS^XRG@^%:O.A%?]FP[T.\$B\+^R;2^_TJW+&NH>:=LRN8#%. 4H6.PX MO$-HE)CZ1\O["YI2/<:0I^+FD0-G64[-U\5B@>E/LCS'VS;B[OG$M@JV[R+& MMN =@#N)K4FTQ\I!\@(>*&)M5GF+>*P(7>FRJL7]I%-6@/8*+X,X95%(\*W%Q&6PDQV8K#F=PM!.]P9Z>' ;0K&0<.MXK)G3;%D-/*1]:<<:)L#-/ MPQRS-SX$IF&\"I)*;"JT!D%V?,YP-$:-!DTV3# P-4+2H8NO8J4K*.=M,$8! MMB]\37&>$]]J7I?TMHL8[9#\$-S9>0/U#?@[\]DHICX%ZKB]XW5KD0?OH<(P MIROK7M_@[BG$N-K SM+HBH9ZBC&EBN[0LS@-%K80OA,1K*$'@S8+(15'U@(] MT->L4Y5@ZTV#*HGS25R$U.,A295@S>5L;;57H5E9S2S>D3-.SD'5%&Z]4);' M=S$MY\>. 2BJ.&&8J:YVQQDY@.=E3-9Z_L\BSE)V]%8EDAS![V\IM5!+O9)J MF+T#=%N)!R7K&C)'/A1;@>LX9O/$M&G#DSFT5T]A',T->$?B+E++T<@8J8>$ M-$5S0M39T_>4FW#46OQ#D,?T +3=FBSG]KPVZU0RK-$R5H@ M)!WD%N\(NVM MU8#.%=?W65XVA;3XXS'QN9KN:M.2UVUZK!'J=%-<63!Z1^4VTDJN0VL3".XA M;2\H:'A]JB/T&(#5NU)54X%!D%(TZ>WYBF=CVLM=J]5*>;V^+?"O:\'J7N9X M&:\'(50C>3VMDF9U%&NDFM$[DK:15@JNHN%BRR1S$Z\J/AAFZ3+/0HRC@F9; MTMQSFE]0XR2P$'OI**G">PVNNEUA0+';\7CL,JZ5USXV)E MN]7,_A9$DT+J15+%"0:)H\0=7#"PC1F]:&UNQCQ%F&IC$]KS]<5".#VWZ>>D M.^B=6G0@0F4]%UV0YQN3UT#/XM&K+Q5>X\CO MT(/!EH60@WB->M=-P"4X2&E$61@4]YY6J+V$K(-["V&4=%#XYI.2S-9>[N"QK%=JH+".+]^D]3LX1,WS1,D_GV:D^6*U[ M..HDME3X%0P\+CTY5N*+'APM PPL64JI\1Z'-1\J,YHDFG#R .6I<73Z%-[3 MG/&T4ODY?FQ%TNJIX7*/):,*0S0I68#AR22G$E$T[3CG9(8IQ8^"K8*QW>UM MW(>)$O0;?9'>XU%)G]]!20PKV8!)3$,4P%0;J.[^[E,:+&DZB=_(;"";N#2L M7GJ87>EJ3D]7&"95%!<8*C8P1LM>5FG>D'7+PQ_<;9XG[[!FOSW9EV!LT:=63[VZ96D;C\3]IB4*T@@]5J^XGO>*I^@??M== MO^ ]P?R_>S9V([_]'%;$K;IS'RODJ ]#RQ;L4NG!<8/Y&NDA8T&DX$\RZ5*Z MP4&.< KD@GT2\^=F-.IO/>/IV^VN":W%T1(>H,6LY13%POE[>:DGWMF6UQMI^UYDRO]UDO:YNH4' 26$%IV M;[#7R;$]10O1:[&)197NZR%EZJ*8.E\YU:=1ASMIPLZH0J[->E]FNQ7#_6LJ=S3U?,BQ[NPR3)*@[D['RFO,@6< M??J9":?I7A/S@1FB4=(.4[90/W [CX!<\YPN5TFVP?B:'-P(7NJ*SC@B"RK= MY+&3VWG&4(FC&1$^*FYH7)7X.PUF.\_*?^*2GOCN4AH(Q9;BBQ4[^"GZT=&W MG=9H=MF=G8K/+CX,9JUSJ6U_(K-VT#K-&R9$OA+3JLCD7Y5@=/?8?(C%!,*8 M[O*>FE&+=,<<.>\W+4GU^)QUW^FO:^II;^MB793W.+^Y#]*JMYK>YCL&Q< Y M_+[;]%".N[6;8LK1QR'&1;E6?N#M;I?^O<9+09_NW[,]S#SE5^/.!Z?_^96=ZF:N=[\-9J5WK'!_>C.BR3)J3Z?:V@ 352KXK[S[^[6BO;;G\E:,5!8 ML5:PG/;/=[XVUNE'3.^%<%2E4-?5[84AT@N8UZ,ZW\%@-78 MN@G1#8IO(R*3[7]SA^/"LA7H!J]_( 7#KLP?CR?.WRHWKC9W=_!"O MAZN>$ S>!-? JH]X68^FB\(UJOF9Q-M*]Y#?YUFA>CLSR9>>112MN:OV.0$E MGX%BZ:=7<2*W*8RY=I;E"QRS(A!3A;'KOO2%J@>W:,CI7-E:4>NBI=)6P*TJVVH Q9OUS/?Y;E-%31O6 M:532B3,)QK;#%-,YX7>>TY9#&Z4YV4=>WISS&H )8\8)QF2$3]?YUY_3[!S9 MI1.ME&#Z]9(!B*!U-\F*4%V.*B;Y/"4!-]OUW[:@)O[_/@SM#.5?]>7OL M3-TA\9[XF.BCQ7A6LWW+3M[KE!\IPXN;]]OI#]V%N&NOU#I[G?PCA7A64W^K M#M[KQ!\EP8N;]MMH_X+=K5"/EH!" GVI_GDZ;#VXCT#%_GGJTHE. M8!>!>[M&]]Z:-;T=;>=VDZN>Y9G>[PL'2//C@,UV!%1TWT4+;^QK0V3FE MKB_YY>LS<-\".]4YU+@///94 V6LL1'% 7?PWYZ0"?A M'S LS3Z,:":EG6Q M[Q@73?EP^G]89]S@\#Z-?UWC_F/7W9MSYD_=@]*-7W2'MKS#?D\*]%%\@HLP MCSF(LP5ZJ!GI_XB:KR&R_VGJE"9U?7D8FR"9_B=Q$299LTW"]]M$=6E;AHI+Q(Z8,^&A5VL:#%V]O9*;6\+K_NS%"[[]+& MKKO[-!0'EA^U^W.U845DP8@K9KYRW);BF@&D)N^>.^R&J%8L<%Z).'U#FJ0N+\A/G@[/>^X.'N[G 4Z-Y$KK^-!0PX?J2?P01SB-M@1JEQT* M3&5*V8)4Y'U.$)7(K01H5-%"!3(W M"I!&R-H'CT !PZK5@+\,-M1=<+S.8RST*,H^*,0.8Z2/#%8O80Q D%-[%^ M]"^MHO3*6=&#XYMQ:86V55+$_-@VO#N==Q1\8,SN[G*6))[>0Q9DJY\+46BW MQ B:5DE'XRM,49NA[)$[O@2TL$TVP@X,#RY1&!3W:%4QVX^2.\M#-6BK+8E; M>=$&*WK%EMFEE1FGD A(.TXP%F64N'ULSFV/85,=WS6UOT%6'L_TT@+XC\R88^Q"GOT(/*DS4Y8 M*3O;&A\PS;F^-#@QHR7X4-1$)*,*4@4BU/3V.D@Y28%#ILAC7-Z3/S,9[[.$ M[%**+RNPOP)@;$Q&!A:(Y<(-4VWF^88^O6Q@NNR9F0,4L!W(;9"P\-/B'I,- M2D2P[65,NA.R]G$7<_HR"0?YT-%E8H U:I;2]H>Q84/\V53#B.8IJEA]C-9L MF1$[^AM3ET8]:Y_7T+<+V3H=+N9;M0)K7'=18> 5IV--;'J&@B4E8^$_0OOL MO% U04-/3>^,O,SC\RP])H<

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end